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1 From glycoacetylenes to 
glycoamino acids 
Abstract 
Glycoacetylenes, carbohydrate derivatives functionalized with an acetylene-function 
at one of the ring-carbons, can be synthesized by a range of different methodologies. 
In general, the methods leading to glycoacetylenes comprise the application of 
nucleophilic metal acetylide addition to carbohydrate electrophiles, in particular at 
the anomeric carbon. A sophisticated choice of conditions and metal counterions (e.g. 
magnesium, lithium, zinc and tin) gives selective formation of either  - or β-
configured glycoacetylenes. 
Glycoacetylenes can be applied in different ways for the synthesis of C-glycoamino 
acids. Examples given involve the synthesis of alkane-, alkyne-, tryptophan-, and 
triazole-linked glycoamino acids, as well as conformationally restricted glycoamino 
acids. 
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1.1 Synthesis of glycoacetylenes 
C-Glycosidation is of great significance in the synthesis of optically active 
compounds, since it allows the introduction of carbon chains into sugar chirons.1, 2 A 
C-glycoside results when the anomeric oxygen of a glycoside is replaced by a carbon 
atom (Figure 1.1). Versatile C-glycosidic building blocks are glycoacetylenes, which 
are carbohydrate derivatives functionalized with an acetylene at the anomeric center. 
This chapter will focus on the synthesis of the latter C-glycosides. 
O
RO
OHn
(RO) O
RO
n(RO)
X
X= CH2R', C=CR', or C CR'
~
 
Figure 1.1 Replacement of the anomeric oxygen by a carbon results in a C-glycoside 
Sugar-derived acetylenes are attractive due to the presence of a triple bond that can 
be applied as a handle for attachment to other chiral molecules or carbohydrate 
analogues. In addition, sugar-derived acetylenes are useful chiral scaffolds for the 
synthesis of natural products such as ciguatoxin3, 4 and tautomycin,2 or for the 
preparation of glycosidase inhibitors and lead compounds for drug discovery.5 
In 1958 the first example of a glycosylated acetylene was reported by Zelinsky and 
Meyer,6 prepared by addition of phenylethynylmagnesium bromide to peracetylated 
 -D-glycopyranosyl bromide 1, leading to a 3:1 mixture of β and  –configured 
glycoacetylenes 2 in 49% yield (Scheme 1.1). 
O
AcO
AcO
AcO
AcOBr
BrMg Ph O
AcO
AcO
AcO
OAc
1)
Et2O, ∆
2) Ac2O
Ph
1 2α
O
AcO
AcO
AcO
AcO
Ph
2β(49%)
 
Scheme 1.1 Addition of phenylethynylmagnesium bromide to tetraacetyl- -D-
glycopyranosyl bromide 1 
Decades later Sinaÿ et al.7 achieved a fully stereoselective synthesis of 
C-β-D-glycopyranosylalkynes by the sequential addition of lithium acetylides to 
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gluconolactone 3, followed by deoxygenation of the intermediate hemiacetal using 
triethylsilane and a Lewis acid. The axial attack of hydride to the pyranoid oxonium 
species generated by the Lewis acid proceeded with excellent stereochemical control 
(Scheme 1.2). From compound 4c, a fragment of the antifungal antibiotic ambruticin 
was synthesized after selective reduction of the triple bond to E double bond and 
protective group removal. 
O
BnO
BnO
BnO
BnO
Li R O
BnO
BnO
BnO
BnO
R
O 4a R = (CH2)2OBn
4b R = C6H13
4c R =
THF
OH
O
BnO
BnO
BnO
BnO
R
Et3SiH
BF3·OEt2
CH2Cl2
3 5a-c 6a-c
O
BnO
BnO
BnO
BnO
R
BF3·OEt2
H-
 
Scheme 1.2 Lithium acetylide addition to lactone 3 
The lithium acetylide-mediated synthesis of glycoacetylenes is by far the most 
common method for the synthesis of β-configured glycoacetylenes.8 For the synthesis 
of  -glycoacetylenes, however, a different strategy must be applied. For example, 
lithium acetylide addition onto the readily obtained  -1,2-epoxide 7,9 induced by the 
weak Lewis acid zinc chloride, leads stereoselectively to  -glycoacetylene 8 (Scheme 
1.3).10 The selectivity in the addition can be explained by formation of a zinc acetylide 
intermediate that chelates to the epoxide to form the anomeric β-chloride alkoxy-zinc 
complex B, which is in equilibrium with the ion-pair C. Intramolecular  -directed 
delivery of the alkynyl moiety results in the formation of  -C-glycoside 8.11 
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Scheme 1.3 Zinc-mediated lithium acetylide addition to  -1,2-epoxide 7 
In 1988, Williams et al. reported the alkynylation of mixed acetals with organotin 
acetylides 10.12 Addition of such organotin acetylides to glycopyranosyl bromide 9 in 
the presence of zinc chloride, gave the desired alkynyl glycopyranose 11 with good 
 -selectivity in a moderate yield of 44-61% (Scheme 1.4). Similar addition reactions 
have been reported under the action of a variety of Lewis acids, such as silver 
tetrafluoroborate at low temperature (−30-0 °C),13 or TMSOTf.8, 14 The latter method 
is, in contrast to the acetylide addition onto epoxides, not only more widely 
applicable, but can also be used for the synthesis of glycosamines with an azide at 
C-2.8 
O
BnO
BnO
BnO
BnOBr
ZnCl2
CCl4, ∆
Bu3Sn R
O
BnO
BnO
BnO
BnO
R
10a R = Ph
10b R = C6H13
10c R = CH2OMe
9 11a-c
44-61%
 
Scheme 1.4 Addition of organotin acetylides to glucopyranosyl bromide 9 
McGarvey et al.15 developed an alternative route involving oxidative double bond 
cleavage16 of allylic glycosides 12, readily prepared by allyltin addition to the 
corresponding chloride in the presence of AIBN,17, 18 followed by Seyferth-Gilbert 
homologation with the Bestmann-Ohira reagent to give propargylated glycosides 13 
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(Scheme 1.5). Though such a route is not straightforward, it provides a suitable 
solution to the lack of direct stereoselective propargylation methodology.19 
O
BnO
BnO
BnO
AcHN
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2) K2CO3, MeOH
O
P
N2
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O OMe
O
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BnO
BnO
AcHN
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1) OsO4, NaIO4
THF, H2O
2) K2CO3, MeOH
O
P
N2
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O OMe
(72%)
O
BnO
BnO
BnO
AcHN
O
BnO
BnO
BnO
AcHN
12α
12β
13α
13β
 
Scheme 1.5 Synthesis of propargyl glycosides 
Apart from the oxidation-chain extension methodology presented above, metal-
catalyzed isomerization of the intermediate allylic glycosides was examined (Scheme 
1.6), thereby providing access to the glycoacetylenes 15 via the same sequence of 
conversions. Also by this strategy both  - and β-configured alkynyl glycosides can be 
obtained. 
O
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Scheme 1.6 Isomerization of allylic glycosides and conversion to glycoacetylenes 
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In some specific cases, an epimerization strategy can also be applied to convert  -
configured acetylenes into β-glycosides (Scheme 1.7).3,10,13 Thus, reaction of 
glycoacetylene 16α with dicobalt octacarbonyl leads to the formation of the 
corresponding acetylene-dicobalt hexacarbonyl complex. The latter complex, upon 
treatment with an acid such as TfOH, generated a propargyl cation as stable as the 
triphenylmethyl cation. Consequently, the α-configured alkyne can be readily 
epimerized to the more stable β-configuration via the oxocarbenium ion. The  /β 
ratio (i.e. 1:6) is constant in equilibrium at 40 °C. 
O
AcO
AcO
TMS
O
AcO
AcO
TMS1) Co2(CO)8, CH2Cl2
2) 0.1 equiv TfOH, CH2Cl2
3) I2, THF
16α 16β
OH
AcO
AcO Co(CO)3
Co(CO)3
TMS
+
 
Scheme 1.7 Epimerization from  -linked 16α to β-glycoside 16β 
1.2 Synthesis of C-glycoamino acids 
C-glycosides are often applied as isosteres of natural glycosides in the synthesis of 
glycopeptides. Natural glycopeptides i.e. O- and N-glycopeptides, are rather labile 
with respect to chemical and enzymatic degradation.20,21 C-Glycopeptides are 
therefore interesting isosteres, because of the high stability of the C-glycosidic bond 
against chemical and enzymatic cleavage (Figure 1.2).5 
17α 17β
O
RO
X CO2H
NHBoc
n(RO)
O
RO
X
CO2H
NHBocn(RO)
 
Figure 1.2 Natural  - and β-linked O-glycosyl serines (X = O) and the corresponding 
methylene isosteres (X = CH2). 
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Dondoni et al.5 reported a new expeditious method for the synthesis of β-linked 
C-glycosyl serines employing the ethynyloxazolidine 18 as a homoalanine precursor 
and sugar lactones as glycosidic electrophiles. Thus, acetylene 1822 was converted 
with n-BuLi in THF into the corresponding acetylide thereby leaving the 
configuration of the stereocenter of the oxazolidine ring intact (Scheme 1.8). A slight 
excess (1.3 equiv) of the lithium acetylide was added to D-galactonolactone 19 in THF 
at −30 °C, to afford a mixture of diastereomeric oxazolidinylacetylenes 21 in 64% 
isolated yield. Applying the same conditions to gluconolactone led to the isolation of 
22 in a yield of 73%. The derivatives 21 and 22 were converted into the desired 
β-D-linked C-glycosyl serines 23 and 24 in 4 steps.5 
THF, -30 °C
64-73%
19, 20 21, 22 23, 24
O
BnO
OBn
BnO
R1
O
R2 O
BnO
OBn
BnO
R1
R2 O
BocNO
Boc
N
n-BuLi
OH
18
O
AcO
OAc
AcO
R1
R2
CO2H
NHBoc
 
Scheme 1.8 Galacto-series: for 19, 21 R1 = OBn, R2 = H; for 23 R1 = OAc, R2 = H. Gluco-series: 
for 20, 22 R1 = H, R2 = OBn; for 24 R1 = H, R2 = OAc. 
OHHO
HO
O
OAcHN NH2
CO2H
OHHO
HO
O
OAcHN
CO2HH2N
H
25 26  
Figure 1.3 Conformationally constrained glycosylated amino acids 
In the synthesis of conformationally constrained glycoamino acids 25 and 26 (Figure 
1.3), Halcomb et al.23-25 describes similar lithium acetylide additions on sugar-derived 
lactones, with the difference that oxazolidine 28 and acetal 30 were applied as the 
amino acid precursors and addition is performed in the presence of TMEDA23 or 
HMPA24 (Scheme 1.9). The latter additives have a dual function to avoid removal of 
the silyl protective groups, as well as to make the acetylides more nucleophilic, since 
in the absence of TMEDA and HMPA no addition of the acetylide to lactone 27 
occurred. Both compounds 29 and 31 were obtained mixtures of anomers, although 
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the ratio could not be determined. Precursors 29 and 31 could be converted in several 
steps to 25 and 26, respectively. 
O
BocN
R'R
Li
TMEDA
1) n-BuLi (2.2 equiv.)
HMPA
2) 27O O
C6H4-p-OMe
BocHN
O
OTBDPSTBSO
TBSO
N3OH
O
BocN
R'R
O
OTBDPSTBSO
TBSO
N3OH O
O
NHBoc
C6H4-p-OMe
27
28
29
30 31
O
TBSO
OTBDPS
N3
TBSO
O
 
Scheme 1.9 Lithium acetylide addition to lactone 27 
The perbenzylated β-D-galactopyranosyl-ethyne 33 was prepared by van Boom et 
al.26 based on a procedure of Meldal et al.27 From the nosyl-protected aziridine 
orthoester 32, C-glycosidic amino acid 35 was prepared by ethynylation with the 
acetylide derivative of compound 33 to give the ring-opened product 34 in a yield of 
82% (Scheme 1.10). 
N
O
O
O
oNs
O
OBnBnO
BnO
BnO
O
OBnBnO
BnO
BnO
O
O O
NHoNs
THF
0 °C to rt
33
32
34
O
OBnBnO
BnO
BnO 35
OMe
NHBoc
O
n-BuLi
 
Scheme 1.10 Lithium acetylide addition to aziridine 32 provides a direct precursor to 
glycoamino acid 35 
Our group investigated organozinc couplings of amino acids to carbohydrates,28,29 
involving alkyl iodide derivatives of amino acids and iodo- or bromoacetylene 
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derivatives of the carbohydrate. In the presence of Rieke zinc, insertion in the iodine-
carbon bond takes place, followed by trans-metallation exchange by copper(I). The 
resulting zinc/copper species reacts with the halogenated acetylene to form the 
desired carbon-carbon bond. For example, application of the method to 
bromoglucoacetylene 36 and iodoalanine 37 gave the acetylene-linked glycoamino 
acid 38 in moderate yield.29 Around the same time, Isobe et al.30 published a similar 
reaction (Scheme 1.11) and used the thus formed glucoamino acid 38 for further 
transformation to  -C-glycosyltryptophan 40 using Larock’s palladium-catalyzed 
heteroannulation methodology.31 Interestingly only iso-tryptophan derivative 40 was 
formed instead of the expected tryptophan. 
O
BnO
BnO
BnO
BnO
I
BocHN CO2Me
I
Zn*, CuCN·2LiCl
THF,
–78 °C → 0 °C
O
BnO
BnO
BnO
BnO
O
BnO
BnO
BnO
BnO
NTsHN
CO2Me
Boc
Pd(OAc)2
Ph3P
n-Bu4NCl
Na2CO3
DMF, 100 °C
CO2Me
BocHN
I
NHTs
(43%)
(89%)
36
37
38
39
40
 
Scheme 1.11 Organozinc coupling of acetylene 36 and iodoalanine 37 and the formation of 
tryptophan-linked glycoamino acid 40 
The  - and β-glycoacetylenes described in the previous paragraph were also applied 
by Dondoni et al. in the synthesis of glycoamino acids involving Li-acetylide addition 
to Garner's aldehyde 41.8, 32 An example of this addition is shown in Scheme 1.12, 
which is followed by the subsequent transformation to the desired glycoamino acid 
43, via hydrogenation, deoxygenation, and oxidative cleavage of the oxazolidine 
ring. Following this protocol, a set of 12 different C-glycosyl asparagine isosteres, 
having the amide linkage replaced by an ethylene and six pairs of  - and β-anomers, 
were prepared incorporating gluco-, galacto-, manno- and the corresponding 
2-acetamido-2-deoxygluco-residues. 
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O
BnO
BnO
BnO
AcHN
BocN
OO
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THF, –50 °C
O
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Scheme 1.12 Lithium acetylide addition to Garner's aldehyde 41 
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Scheme 1.13 1,3-Dipolar cycloaddition by Dondoni et al. 
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In 2004, Dondoni33 and our group34 independently reported the synthesis of triazole- 
linked glycoamino acids from glycoacetylenes and azidoamino acids, as described 
extensively in Chapter 3. Dondoni initially studied the 1,3-dipolar cycloadditions by 
heating the glycoacetylenes 44 and 45 and azidomethylene-oxazolidine 46 without 
solvent (Scheme 1.13). Under these conditions, two regioisomers were formed, i.e. the 
1,4- and 1,5-substituted triazoles with a preference for the 1,5-regioisomer 48. 
Cycloaddition to azidoalanine 49 afforded similar regioisomer ratios (conditions a). 
In contrast, the newly developed copper(I)-catalyzed cycloaddition methodology 
(condition b)35, 36 proved highly fruitful, producing only the 1,4-regioisomer 50. 
 
1.3 Purpose and outline of this thesis 
In this thesis, the development of new methods to synthesize stable C-glycoamino 
acids from glycoacetylenes is investigated. The resulting glycoamino acid isosteres 
are incorporated into glycopeptide structures by chemical and enzymatic procedures 
and compared to the natural glycoamino acids in order to evaluate the value of the 
triazole function as an amide isostere. Apart from that, the glycoacetylenes are 
applied in the preparation of two oligomeric glycosides of which the supramolecular 
behavior was studied. 
Chapter 1 gives an overview of the synthesis of glycoacetylenes and their application 
in the synthesis of stable C-glycoamino acids. 
In Chapter 2 ring-closing alkyne metathesis (RCAM) is presented as a new tool to 
synthesize alkyne-linked glycoamino acids. 
The synthesis of triazole-linked glycoamino acids and glycopeptides via copper(I)- 
catalyzed azide–alkyne cycloaddition is described in Chapter 3. 
Chapter 4 delineates the chemoenzymatic transglycosylation of triazole-linked C- 
and N-glycopeptides. Furthermore the resistance towards PNGase digestion of a 
triazole-linked glycopeptide is shown. 
Chapter 5 details the synthesis of oligomeric glucosides via copper(I)-catalyzed 
azide–alkyne cycloaddition. The supramolecular aggregation of these compounds is 
studied. 
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Chapter 6 describes alcalase-mediated enzymatic peptide coupling involving the 
incorporation of nonproteinogenic amino acids, i.e. alkyne-, azide-, and triazole-
linked glycoamino acids. 
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2 Ring-closing alkyne 
metathesis in the synthesis 
of alkyne-linked glycoamino 
acids1 
Abstract 
Synthesis of alkyne-linked glycoamino acids via ring-closing alkyne metathesis is 
investigated. Two different strategies are described to attach alkynylamino acids to 
an alkynylsugar, via a linker at O-4 or O-9 of the alkynylsugar. Subsequent ring-
closing alkyne metathesis of the O-4–linked diynes failed to proceed, but alkyne-
linked glycoamino acids of different chain length were effectively synthesized via 
attachment at O-9. 
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1 Part of this chapter has been published: Groothuys, S.; van den Broek, S.A.M.W.; Kuijpers, 
B.H.M.; IJsselstijn, M.; van Delft, F.L.; Rutjes, F.P.J.T., Synlett 2008, 111. 
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2.1 Introduction 
Rarely a novel synthetic transformation attained wide application in synthetic 
organic chemistry as rapidly as the olefin metathesis reaction for the synthesis of 
unsaturated carbocycles. Although already broadly applied in hydrocarbon industry, 
not until the early 1990s olefin metathesis attained legendary status in synthetic 
chemistry, largely owing to the preparation of the first efficient well-defined catalyst 
by Schrock,1 and to the efforts of Grubbs, who developed air stable catalysts with 
much broader functional group compatibility.2 Not surprisingly, the Nobel Prize in 
chemistry was awarded to Grubbs and Schrock in 2005, as well as to Chauvin, who 
already in 1971 proposed the actual mechanism of olefin metathesis and predicted 
what types of metal compound could act as catalysts.3 The number of applications of 
olefin metathesis in the mid 1990s rose steeply and at present forms an indispensable 
technique in the organic chemistry toolbox. 
A conceptually similar transformation is alkyne metathesis. As indicated by the 
name alkyne metathesis, first reported by Pennella et al. in the late 1960s,4 and 
applied in the synthesis of organic macrocycles by Fürstner et al.,5 involves an 
exchange reaction of alkynes. The inherent advantages of alkyne over alkene 
metathesis reside in the fact that ring-closing alkyne metathesis (RCAM) is 
particularly useful for the synthesis of large (>12-membered) rings without high 
dilution and cannot lead to E,Z-mixtures. More than that, under the proper 
conditions the resulting triple bond can be stereoselectively reduced to either E- or Z-
olefin. However, alkyne metathesis is lagging far behind olefin metathesis in 
popularity, particularly due to the lack of a mild catalyst not requiring stringent 
exclusion of moist or oxygen during reaction. Nevertheless large improvements have 
been achieved. Initially requiring temperatures as high as 400 °C when catalyzed by 
heterogeneous silica-bound tungsten oxides, Mortreux and coworkers later 
discovered6 a soluble Mo(CO)6 alkyne metathesis catalyst able to perform at much 
lower temperatures (Scheme 2.1). 
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Scheme 2.1 Alkyne metathesis by Pennella et al. (A) and Mortreux et al. (B) 
Similar to olefin metathesis,7 Katz postulated a mechanism for alkyne metathesis 
involving the metal alkylidyne complex 7, and a sequence of formal [2+2] 
cycloaddition and cycloreversion steps as indicated for RCAM of a diyne in Scheme 
2.2.8 
 
Scheme 2.2 Mechanism of RCAM based on the proposed alkyne metathesis mechanism 
The mechanism proposed by Katz has been experimentally corroborated by Schrock 
et al.9 following the preparation of the well-defined tungsten catalyst 
[(tBuO)3W≡CCMe3] (8) and demonstration of its applicability in the cross-metathesis 
of 3-heptyne.10 Several intermediate complexes formed by the [2+2] cycloaddition 
were isolated and characterized. Apart from that, it was observed that only internal 
acetylenes undergo metathesis, with terminal acetylenes leading exclusively to 
polymerization.11 Fürstner et al. developed several molybdenum catalysts of the 
general type [Mo{N(tBu)(Ar)}3].12 However, as mentioned, a major drawback of these 
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complexes is the incompatibility with oxygen, nitrogen, moisture, acidic protons, and 
even secondary amides. 
In the last decade, several examples on the application of RCAM for the total 
synthesis of natural products were published, either in combination with partial 
selective reduction of the triple bond to the Z-double bond as in nakadomarin A,13 
sophorolipid lactone,14 and lantrunculin B15 (Figure 2.1) or in combination with other 
post-metathesis transformations, as for citreofuran.16 
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Figure 2.1 Natural products synthesized via RCAM 
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Scheme 2.3 Diaminosuberic acid (9) and derivatives (10-12) by Aguilera et al.17 
An example from our own group in a collaborative effort with van Boom et al. shows 
that RCAM can be successfully applied in the synthesis of diaminosuberic acid 
derivatives 10-12, each with an all-carbon chain mimicking the natural cystine bridge 
(9, Scheme 2.3).17 Along the same line, we showed18, 19 that conformationally 
restricted β-turn peptide mimetics can be obtained by performing RCAM on a 
dialkyne-containing linear peptide 14 as illustrated in Scheme 2.4, an approach 
followed as well by Liskamp et al.20 in the synthesis of a mimic of the lantibiotic 
nisin Z. 
Ring-closing alkyne metathesis  
 19 
BocHN
N
CO2Me
HNO
O
N
H O
Me
BocHN
N
CO2Me
HNO
O
N
H O
Me
Me Me
toluene, 80 °C
(72%)
14
W tBu
OtBu
tBuO
OtBu
8
15
 
Scheme 2.4 Conformationally restricted β-turn mimetics by IJsselstijn et al.18 
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Figure 2.2 Retrosynthesis for alkyne-linked glycoamino acids 
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Scheme 2.5 Synthesis of alkene-linked glycoamino acids via RCM 
The examples above demonstrate the versatility of RCAM as an alternative for olefin 
metathesis, in particular for the synthesis of cycloalkynes or Z-configured alkenes. 
Based on these observations, we became interested in the synthesis of alkyne-linked 
glycoamino acids via RCAM of alkynylglycoside 17 and 2-butynylglycine 18 (Figure 
2.2). Not only is RCAM on carbohydrate derivatives largely unexplored, but the 
resulting alkyne-linked glycoamino acids 16 could also be valuable compounds for 
the assembly of chemically and metabolically stable all-carbon glycopeptide 
isosteres. Moreover, the alkyne-linked glycoamino acids can be chemo- and 
stereoselectively (partially) reduced, giving access to either the E- or the Z-configured 
alkene-linked derivatives from a common precursor.21 Similar C-glycoamino acids 22 
have earlier been prepared via olefin metathesis by Westermann et al.22 (Scheme 2.5). 
However, with longer chains mixtures of E- and Z-cycloalkenes are formed upon 
ring closure. 
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2.2 RCAM of diynes linked at the anomeric center 
Two retrosynthetic strategies were investigated for the assembly of alkyne-linked 
glycoamino acids 16 via RCAM of an alkynylsugar and 2-butynylglycine. One via 
connection to the carbohydrate at the former C-1 position, and the other via the 
former C-6 position (C-4 and C-9 in the alkynylsugar 16, Figure 2.3). 
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Figure 2.3 Retrosynthesis via C-4 and C-9 linkage 
First, the RCAM route of diynes linked via C-4 was investigated. To this end, the 
known lactone 23,23 readily prepared from commercially available tetra-O-benzyl 
glucose by Swern-Moffat oxidation (DMSO, acetic anhydride), was converted into 
alkynylglucoside 24 (Scheme 2.6) by subjection to nucleophilic addition of 
Li-acetylide. The latter nucleophile was generated in situ from 1-bromopropene and 
2 equivalents n-BuLi, similar to the procedure described by Leeuwenburgh et al.24 
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Scheme 2.6 Synthesis of anomerically coupled linkers 
Since it is known that RCAM is suitable for the formation of cycloalkynes of ring 
sizes larger than 12,13 a linker has to be introduced between the alkynylsugar and 
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2-butynylglycine. The newly generated anomeric center C-4, the former C-1 of 
gluconolactone, appeared ideally suitable for this purpose, in particular by 
attachment of a diol, thus leaving one alcohol free for esterification to 
2-butynylglycine. Three different diols were investigated as linkers. Firstly, hemi-
acetal 24 was condensed with diethyleneglycol, under the action of a Lewis acid 
(TMSOTf) in the presence of a drying agent (MgSO4).25 However, despite the fact that 
a large excess of diethyleneglycol was added (5 equiv), compound 25 could only be 
obtained in a disappointing yield of 18%, due to incomplete conversion and the 
formation of dimers. Apparently, an equilibrium is established between product and 
starting material, despite the presence of magnesium sulfate. Moreover, the five-fold 
excess of diethyleneglycol is apparently not sufficient to prevent double 
glycosylation with carbohydrate 24. A similar result was obtained by addition of 1,4-
benzenedimethanol instead of diethyleneglycol (26, 24%), while a slight increase in 
yield was observed for ortho-benzenedimethanol, particularly due to the isolation of 
smaller amounts of dimer, to afford the desired glycoside 27 in 33% yield. 
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Scheme 2.7 Synthesis of cyclic sulfate 28 
An alternative mode of introduction of a linker, instead by dehydrative condensation 
with excess diol, entails nucleophilic attack of 24 at a suitable electrophile. Obviously, 
such a strategy could be attained by monoprotection of a diol, conversion to a 
suitable electrophile and condensation with 24, before removal of the protective 
group. A more elegant approach involves the conversion of the diol to a cyclic 
sulfate, with the inherent advantage that only single addition is possible. Thus, as 
exemplified in Scheme 2.7, 1,2-benzenedimethanol was converted into cyclic sulfate 
2826 as described by O’Brien et al.27 
Moreover, it was realized that conversion of 24 into a good nucleophile could be 
effected by deprotonation with a suitable base (e.g. NaH), but a more direct approach 
would involve addition of cyclic sulfate 28 to the alkoxide formed in situ by acetylide 
addition to lactone 23 (Scheme 2.8). Subsequent removal of the O-sulfate with 
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sulfuric acid and water proceeds in a one-pot procedure leading to the desired 
alcohol 27 in 52% overall yield from lactone 23. Compound 27 was isolated as an α,β-
mixture in a ratio of 3:4. 
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Scheme 2.8 Coupling of amino acid 29 to the anomeric linker and RCAM 
Next, Boc-protected 2-butynylglycine 2928 was coupled to the free hydroxyl of 27 
under the action of DCC and DMAP, leading to diyne 30 as the desired substrate for 
RCAM. Thus, compound 30 was dissolved in toluene and degassed with argon, 
before addition of the tungsten-based catalyst 8 in a glove box. Heating the reaction 
mixture to 80 °C for 30 minutes, followed by TLC analysis showed the disappearance 
of starting material and the formation of less lipophilic product. Unfortunately, 
analysis of the formed product after work-up and silica gel purification showed that 
solely cross-metathesis had occurred, leading to quantitative dimer formation.29 
Since the ring-size of the desired product (12-ring) is sufficiently large to enable 
formation of a cycloalkyne (as indicated by Fürstner’s rule), a possible alternative 
explanation for the lack of ring-closure may be found in the fact that the tertiary 
anomeric center, directly adjacent to the sugar alkyne, causes too much steric 
hindrance. 
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2.3 RCAM of diynes linked at the primary 
hydroxyl 
Since the RCAM of a diyne linked via the anomeric center was not successful, 
another strategy was considered to attach 2-butynylglycine to the carbohydrate. 
Although in principle any other position in the carbohydrate could be applied, the 
C-9 position (former C-6) was considered most amenable for selective deprotection. 
An additional advantage of such a strategy is that a late-stage deoxygenation of the 
anomeric carbon (C-4) is avoided. Thus, the hemi-acetal at C-4 of 24 was first 
deoxygenated under the action of BF3·OEt2 and Et3SiH yielding stereoselectively the 
β-configured alkynylglycoside 31 (Scheme 2.9).30 Selective removal of the benzyl 
protecting group at O-9 by acetolysis with H2SO4 in acetic anhydride, followed by 
removal of the resulting acetyl group gave the desired glycoacetylene 32 with a free 
primary hydroxyl. Introduction of the linker could be performed under similar 
conditions as above. Thus, deprotonation of the alcohol by KHMDS in THF, and 
subsequent addition of cyclic sulfate 28 led to the chain-extended compound 33. 
Diimide-mediated esterification of 33 with Boc-protected D-2-butynylglycine 
proceeded uneventfully, leading to the RCAM precursor 34 in excellent yield. 
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Scheme 2.9 Synthesis of gluco amino acid 34 
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Table 2.1 Synthesis of RCAM precursors and RCAM products 
entry esterificationa yield RCAMb yield 
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39 (n = 2) 
62% 
41 (n = 3) 
29% 
a DCC, DMAP, CH2Cl2; b 8, toluene, 80°C 
 
Diyne 34 was now subjected to identical conditions for ring-closing alkyne 
metathesis as described earlier. Thus, thorough drying and degassing was executed 
to avoid premature decomposition of the sensitive catalyst. Much to our satisfaction, 
prolonged treatment of 34 with the tungsten-based RCAM catalyst 8 led to the 
cyclized alkyne 35 in 80% yield (Entry 1, Table 2.1). The structure of cycloalkyne 35 
was corroborated by NMR and mass spectral analysis. Since the formed glycoamino 
acid posessed the unnatural D-configuration at the amino acid α-carbon, we were 
interested if RCAM could also afford the more versatile L–isomer. To this end, due to 
the lack (at the time) of L–2-butynylglycine, racemic butynylglycine (±)-29 was 
attached to the carbohydrate derivative 33 and subjected to ring–closure. No 
difference in reaction rate between the two epimers could be observed, leading to a 
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1:1 mixture of diastereomeric cycloalkynes 37. Some L-diastereomeric glycoamino 
acids could in fact be prepared by applying L-3-pentynylglycine and 
L-4-hexynylglycine28 to the synthetic sequence of esterification-RCAM (entries 3 and 
4, respectively). In both cases, the desired cycloalkynes were successfully formed, 
although a clear negative correlation was observed between expansion of the amino 
acid side–chain, giving the corresponding cyclic acetylenes from 3-pentynylglycine 
and 4-hexynylglycine in yields of 62 and 29%, respectively. The RCAM of 40 gave 
only 0.8 mg and therefore the product could only be confirmed by HRMS. 
2.4 Conclusions 
Acetylene-linked glycoamino acids were successfully prepared by application of 
ring-closing alkyne metathesis. To this end, alkynylsugars and alkynylamino acids 
were coupled via a benzenedimethanol linker, derived from cyclic sulfate 28. 
Attachment points for the amino acid were either the newly formed anomeric center 
at C-4 or the primary hydroxyl at C-9. Performing RCAM on the anomerically-linked 
dialkyne led exclusively to dimerization and failed to yield cycloalkyne product, 
presumably due to sterical hindrance. Linkage via O-9 proceeded smoothly for 
2-butynylglycine derivatives of different configuration and chain-lengths, upon 
RCAM successfully leading to the desired glucoamino acids with ring-sizes varying 
between 15 and 17. 
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2.6 Experimental section 
General information 
1H-NMR spectra were recorded on a Varian Inova 400 (400 MHz) spectrometer and 
13C-NMR spectra on a Bruker DMX300 (75 MHz) or Bruker DPX200 (50 MHz) 
spectrometer. Chemical shifts (δ) are given in ppm, downfield from 
tetramethylsilane. IR spectra were recorded on an ATI Mattson, Genesis series, or a 
Bruker Tensor 27 FTIR spectrometer. High resolution mass spectra were recorded on 
a JEOL AccuTOF (ESI), or a MAT900 (EI, CI, and ESI). All reactions were performed 
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under N2 unless stated otherwise. The tungsten catalyst was handled in a glove box. 
Rf values are obtained using thin layer chromatography (TLC) on silica gel-coated 
plates (Merck 60 F254) with the indicated eluens and compound were detected with 
UV-light, ammonium molybdate, potassium permanganate, ninhydrin, or 
anisaldehyde. Optical rotations were determined with a Perkin Elmer 241 
polarimeter. 
2,3,4,6-Tetra-O-benzyl-D-glucono-δ-lactone (23) 
A solution of 2,3,4,6-tetra-O-benzyl-D-glucose (15.0 g, 27.7 mmol) in 
DMSO/Ac2O (3/2 100 mL) was stirred at rt for 16 h and poured onto 
ice water. The water layer was extracted 3 times with an 
EtOAc/heptane solution (1/1). The organic layer was washed twice with water and 
once with brine. The organic layer was dried (MgSO4) and concentrated. The crude 
product 23 (15 g, quant.) was used in the next step without further purification. 
Rf (1/2 EtOAc/heptane) = 0.49. 1H-NMR (400 MHz, CDCl3) δ = 7.39-7.16 (m, 20 H), 
4.99 (d, J = 11.4 Hz, 1 H), 4.74-4.44 (m, 8 H), 4.12 (d, J = 6.5 Hz, 1 H), 3.97-3.89 (m, 
2 H), 3.73 (dd, J = 2.4, 11.0 Hz, 1 H), 3.67 (dd, J = 3.3, 11.0 Hz, 1 H); in agreement with 
literature.23 
1,2-Benzenedimethanol cyclic sulfate (28) 
To a solution of the 1,2-benzenedimethanol (4.84 g, 35.0 mmol) and 
Et3N (19.0 mL, 137 mmol) in CH2Cl2 (100 mL) at 0 °C was added a 
solution of SOCl2 (3.85 mL, 52.7 mmol) in CH2Cl2 (10 mL), dropwise in 
15 min. After 15 min the reaction was diluted with cold Et2O (100 mL) and washed 
with cold water (2 × 50 mL), brine, dried (MgSO4) and evaporated. Subsequently at 
0 °C crude sulfite was dissolved in CCl4/MeCN/H2O (1/1/1.5 350 mL). RuCl3 and 
NaIO4 were added and the reaction was stirred for 1 h. The reaction was diluted with 
Et2O (200 mL). The organic and water layer were separated and the water layer was 
extracted with Et2O (100 mL). The organic layer was washed with brine, dried 
(MgSO4) and evaporated. Recrystallization from heptane/acetone gave the desired 
cyclic sulfate 28 (4.90 g, 70%). 1H-NMR (200 MHz, CDCl3) δ = 7.48-7.35 (m, 4 H), 5.44 
(s, 4 H); in agreement with literature.27, 31 
1-O-Diethyleneglycolyl-1-prop-1-ynyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose (25) 
At 0 °C, a solution of compound 24 (0.15 g, 0.25 mmol) in 
CH2Cl2 (2 mL), was treated with MgSO4 (0.13 g, 1.0 mmol), 
diethylene glycol (0.12 mL, 1.25 mmol), and TMSOTf 
(4.5 µL, 0.026 mmol). After stirring for 3 hours, additional 
TMSOTf (10 µL, 0.058 mmol) was added. The reaction was quenched with Et3N 
(0.1 mL) and the solution was evaporated. Column chromatography afforded 
compound 25 (31 mg, 18%) and the dimer (41 mg). 1H-NMR (300 MHz, CDCl3) δ = 
7.38-7.25 (m, 20 H), 5.12-4.85 (m, 8 H), 4.77-3.41 (m, 14 H), 1.98 (s, 3 H). 
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1-O-(2-Methanolbenzyl)-1-prop-1-ynyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose (27) 
A solution of (E,Z)-1-bromo-1-propene (65 µL, 0.75 mmol) in dry THF (2.5 mL) was 
stirred at −78 °C. n-BuLi (0.69 mL, 1.1 mmol) was added and the 
reaction mixture was stirred for 2 h. A solution of lactone 23 
(0.22 g, 0.40 mmol) in THF (2.5 mL) was added dropwise at 
−78 °C and the reaction mixture was stirred for 1 h. After the 
reaction was complete, cyclic sulfate 28 (0.15 g, 0.75 mmol) and 
HMPA (2.5 mL) were added. The reaction was stirred for 20 min 
at −78 °C and then slowly warmed to 0 °C. The reaction was stirred till completion 
and warmed to rt and was poured into aq. sat. NH4Cl. The mixture was extracted 
with EtOAc (3 × 30 mL). The organic layer was evaporated and redissolved in THF 
(2.5 mL), before H2SO4 (50 µL) and H2O (18 µL) were added. The reaction was stirred 
till completion and diluted with EtOAc. The organic layer was washed with 
saturated NaHCO3, dried with MgSO4 and evaporated. Purification by column 
chromatography afforded compound 27 (0.15 g, 0.21 mmol, 52%) as an Y/β mixture 
(3:4). 1H-NMR (300 MHz, CDCl3) δ = 7.38-7.25 (m,24 H), 5.12-4.85 (m, 8 H), 4.80-3.41 
(m 10 H), 2.03 and 1.98 (2 s, 3 H). 
1-O-(2-Methylhydroxyl[2-(R)-{tert-butoxycarbonylamino}hex-4-ynoate]benzyl) -1-
prop-1-ynyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose (30) 
A solution of Boc-2-butynylglycine (29, 73 mg, 0.32 mmol) 
in CH2Cl2 (2 mL) was stirred at 0 °C. DMAP (2.6 mg, 
0.021 mmol), DCC (43 mg, 0.21 mmol) and compound 27 
(0.15 g, 0.21 mmol) in CH2Cl2 (1 mL) were added and the 
reaction was stirred overnight at rt. The reaction mixture 
was filtered and the residue was washed with CH2Cl2. The 
organic layer was evaporated and the product was purified by column 
chromatography affording compound 30 (0.17 g, 0.19 mmol, 89%). 1H-NMR 
(300 MHz, CDCl3) δ = 7.25-7.38 (m, 24 H), 5.46 (br d, 1 H), 5.12-4.85 (m, 9 H), 4.80-3.41 
(m, 10 H), 2.75-2.81 (m, 2 H), 2.03 and 1.98 (2 s, 3 H), 1.68 (s, 3 H), 1.53 (s, 9 H). 
4,8-Anhydro-5,6,7,9-tetra-O-benzyl-1,2,3-trideoxy-D-glycero-L-mannonon-2-ynitol 
(31) 
To a solution of (E,Z)-1-bromo-propene (0.90 mL, 10 mmol) in THF 
(35 mL) was added n-BuLi (0.60 M in hexane; 8.8 mL, 14 mmol) in 
5 min at −78 °C. The solution was stirred for 1 h. A solution of 
lactone 23 (3.4 g, 6.4 mmol) in THF (35 mL) was added in 10 min. The reaction was 
stirred for ½ h at −78 °C, quenched with NH4Cl (aq. sat.), warmed up to rt, extracted 
with EtOAc (2 × 100 mL), and washed with brine. Drying (Na2SO4) and 
concentrating, yielded the crude hemiacetal 24 (3.6 g, 6.2 mmol, 97%). Compound 24 
was used for the next step without further purification. A solution of BF3·OEt2 
(3.8 mL, 30 mmol) and Et3SiH (4.9 mL, 30 mmol) in MeCN/DCM (1/1, 30 mL) was 
added to a solution of the hemiacetal 24 in MeCN/DCM (1/1, 30 mL) in 15 min at 0 
°C. After stirring at 0 °C for 1 h, the reaction was quenched with saturated NaHCO3, 
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Extracted with EtOAc (2 × 150 mL), washed with brine, dried (Na2SO4) and 
concentrated and purified by column chromatography (1/5 EtOAc/heptane), to give 
31 in 74% (2.6 g, 4.6 mmol) as a colorless oil. 1H NMR (400 MHz, CDCl3) δ = 7.39-7.09 
(m, 20 H), 5.00 (d, J = 10.5 Hz, 1 H), 4.91 (d, J = 11.0 Hz, 1 H), 4.83-4.79 (m, 3 H), 4.61 
(d, J = 12.1 Hz, 1 H), 4.52 (dd, J = 11.3, 2.6 Hz, 2 H), 4.05-3.98 (m, 1 H), 3.77-3.52 (m, 
5 H), 3.44-3.41 (m, 1 H), 1.88 (d, J = 2.1 Hz, 3 H); in agreement with literature.30 
4,8-Anhydro-5,6,7-tri-O-benzyl-1,2,3-trideoxy-D-glycero-L-mannonon-2-ynitol (32) 
To a solution of 31 (1.3 g 2.4 mmol) in Ac2O (45 mL), H2SO4 (5% 
in Ac2O, 10 mL) was added dropwise at −20 °C. The reaction was 
stirred for 10 min, quenched with aqueous NaOAc, diluted with 
EtOAc, and washed with saturated NaHCO3, and brine. The organic phase was dried 
(Na2SO4), concentrated and purified by flash chromatography (1/5 EtOAc/heptane) 
to yield the acetolyzed product (1.0 g, 1.9 mmol) as a white solid. 
Rf (1/4 EtOAc/heptane) = 0.20. 1H-NMR (400 MHz, CDCl3) δ = 7.38-7.22 (m, 15 H), 
5.01 (d, J = 10.6 Hz, 1 H), 4.95 (d, J = 10.9 Hz, 1 H), 4.87-4.80 (m, 3 H), 4.56 (d, 
J = 10.9 Hz, 1 H), 4.32 (d, J = 11.7 Hz, 1 H), 4.20 (dd, J = 4.4, 12.01 Hz, 1 H), 4.03 (dd, 
J = 2.1, 9.5 Hz, 1 H), 3.66-3.47 (m, 4 H), 2.04 (s, 3 H), 1.88 (d, J = 2.1 Hz, 3 H). 13C-NMR 
(50 MHz, CDCl3) δ = 171.0, 138.5, 138.1, 137.8, 128.7, 128.6, 128.4, 128.2, 128.1, 128.0, 
128.0, 127.9, 86.1, 83.1, 82.7, 77.5, 77.0, 76.3, 75.9, 75.6, 75.3, 70.2, 63.6, 21.1, 4.0. 
[α]D20 = +16.8 (c = 1.04, CHCl3). IR (neat) ν = 3031, 2907, 2860, 2245, 1740. HRMS (CI) 
m/z calculated for C32H35O6 (M+H)+ 515.2434 found 515.2435. This was then dissolved 
in MeOH (40 mL) and KCN (15 mg, 0.23 mmol) was added. The reaction was stirred 
for 24 h. The mixture was neutralized with basic Amberlyst, filtrated and evaporated. 
The mixture was redissolved in EtOAc, washed with saturated NH4Cl, dried 
(MgSO4) and evaporated. Purification by flash chromatography 
(1/2 EtOAc/heptane) gave 32 as a white solid (0.75 g, 1.6 mmol, 66% from 31. 
Rf (1/2 EtOAc/heptane) = 0.30. 1H-NMR (400 MHz, CDCl3) δ = 7.37-7.24 (m, 15 H), 
4.99 (d, J = 10.6 Hz, 1 H), 4.92 (d, J = 11.1 Hz, 1 H), 4.87-4.80 (m, 3 H), 4.65 (d, 
J = 10.9 Hz, 1 H), 4.05 (dd, J = 1.6, 9.5 Hz, 1 H), 3.87 (dd, J = 2.3, 12.0 Hz, 1 H), 
3.70-3.50 (m, 4 H), 3.35-3.31 (m, 1 H), 2.05 (br s, 1 H), 1.88 (d, J = 1.2 Hz, 3 H). 
13C-NMR (50 MHz, CDCl3) δ = 138.6, 138.2, 138.0, 128.6, 128.5, 128.3, 128.1, 128.0, 
128.0, 127.9, 127.8, 86.0, 83.0, 82.8, 79.4, 77.6, 76.5, 75.8, 75.6, 75.3, 70.1, 62.1, 3.9. 
[α]D20 = –8.25 (c = 0.63, CHCl3). IR (neat) ν = 3373, 3036, 2902, 2859, 2245. HRMS (CI) 
m/z calculated for C30H33O5 (M+H)+ 473.2328, found 473.2331. 
4,8-Anhydro-5,6,7-tri-O-benzyl-9-O-(2-methanolbenzyl)-1,2,3-trideoxy-D-glycero-L-
mannonon-2-ynitol (33) 
Compound 32 (0.76 g, 1.6 mmol) was dissolved in dry THF 
(50 mL) and cooled to −78 °C. KHMDS (0.5M in toluene, 4.8 mL, 
2.4 mmol) was added and stirred for 30 min at −78 °C. Cyclic 
sulfate 28 (0.64 g, 3.2 mmol) was added. The temperature was 
raised overnight to rt. After stirring for 20 h, the reaction mixture 
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was poured into saturated NH4Cl and extracted with EtOAc (2 × 100 mL). The sulfate 
was concentrated and redissolved in THF (100 mL). H2SO4 (0.40 mL) and H2O 
(0.15 mL) were added and the reaction was stirred for 4 d. Half of the THF was 
evaporated, the reaction mixture was diluted with EtOAc (200 mL) and washed with 
water (3 × 100 mL), brine (200 mL), dried (MgSO4) and evaporated. Purification by 
flash chromatography (1/2 EtOAc/heptane) afforded compound 33 (0.51 g, 54%) as a 
white solid. Rf (1/2 EtOAc/heptane) = 0.20. 1H-NMR (400 MHz, CDCl3) δ = 7.42-7.20 
(m, 19 H), 4.98 (d, J = 10.6 Hz, 1 H), 4.90 (d, J = 11.1 Hz, 1 H), 4.84-4.76 (m, 3 H), 4.66 
(d, J = 5.3 Hz, 2 H), 4.61 (d, J = 11.5 Hz, 2 H), 4.53 (d, J = 11.1 Hz, 1 H), 3.99 (dd, 
J = 2.0, 9.2 Hz, 1 H), 3.72 (dd, J = 2.0, 10.6 Hz, 1 H), 3.63-3.50 (m, 4 H), 3.43-3.40 (m, 
1 H), 3.10 (br t, J = 6.1 Hz, 1 H), 1.88 (d, J = 2.2 Hz, 3 H). 13C-NMR (75 MHz, CDCl3) 
δ = 140.6, 138.4, 138.0, 138.0, 135.7, 130.2, 129.8, 128.9, 128.4, 128.3, 128.2, 127.9, 127.8, 
127.8, 127.7, 127.6, 86.1, 83.0, 82.7, 78.4, 77.8, 76.2, 75.8, 75.5, 75.2, 72.8, 70.3, 69.0, 63.7, 
4.2. [α]D20 = + 6.4 (c = 1.0, CHCl3). IR (film) ν = 3480, 3062, 3027, 2905, 2868, 2250. 
HRMS (CI) m/z calculated for C38H41O6 (M+H)+ 593.2903, found 593.2875.  
4,8-Anhydro-5,6,7-tri-O-benzyl-9-O-(2-methylhydroxyl[2-(R)-{tert-
butoxycarbonylamino}hex-4-ynoate]benzyl)-1,2,3-trideoxy-D-glycero-L-mannonon-
2-ynitol (34) 
A solution of Boc-2-butynylglycine 29 (18 mg, 79 µmol) 
and alcohol 33 (34 mg, 56 µmol) in CH2Cl2 (1 mL) was 
stirred at 0 °C. DMAP (0.7 mg, 6 µmol) and DCC (15 mg, 
73 µmol) in CH2Cl2 (1 mL) were added and the reaction 
was stirred overnight at rt. The reaction mixture was 
filtered, the residue was washed with CH2Cl2 and the 
filtrate was evaporated. Flash chromatography (1/4 EtOAc/heptane) afforded 
dialkyne 34 (42 mg, 94%) as a white solid. Rf (1/2 EtOAc/heptane) = 0.43. 1H-NMR 
(400 MHz, CDCl3) δ = 7.41-7.12 (m, 19 H), 5.34-5.25 (m, 3 H), 5.00 (d, J = 10.6 Hz, 1 H), 
4.91 (d, J = 11.0 Hz, 1 H), 4.82-4.79 (m, 3 H), 4.64 (d, J = 12.4 Hz, 2 H), 4.50 (d, 
J = 10.8 Hz, 1 H), 4.45-4.42 (m, 1 H), 4.00 (dd, J = 1.7, 9.2 Hz, 1 H), 3.73 (d, J = 10.8 Hz, 
1 H), 3.67 (dd, J = 4.5, 10.8 Hz, 1 H), 3.63-3.53 (m, 3 H), 3.43 (dd, J = 2.9, 9.2 Hz, 1 H), 
2.72-2.56 (m, 2 H), 1.88 (d, J = 1.8 Hz, 3 H), 1.67 (t, J = 2.2 Hz, 3 H), 1.44 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ = 170.5, 154.9, 138.4, 138.1, 137.9, 136.4, 133.7, 129.3, 
129.0, 128.3, 128.3, 128.1, 127.9, 127.8, 127.8, 127.7, 127.7, 127.6, 86.1, 82.7, 82.7, 80.1, 
79.4, 78.9, 78.0, 76.675.8, 75.5, 75.2, 73.2, 71.1, 70.2, 69.3, 64.9, 52.6, 28.6, 23.4, 4.2, 3.9. 
[α]D20 = +6.6 (c = 0.8, CHCl3). IR (film) ν = 3723, 3425, 3058, 3028, 2967, 2911, 2855, 
2250, 1740, 1722. HRMS (ESI) m/z calculated for C49H55NNaO9 (M+Na)+ 824.3775, 
found 824.3774. 
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RCAM product 35 
RCAM was performed under an argon atmosphere in a 
flame dried Schlenk flask. Dialkyne 34 (108 mg, 0.135 mmol) 
was co-evaporated with toluene (2 × 10 mL) and 
subsequently (tBuO)3W≡CtBu (8, 22 mg, 47 µmol) was 
added. This was dissolved in toluene (2 mL) and stirred for 
30 minutes at 80 °C. The reaction was purified by flash 
chromatography (1/4 EtOAc/heptane) to yield cyclized product 35 (81 mg, 80%) as a 
solid. Rf (1/2 EtOAc/heptane) = 0.43. 1H-NMR (400 MHz, CDCl3) δ = 7.35-7.26 (m, 
19 H), 5.34-5.23 (m, 3 H), 4.94-4.77 (m, 6 H), 4.71 (d, J = 11.7 Hz, 1 H), 4.62-4.58 (m, 
2 H), 3.92 (d, J = 9.6 Hz, 2 H), 3.61-3.43 (m, 5 H), 2.96 (d, J = 16.4 Hz, 1 H), 2.56 (ddd, 
J = 2.1, 5.5, 16.6 Hz, 1 H), 1.39 (s, 9 H). 13C-NMR (50 MHz, CDCl3) δ = 171.1, 155.2, 
138.5, 138.1, 138.0, 138.0, 137.5, 132.8, 130.2, 128.9, 128.6, 128.6, 128.5, 128.4, 128.2, 
128.1, 128.0, 128.0, 127.9, 127.8, 85.9, 82.2, 81.9, 81.4, 80.4, 79.5, 78.3, 75.9, 75.3, 75.3, 
71.8, 69.7, 69.3, 65.2, 53.5, 28.4, 23.9. [α]D20 = –30.0 (c = 0.26, CHCl3). IR (film) ν = 3321, 
3062, 3032, 2967, 2907, 2868, 2258, 1701. HRMS (ESI) m/z calculated for C45H49NNaO9 
(M+Na)+ 770.3305, found 770.3366. 
4,8-Anhydro-5,6,7-tri-O-benzyl-9-O-(2-methylhydroxyl[2-(S)-{tert-
butoxycarbonylamino}hept-5-ynoate]benzyl)-1,2,3-trideoxy-D-glycero-L-
mannonon-2-ynitol (38) 
Coupling of 33 (16 mg, 27 µmol) with 3-pentynylglycine 
(7.9 mg, 32 µmol)28 as described for 34 gave 38 (20 mg, 
92%).Rf (1/2 EtOAc/heptane) = 0.43. 1H-NMR (400 MHz, 
CDCl3) δ = 7.41-7.12 (m, 19 H), 5.29 (d, J = 12.7 Hz, 1 H), 
5.25 (d, J = 12.7 Hz, 1H), 5.13 (br d, J = 8.0 Hz, 1 H), 5.00 
(d, J = 10.6 Hz, 1 H), 4.91 (d, J = 10.9 Hz, 1 H), 4.82-4.79 
(m, 3 H), 4.68 (d, J = 12.3 Hz, 1 H), 4.59 (d, J = 12.3 Hz, 1 H), 4.50 (d, J = 10.9 Hz, 1 H), 
4.42-4.36 (m, 1 H), 4.00 (dd, J = 2.1, 9.2 Hz, 1 H), 3.74-3.52 (m, 5 H), 3.44-3.41 (m, 1 H), 
2.20-2.14 (m, 2 H), 2.06-1.98 (m, 1 H), 1.88 (d, J = 2.0 Hz, 3 H), 1.85-1.79 (m, 1 H), 1.74 
(t, J = 2.4 Hz, 3 H), 1.42 (s, 9 H). 13C-NMR (50 MHz, CDCl3) δ = 172.2, 138.6, 138.3, 
138.1, 136.5, 133.9, 129.4, 129.3, 128.6, 128.5, 128.5, 128.4, 128.2, 128.0, 128.0, 128.0, 
127.9, 127.8, 86.1, 82.8, 82.7, 78.9, 77.9, 77.6, 76.9, 75.8, 75.5, 75.2, 71.1, 70.2, 69.3, 64.6, 
53.1, 31.9, 28.4, 15.2, 3.9, 3.6. [α]D20 = +5.6 (c = 1.25, CHCl3). IR (film) ν = 3347, 3028, 
2971, 2923, 2867, 2250, 1740, 1710. HRMS (ESI) m/z calculated for C50H57NNaO9 
(M+Na)+ 838.3931, found 838.3914. 
RCAM product 39 
RCAM was performed on dialkyne 38 (20 mg, 25 µmol) as 
described for 35 to give product 39 (11 mg, 62%). 
Rf (1/2 EtOAc/heptane) = 0.43. 1H-NMR (400 MHz, 
CDCl3) δ = 7.37-7.27 (m, 19 H), 5.61 (d, J = 13.7 Hz, 1 H), 
5.56 (d, J = 13.7 Hz, 1 H), 5.41 (br d, J = 6.2 Hz, 1 H), 4.99 
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(d, J = 10.8 Hz, 1 H), 4.91 (d, J = 11.0 Hz, 1 H), 4.87-4.79 (m, 4 H), 4.73-4.71 (m, 1 H), 
4.61 (d, J = 10.9 Hz, 1 H), 4.55-4.50 (m, 1 H), 3.92 (dt, J = 1.6, 9.5 Hz, 1 H), 3.75-3.57 (m, 
5 H), 3.39 (dt, J = 3.1, 9.2 Hz, 1 H), 2.37-2.34 (m, 1 H), 2.22-2.18 (m, 1 H), 1.85-1.71 (m, 
2 H), 1.42 (s, 9 H). 13C-NMR (50MHz, CDCl3) δ = 172.3, 155.2, 138.7, 138.4, 138.2, 
135.9, 130.1, 128.8, 128.7, 128.5, 128.4, 128.3, 128.0, 128.0, 128.0, 127.9, 127.8, 86.2, 86.0, 
84.5, 82.8, 82.7, 82.0, 79.0, 75.8, 75.5, 75.3, 73.4, 69.5, 68.4, 65.0, 52.1, 31.1, 28.5, 13.3. IR 
(film) ν = 3421, 3326, 3062, 3028, 2924, 2855, 2250, 1709. HRMS (ESI) m/z calculated for 
C46H51NO9Na (M+Na)+ 784.3461, found 784.3440. 
4,8-Anhydro-5,6,7-tri-O-benzyl-9-O-(2-methylhydroxyl[2-(S)-{tert-
butoxycarbonylamino}oct-6-ynoate]benzyl)-1,2,3-trideoxy-D-glycero-L-mannonon-
2-ynitol (40) 
Coupling of 33 (2.6 mg, 4.3 µmol) with 4-hexynylglycine 
(1.3 mg, 5.2 µmol)28 as described for the synthesis of 34 
gave 40 (3.0 mg, 84%). Rf (1/2 EtOAc/heptane) = 0.43. 
1H-NMR (CDCl3, 400 MHz) δ: 7.40-7.11 (m, 19 H), 5.31 (d, 
J = 12.8 Hz, 1 H), 5.24 (d, J = 12.9 Hz, 1 H), 5.04-4.99 (m, 
1 H), 4.99 (d, J = 10.6 Hz, 1 H), 4.91 (d, J = 10.9 Hz, 1 H), 
4.82-4.79 (m, 3 H), 4.68 (d, J = 12.3 Hz, 1 H), 4.58 (d, 
J = 12.4 Hz, 1 H), 4.49 (d, J = 10.9 Hz, 1 H), 4.35-4.29 (m, 1 H), 4.00 (dd, J = 9.1, 2.1 Hz, 
1 H), 3.72 (dd, J = 10.9, 1.8 Hz, 1 H), 3.68-3.40 (m, 5 H), 2.1-1.4 (m, 6 H), 1.88 (d, 
J = 2.1 Hz, 3 H), 1.74 (t, J = 2.5 Hz, 3 H), 1.42 (s, 9 H). IR (film) ν = 3295, 2919, 2863, 
2254, 1750, 1718. HRMS (ESI) m/z calculated for C51H59NO9Na (M+Na)+ 852.4088, 
found 852.4114. 
RCAM product 41 
 RCAM was performed on dialkyne 40 (3.0 mg, 3.6 µmol) 
as described for 35 to give product 41 (0.8 mg, 29%). 
Rf (1/2 EtOAc/heptane) = 0.43. HRMS (ESI) m/z calculated 
for C47H53NO9Na (M+Na)+ 798.3618, found 798.3606. 
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3 Expedient synthesis of 
triazole-linked glycoamino 
acids and peptides1 
Abstract 
Methodology is presented for the synthesis of triazole-linked glycoamino acids and 
peptides based on copper(I)-catalyzed azide acetylene cycloaddition with 
glycoacetylenes and azidoamino acids. The resulting triazolyl glycoamino acids were 
suitable building blocks for the assembly of isosteric glycopeptides. An alternative 
route towards such triazolyl glycopeptides was also developed by late-stage 
introduction of the carbohydrate portion, involving similar cycloaddition of 
glycoacetylenes with azidopeptides. 
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3.1 Introduction 
In 2002 the groups of Meldal1 and Sharpless2 independently discovered that the 
1,3-dipolar cycloaddition of an alkyne with an azide is effectively catalyzed by Cu(I)-
salts. The original discovery, by Huisgen in 1967, involved heat-induced 
cycloaddition and usually led to a mixture of two regioisomers, i.e. the 1,4- and 
1,5-regioisomer.3 The copper(I)-catalyzed variation, in contrast, not only proceeds at 
ambient temperature, but also leads exclusively to the 1,4-substituted triazole. It is 
not surprising, therefore, that the procedure developed by Meldal and Sharpless, 
now postulated as the Cu(I)-mediated azide-alkyne cycloaddition (CuAAC), rapidly 
gained popularity in the synthetic community. 
Among the many possibilities of application of triazoles in biologically relevant 
molecules4,5 is the incorporation of a triazole as a bridging moiety in a glycoamino 
acid. Triazole-linked glycoamino acids may function as useful building blocks for the 
assembly of N-glycoproteins (1, Figure 3.1), in particular since the triazole function 
has been postulated as a useful amide isostere,6,7 in terms of electronic properties and 
atom placement. Therefore, our research efforts were aimed at an efficient, high-
yielding synthesis of triazole-linked isosteric glycopeptides such as 2 (Figure 3.1). 
The latter glycopeptide, termed CTGA from C-linked triazolylglycoamino acid, can 
be synthetically obtained by cycloaddition of acetylenic glycosides 3 and azidoamino 
acids 4. In addition, besides the aim of merely constructing stable glycopeptide 
mimics, the resulting substituted triazole-linked glycopeptides more generally may 
display relevant biological activity against various targets. 
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Figure 3.1 Retrosynthesis for isosteres of amide-linked glycoamino acids 
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3.2 Triazole-linked C-glycoamino acids 
From the retrosynthesis depicted in Figure 3.1 it becomes clear that the synthesis of 
triazolyl glycoproteins of type 2 requires the cycloaddition between a carbohydrate-
derived acetylene and an azido-containing amino acid. Therefore, attention was first 
focused on the synthesis of glycoacetylenes of type 3. To this end, the known lactone 
5 (Section 2.6)8 was converted into alkynylglucoside 6 (Scheme 3.1) by subjection to 
nucleophilic addition of Li-acetylide, generated in situ from TMS-acetylene and 
n-BuLi.9 Hemi-acetal 6, obtained as an @,β-mixture (ratio 1:1), was deoxygenated at 
the anomeric center under the action of BF3· OEt2 and Et3SiH yielding 
stereoselectively the β-configured alkynyl glucoside 7, after subsequent removal of 
the silyl group. Apart from the perbenzylated derivative 7, be it a good building 
block for the CuAAC reaction, the acetylated and unprotected gluco-acetylenes 8 and 
9 were also synthesized, bearing in mind the inevitable final deprotection steps to 
biologically relevant structures. 
O
BnO
BnO
BnO
BnO O
O
RO
RO
RO
OR
n-BuLi
THF, –78 °C
(78%)
TMS
BF3·OEt2
Ac2O
NaOMe
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BnO
BnO
BnO
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Et3SiH
MeCN
CH2Cl2 0 °C
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MeOH
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(67%)
5 6 7 R = Bn
8 R = Ac (88%)
9 R = H (>99%)  
Scheme 3.1 Synthesis of β-glucoacetylenes 7-9 
The requisite azidoamino acids of type 4 were readily synthesized from the 
corresponding α-N protected L-lysine, L-ornithine, L-diamino-butanoic and 
propanoic acid via a diazotransfer reaction with TfN3.10 
O
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NN
BocHN CO2H10 11 12  
Scheme 3.2 Synthesis of triazole-linked N-glycoamino acid (NTGA) 12 
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Table 3.1 CuAAC reactions of glycoacetylene 7 and a variation of azidoamino acids 
Cu(OAc)2, Na ascorbate
H2O, t-BuOH
O
BnO
BnO
BnO
OBn
azidoamino acid
O
BnO
BnO
BnO
OBn
N
NN
R
7  
entry azidoamino acid CTGA yield 
1 70% 
2 73% 
3 71% 
4 84% 
5 87% 
6 69% 
7 
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BocHN CO2Me
BocHN CO2H
BocHN CO2H
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71% 
With the requisite building blocks in hand, several conditions were considered for 
the desired CuAAC. At an earlier occasion, it was found in our lab that optimal 
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CuAAC conditions for the inverse N-linked triazolylglycoamino acid, i.e. 
N-glycoamino acid (NTGA; Scheme 3.2) involved 0.2 equiv Cu(OAc)2 and 0.4 equiv 
sodium ascorbate in a 1:1 (v/v) mixture of H2O and t-BuOH (modified Sharpless 
conditions2).11 
Applying the latter optimized conditions to glycoacetylene 7 and Boc-protected 
azidoamino acid 13, provided the targeted Boc-T1M(4-GlcBn4)-OH12 14 in 70% yield 
(entry 1, Table 3.1). Elongation of the amino acid side-chain had virtually no 
influence on the reactivity as can be inferred from Table 3.1, entries 2 and 3. 
Azidoamino acid derivatives containing a methyl ester appeared somewhat easier to 
purify than their free carboxylic acid counterparts, which may explain the slightly 
better yields (entries 4 and 5). Furthermore, it was shown that the reaction is 
compatible with a variety of the most commonly applied amine protective groups, 
i.e. Boc, Cbz and Fmoc. 
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Scheme 3.3 Cycloaddition of pipecolic acids 27, 29, and 31 with glucoacetylene 7 
Apart from open-chain amino acids, cycloaddition of acetylene sugar 7 with the 
diastereomeric pipecolic acid derivatives 27 and 29 was also feasible, although with 
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lower efficiency (Scheme 3.3). The somewhat higher yield for the condensation with 
29 with respect to 27 may be rationalized by the respective equatorial and axial 
orientation of the azide where the latter experiences more steric hindrance. 
Unfortunately, 6-azidopipecolic acid derivative 31 failed to undergo cycloaddition 
with glucoacetylene 7, neither under the influence of Cu(OAc)2/Na ascorbate nor in 
the presence of CuI and base.13 Presumably, steric hindrance from the neighboring 
Cbz protective group and 2,6-diaxial interaction with the methyl ester preclude 
access to the azide. 
The above experiments firmly established the compatibility of the 1,3-dipolar 
cycloaddition with a range of protected amino acid derivatives, but led invariably to 
the β-linked triazole adduct. However, since O-linked glycoproteins are 
characterized by serine or threonine glycosylation with α-configuration, we became 
interested in expanding the scope of the sugar-amino acid CuAAC with α-configured 
acetylenes. Thus, synthesis of @-glucoacetylene 36 was accomplished by 
C-glycosidation (ethynylation) of sugar acetate 33 with 1-tributylstannyl-2-
trimethylsilylacetylene 3414 in the presence of trimethylsilyl triflate followed by 
desilylation of the initial adduct as described by Dondoni et al. (Scheme 3.4).15 
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Scheme 3.4 Synthesis of @-glycoamino acids 37 and 38 
Much to our satisfaction, under the influence of the previously established 
conditions, @-glycoacetylene 36 was successfully coupled to azidoamino acid 13 and 
15, to obtain @-glycoamino acids 37 and 38, respectively, in 60% yield (Scheme 3.4). 
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3.3 Triazole-linked glycopeptides 
The smooth cycloaddition of acetylenic sugars with a range of amino acid derivatives 
encouraged us to corroborate whether CuAAC is also suitable for the synthesis of 
glycopeptides. In theory, two alternative strategies can be followed to achieve such a 
goal, involving either incorporation of a presynthesized glycoamino acid in a 
growing peptide chain, or 1,3-dipolar cycloaddition of glycoacetylenes onto azido-
functionalized oligopeptides. Since several triazole-linked glycoamino acids were 
already at hand, the first strategy initially appeared most straightforward, as is 
illustrated in Scheme 3.5. The methyl ester of 22 was readily saponified to the 
carboxylic acid under the action of sodium hydroxide. Subsequent diimide-mediated 
coupling with glycine- and phenylalanine amide gave dipeptides 39 and 40 
uneventfully, as an illustration that the triazolyl glycoamino acids behave normally 
under standard peptide coupling conditions. 
22
1) NaOH, THF
2) EDCI, HOAt
Gly-NH2, or Phe-NH2
DIPEA, CH2Cl2
O
BnO
BnO
BnO
OBn
N
NN
CbzHN
( )3 H
N
O39 R = H (82%)
40 R = CH2Ph (86%)
NH2
O
R
 
Scheme 3.5 Peptide coupling of Cbz-T1P(4-GlcBn4)-OMe 22 
The alternative route, involving cycloaddition of dipeptides16 and carbohydrate 
moieties, appeared less trivial beforehand, taking into consideration the potential 
incompatibility of C-terminal amide functionality with the Cu(I)-catalyzed 
1,3-dipolar cycloaddition. To this end, a model dipeptide of azidopropylglycine and 
phenylalanine amide (41) was subjected to phenylacetylene under a range of 
conditions (Table 3.2). Indeed, the standard Cu(OAc)2/Na ascorbate combination in a 
mixture of t-butyl alcohol and water, conditions that served our goal so well before, 
failed to lead to reaction in this case (entry 1). Since it was observed that both 
substrates were only poorly soluble in t-BuOH/H2O, reaction was also performed in 
a THF/H2O mixture, but also to no avail (entry 3). A likely explanation for the 
complete failure to undergo cycloaddition is complexation of copper(I), added in 
substoichiometric amount, to the free amide functionality. As a result of the 
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complexation, oxidation of Cu(I) to Cu(II) may occur, as  may be inferred by the color 
change of the solution from yellow to blue. The latter observation led us to 
investigate the CuAAC in the presence of stoichiometric or excess CuI in acetonitrile 
or THF (entries 5-10). Unfortunately, also with an excess of a copper(I) species, in the 
presence of a variety of tertiary amines, resulted in only minor or no formation of the 
desired product (entries 5, 7 and 9). A more successful modification involved the 
addition of tris(benzyltriazolylmethyl)amine (TBTA), a ligand reported by Fokin et 
al.17 to protect copper from oxidation and disproportionation, while enhancing its 
catalytic activity. Indeed, addition of TBTA under any of the previously applied 
conditions led to a dramatic improvement in yield as well as a significant decrease in 
reaction time. In particular, the use of a CuI/TBTA combination in the presence of 
Et3N in acetonitrile resulted in a conversion of more than 90% of 41 into the desired 
Cbz-T1P(4-Ph)-Phe-NH2 42 (entry 8). 
Table 3.2 Optimization of the 1,3-dipolar cycloaddition of dipeptide 41 with phenylacetylene 
CbzHN
O
H
N
O
NH2 CbzHN
O
H
N
O
NH2
N3 NPh
[Cu]I, 35 °C
Ph Ph
NN
Ph
24 h
( )3( )3
41 42
N N
NN
Bn
TBTA
3
 
entry Cu(I)-source base ligand solvent conv. e 
1 Cu(OAc)2, Na-asca - - t-BuOH, H2O (1:1) 0% 
2 Cu(OAc)2, Na-asca - TBTAd t-BuOH, H2O (1:1) ~50% 
3 Cu(OAc)2, Na-asca - - THF, H2O (1:1) 0% 
4 Cu(OAc)2, Na-asca - TBTAd THF, H2O (1:1) ~40% 
5 CuIb DIPEA, 2,6-lutidineb - MeCN ~30% 
6 CuIb DIPEA, 2,6-lutidineb TBTAb MeCN ~70% 
7 CuIb Et3Nb - MeCN 0% 
8 CuIb Et3Nb TBTAb MeCN >90% 
9 CuBrc - PMDETAc THF 0% 
10 CuBrc - TBTAc THF ~70% 
a 0.2 equiv. of Cu(OAc)2 and 0.4 equiv. of Na-asc (Na ascorbate); b 2 equiv.; c 1 equiv.; d 0.2 equiv.; 
e Conversion determined by TLC and LC-MS based on consumption of 41 
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Having established suitable conditions for the cycloaddition of dipeptide 41 with 
phenylacetylene, condensation with glucose-derived acetylene 8 was investigated 
(Table 3.3). Although not applied to phenylacetylene, it was considered worthwhile 
to reduce the amount of copper iodide for the desired cycloaddition. Gratifyingly, it 
was found that reduction of CuI from two equivalents to one had no detectable effect 
on the conversion, reaching 100% conversion within 16 h (entry 1). With a further 
reduction to 50 mol% of copper, and even 20 mol%, complete conversion was still 
attained within 24 h (entry 2 and 3). Finally, only when the amount of copper was 
further reduced to 10 mol%, conversion failed to go to completion, even after 48 h 
(entry 4), whereas under the action of 1 mol% catalyst no conversion was observed at 
all (entry 5). 
Table 3.3 Optimization of catalyst loading 
+
CuI, TBTA
Et3N
MeCN, 40 °C
O
AcO
AcO
AcO
OAc
N
NN
CbzHN
( )3 H
N
O
NH2
O
Ph
41 8
43  
entry loadinga concentrationb time conversionc 
1 100 mol% 1.1 mM 16 h 100% 
2 50 mol% 1.8 mM 24 h 100% 
3 20 mol% 12 mM 24 h 100% 
4 10 mol% 3.7 mM 48 h 50% 
5 1 mol% 5 mM 48 h 0% 
a Loading of CuI, TBTA, and Et3N; b Concentration of substrates 
c Conversion determined by HPLC 
Since the reduction of the copper(I) catalyst loading below 20 mol% was found to be 
unsatisfactory for complete conversion to the product, subsequent couplings were 
performed under standardized conditions involving 20 mol% CuI, TBTA and Et3N in 
acetonitrile. As summarized in Table 3.4, glycodipeptides 39, 40, 43 and 45 were all 
obtained in excellent yield upon cycloaddition of N-Cbz-protected azidodipeptides 
41 and 44 with acetylenic C-glycosides 7 and 8, irrespective of the carbohydrate 
O-protective groups (acetyl in 8 and benzyl in 7). Deprotection of the acetyl 
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protective groups of 43 using K2CO3/MeOH, proceeded smoothly to give the 
unprotected triazole-linked glycodipeptide 46 (Table 3.4). 
Table 3.4 CuAAC reaction of dipeptides 41 and 44 with glycoacetylenes 7 and 8 and 
deprotection of 43 
Cbz
N
H O
H
N
N
7 or 8
CuI, TBTA, Et3N
MeCN, 40 °C, 16 h
ORO
RO
OR
RO
NN
( )3Cbz N
H O
N3 ( )3 H
N
41 R1 = CH2Ph
44 R1 = H
NH2
O
R1 NH2
O
R1
 
entry carbohydrate R1 glycodipeptide yield 
1 7 H (44) 96% 
2 8  62%a 
3 7 CH2Ph (41) 87% 
4 8  
b
Cbz N
H O
H
N
N
OBnO
BnO
OBn
BnO
NN
( )3
Cbz N
H O
H
N
N
OAcO
AcO
OAc
AcO
NN
( )3
Cbz N
H O
H
N
N
OBnO
BnO
OBn
BnO
NN
( )3
Cbz N
H O
H
N
N
ORO
RO
OR
RO
NN
( )3
O
NH2
O
NH2
NH2
O
NH2
O
Ph
Ph
39
45
40
43 R = Ac
46 R = H
 
88% 
20 mol% CuI, TBTA, and Et3N; a Conversion ca. 70%; b K2CO3, MeOH, 95% 
Whereas the examples so-far all involve cycloaddition of an azidopeptide with an 
acetylenic sugar, the alternative combination, i.e. CuAAC of an azidosugar with an 
acetylenic dipeptides was also investigated. Not unexpectedly, the desired 
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glycodipeptides 49 and 50 (Scheme 3.6) were formed uneventfully and in excellent 
yield upon subjecting acetylenic dipeptides 47 and 48, respectively, to 10. 
Cbz
N
H O
H
N
OAcO
AcO N
OAc
AcO
NN
N
H O
H
NCbz
49 R = H: 99%
50 R = CH2Ph: 92%
CuI, TBTA, Et3N
MeCN, 40 °C, 16 h
10
47 R = H
48 R = CH2Ph
NH2
O
R
NH2
O
R
 
Scheme 3.6 CuAAC reaction of dipeptides 47 and 48 with glucosyl azide 10 
A final example of the versatility of CuAAC for the synthesis of triazolyl 
glycopeptides is provided in the synthesis of a tripeptide with a central azidoalanine 
(Scheme 3.7). Cycloaddition to glycoacetylenes 8 and 9 resulted in the desired 
glycopeptides 52 and 53. In case of the fully unprotected glycoacetylene 9, the 
moderate yield could possibly be due to the fact that the highly hydrophilic character 
of 53 thwarted effective extraction during work-up (Scheme 3.7). 
O
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N
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O
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H
H
N
O
O
BocHN
Ph
OMe
ON3 CuI, TBTA,
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MeCN, 40 °C
52 R = Ac: 91%
53 R = H: 50%
51
8 or 9
BocHN OH
O
1) EDCI, HOBt,
Ala-OMe
DIPEA, CH2Cl2
2) TFA, CH2Cl2
3) EDCI, HOBt,
Boc-Phe-OH
DIPEA, CH2Cl2
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(63%)
13
 
Scheme 3.7 CuAAC reaction of tripeptide 51 with glycoacetylenes 8 and 9 
3.4 Conclusions 
Triazole-linked glycoamino acids of either α- or β-configuration were successfully 
prepared by application of Cu(I)-catalyzed 1,3-dipolar cycloaddition of 
alkynylsugars with a variety of azidoamino acids. The methodology was extended to 
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the synthesis of glycopeptides in two alternative strategies, involving either 
incorporation of triazole-linked glucoamino acids in a peptide chain or peptide 
coupling prior to cycloaddition with gluco-acetylenes. Both strategies successfully 
led to the desired glycopeptides, with no substantial difference in overall yield. In 
case of cycloaddition to C-terminal dipeptide amides, TBTA was found to be an 
essential ligand to stabilize the Cu(I) species and catalyze the cycloaddition, thus 
providing excellent conditions for the high-yielding assembly of 
triazolylglycopeptides. 
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3.6 Experimental section 
For general experimental details, see Section 2.6. Thermal analysis of representative 
azide-containing compounds has shown that upon warming exothermic 
decomposition may take place at onset temperatures lying between 70 and 150 °C. As 
an example, DSC measurements showed that compound 15 has an onset temperature 
of 70 °C, at which a strongly exothermic (576.6 kJ/kg) reaction takes place. Therefore, 
special caution has to be taken when handling these compounds. 
Nomenclature of the triazole-linked glycoamino acids. 
For the sake of clarity the names of the peptides were abbreviated, applying the 
standard three letter codes for natural amino acids. For the non-natural amino acids 
we derived a code as depicted in Figure 3.2. For example, T4M stands for a triazol-4-
yl-methylglycine containing amino acid and triazol-1-yl-butylglycine was 
abbreviated as T1B. Any substituents are presented in brackets. 
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NN
NX
O
n = 1: T1M(4-x)
[2-(4-X-Triazol-1-yl)-Methyl]-glycine
n = 2: T1E(4-x)
[2-(2-[4-X-Triazol-1-yl]-Ethyl)]-glycine
n = 3: T1P(4-x)
[2-(3-[4-X-Triazol-1-yl]-Propyl)]-glycine
Etc.
N
H
N
NN
X
O
n = 1: T4M(1-x)
[2-(1-X-Triazol-4-yl)-Methyl]-glycine
n = 2: T4E(1-x)
[2-(2-[1-X-Triazol-4-yl]-Ethyl)]-glycine
n = 3: T4P(1-x)
[2-(3-[1-X-Triazol-4-yl]-Propyl)]-glycine
Etc.
( )n ( )n
 
Figure 3.2 Nomenclature of the triazole-linked glycoamino acids. 
General procedure A (cycloaddition) 
To a solution of the glycosyl acetylene (1 equiv) and the amino acid derivative 
(1 equiv) in t-BuOH (0.5 M) was added a mixture of Cu(OAc)2 (20 mol%) and sodium 
ascorbate (40 mol%) in H2O (0.04 M and 0.08 M, respectively). The reaction was 
stirred overnight, water was added and the product was extracted with EtOAc (2 ×). 
The combined organic layers were washed with water, dried (Na2SO4) and 
concentrated. The product was purified by flash chromatography using 
EtOAc/heptane mixtures. 
General procedure B (optimized cycloaddition) 
To a solution of the peptide (25 µmol) and the carbohydrate (25 µmol) in MeCN 
(0.5 mL) were added solutions of Et3N in MeCN (10 mM, 0.50 mL, 0.20 equiv) and 
TBTA in MeCN (10 mM, 0.50 mL, 0.20 equiv). Nitrogen was bubbled through the 
solution for 5 min. A solution of CuI in MeCN (10 mM, 0.50 mL, 0.20 equiv) was 
added and the reaction mixture was stirred at 40 °C for 16 h. Brine (2 mL) was added 
and the mixture was extracted with EtOAc (2 × 4 mL). The combined organic layers 
were dried (MgSO4) and concentrated. The product was purified by gradient flash 
chromatography (MeOH/CH2Cl2). 
General procedure C (peptide coupling) 
Cbz-amino acid (1 mmol) was dissolved in DMF (2.5 mL). To the clear cooled (0-5 °C) 
solution was added DIPEA (0.35 mL, 2.1 mmol) followed by EDCI (211 mg, 
1.1 mmol) and HOAt (150 mg, 1.1 mmol) and the mixture was stirred for at least 0.5 h 
at 0-5°C. Subsequently, a solution of Phe-NH2 or Gly-NH2 (1.1 mmol) in DMF 
(2.5 mL) was added and the mixture was stirred for 1 h at 0-5 °C. The mixture was 
warmed to ambient temperature and stirred overnight. TLC analysis (EtOAc) 
showed complete conversion of the carboxylic acid starting material. The reaction 
mixture was partitioned between EtOAc (75 mL) and H2O (15 mL) to which a few 
drops of 1 N aqueous HCl were added. The aqueous layer was extracted with EtOAc 
(40 mL) and the combined organic phase was washed with 0.5 N aqueous HCl 
(40 mL), 1 M aqueous KHCO3 (40 mL) and brine (40 mL) and subsequently dried 
(Na2SO4) and concentrated. 
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1-[(Trimethylsilyl)ethynyl]-2,3,4,6-tetra-O-benzyl-D-glucopyranose (6) 
TMS-acetylene (9.0 mL, 61 mmol) was dissolved in THF 
(250 mL) and cooled to −78 °C. n-BuLi (44 mL, 71 mmol, 1.6 M in 
hexane) was added in 15 min and the reaction mixture was 
stirred for 45 min. The tetra-O-benzylglucolactone 5 (25.5 g, 
47.3 mmol) was dissolved in THF (250 mL) and added dropwise to the reaction 
mixture in 15 min. The reaction was stirred for 30 min, and quenched with saturated 
NH4Cl at −78 °C, extracted with EtOAc, washed with water and brine, dried (MgSO4) 
and concentrated. The product was purified by flash chromatography with 
EtOAc/heptane (1/2) and afforded the hemiacetal 6 (26.5 g, 41.5 mmol, 88%) as a 
colorless oil. Rf (EtOAc/heptane 1/2) = 0.49. 1H-NMR (CDCl3, 400 MHz, α/β = 
1/1.44) δ: 7.38-7.12 (m, 20 H), 5.07-5.03 (m, 1 H), 4.93-4.75 (m, 4 H), 4-64-4.60 (m, 1 H), 
4.56-4.48 (m, 2 H), 4.03-3.84 (m, 2 H), 3.77-3.63 (m, 4 H), 3.51-3.48 (m, 1 H), 0.21 and 
0.18 (s, 9H). 13C-NMR (CDCl3, 75 MHz) δ: 138.7, 138.5, 138.0, 137.9, 137.8, 137.7, 128.2, 
128.2, 128.1, 128.1, 128.0, 127.9, 127.8, 127.8, 127.7, 127.6, 127.6, 127.5, 127.5, 127.4, 
127.4, 127.2, 104.0, 100.7, 95.4, 93.5, 91.3, 89.0, 84.2, 84.1, 83.5, 82.4, 77.7, 77.4, 75.9, 75.7, 
75.6, 75.1, 75.0, 74.3, 74.1, 73.4, 73.4, 72.0, 68.6, 68.5, 0.2, -0.0. Both are in agreement 
with literature.9 
1-Ethynyl-1-deoxy-2,3,4,6-tetra-O-benzyl-β-D-glucopyranose (7) 
At 0 °C, a solution of BF3·OEt2 (13.5 mL, 108 mmol) and Et3SiH 
(17 mL, 107 mmol) in MeCN/CH2Cl2 (1/1, 200 mL) was added in 
15 min to a solution of hemiacetal 6 (13.7g, 21.5 mmol) in 
MeCN/CH2Cl2 (1/1, 200 mL). The reaction was stirred for 30 min and quenched 
with saturated NaHCO3, extracted with EtOAc, washed with brine, dried (MgSO4) 
and concentrated. Purification by flash chromatography with EtOAc/heptane (1/5) 
afforded glucosyl TMS acetylene (11.5 g, 86%). Rf (EtOAc/heptane 1/5) = 0.42. 
1H-NMR (400 MHz, CDCl3) δ = 7.38-7.11 (m, 20 H), 5.04 (d, J = 10.4 Hz, 1 H), 4.91 (d, 
J = 11.0 Hz, 1 H), 4.83-4.77 (m, 3 H), 4.62 (d, J = 12.2 Hz, 1 H), 4.55-4.50 (m, 2 H), 4.08-
4.05 (m, 1 H), 3.74 (dd, J = 10.8, 1.9 Hz, 1 H), 3.68 (dd, J = 10.8, 4.3 Hz, 1 H), 3.66-3.55 
(m, 3 H), 3.45-3.38 (m, 1 H), 0.18 (s, 9 H). Glucosyl TMS acetylene (11.5 g, 17.7 mmol) 
was dissolved in MeOH/CH2Cl2 (5/1, 120 mL), and a 1 M NaOH solution (35 mL) 
was added. The reaction was stirred for 1 h, quenched with 1 M HCl (35 mL), diluted 
with EtOAc (150 mL), washed with water, dried (MgSO4) and concentrated. 
Purification by gradient flash chromatography (EtOAc, heptane) afforded 
glucoacetylene 7 (7.5 g, 77%) as a white solid. Rf (1/5 EtOAc/heptane) = 0.24. 
1H-NMR (400 MHz, CDCl3) δ = 7.38-7.10 (m, 20 H), 5.00 (d, J = 10.4 Hz, 1 H), 4.91 (d, 
J = 11.0 Hz, 1 H), 4.85-4.78 (m, 3 H), 4.61 (d, J = 12.1 Hz, 1 H), 4.53 (d, J = 11.8 Hz, 
2 H), 4.06-4.02 (m, 1 H), 3.74 (dd, J = 10.9, 2.1 Hz, 1 H), 3.69 (dd, J = 10.9, 4.3 Hz, 1 H), 
3.66-3.57 (m, 3 H), 3.44 (ddd, J = 7.5, 4.1, 2.0 Hz, 1 H), 2.53 (d, J = 2.2 Hz, 1 H). In 
agreement with literature.18 
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1-Ethynyl-1-deoxy-2,3,4,6-tetra-O-acetyl-β-D-glucopyranose (8) 
To a solution of tetra-O-benzyl glycoacetylene 7 (2.80 g, 5.11 mmol) in 
Ac2O (80 mL) was added BF3·OEt2 (6.15 mL, 48.8 mmol). The reaction 
was stirred for 2.5 h, cooled to 0 °C quenched with saturated 
NaHCO3 and extracted with EtOAc (3 × 150 mL). The organic layer wash washed 
with brine, dried (MgSO4) and concentrated. Purification by flash chromatography 
with EtOAc/heptane (1/2) gave tetra-O-acetyl glycoacetylene 8. 1H-NMR (400 MHz, 
CDCl3) δ = 5.22-5.07 (m, 3 H), 4.24 (dd, J = 12.5, 4.8 Hz, 1 H), 4.22-4.19 (m, 1 H), 4.13 
(dd, J = 12.5, 2.2 Hz, 1 H), 3.68 (ddd, J = 9.8, 4.8, 2.2 Hz, 1 H), 2.52 (d, J = 2.2 Hz, 1 H), 
2.10 (s, 1 H), 2.07 (s, 1 H), 2.03 (s, 1 H), 2.01 (s, 1 H). In agreement with literature.19 
1-Ethynyl-1-deoxy-β-D-glucopyranose (9) 
A solution of 8 (0.815 g, 2.29 mmol) in MeOH (23 mL) was treated 
with a NaOMe (13.2 mL, 5.8 M in MeOH) at rt over night. The crude 
mixture was neutralized with Amberlite IR-120 (H+) (prewashed with 
MeOH), filtered and evaporated to obtain the desired product 9 (0.457 g, >99%). 
Rf(MeOH/CH2Cl2 1/9) = 0.12. 1H-NMR (400 MHz, CD3OD) δ = 3.95-3.92 (m, 1 H), 
3.86 (dd, J = 1.5 12.0 Hz, 1 H), 3.65 (dd, J = 5.2, 12.0 Hz, 1 H), 3.33-3.23 (m, 4 H), 2.89 
(d, J = 2.1 Hz, 1 H). In agreement with literature.19 
Boc-L-T1M{4-[β-D-Glc(Bn)4]}-OH (14) 
Applying general procedure A gave 14 as a white solid 
(54 mg, 0.07 mmol, 70%). Rf (1% AcOH in EtOAc) = 0.46. 
1H-NMR (400 MHz, CDCl3) δ = 7.52 (s, 1 H), 7.30-6.97 (m, 
20 H), 5.41 (br d, J = 5.3 Hz, 1H), 4.92-4.73 (m, 5 H), 4.57-4.46 
(m, 6 H), 4.17 (d, J = 10.8 Hz, 1 H), 3.90 (t, J = 9.1 Hz, 1 H), 3.79 (t, J = 8.8 Hz, 1 H), 
3.72-3.57 (m, 4 H), 1.41 (s, 9 H). 13C-NMR (75 MHz, CDCl3) δ = 170.3, 155.2, 145.0, 
138.3, 137.9, 137.7, 137.6, 129.0, 128.3, 128.3, 128.2, 128.0, 127.9, 127.9, 127.8, 127.7, 
127.7, 127.6, 127.5, 125.2, 124.6, 86.8, 81.8, 80.8, 79.4, 78.1, 75.8, 75.2, 75.0, 73.8, 73.6, 
69.1, 54.0, 51.4, 28.6. IR (film) ν = 3399, 3058, 2885, 2362, 2327, 1735 cm-1. HRMS (ESI) 
m/z calculated for C44H51N4O9 (M+H)+ 779.3656, found 779.3648. [@] D = +35.5 
(c = 0.68, CHCl3). 
Boc-L-T1E{4-[β-D-Glc(Bn)4]}-OH (16) 
Applying general procedure A gave 16 as a white solid 
(58 mg, 0.07 mmol, 73%). Rf (1% AcOH in EtOAc) = 0.53. 
1H-NMR (400 MHz, CDCl3) δ = 8.93 (br s, 1 H), 7.60 (s, 
1 H), 7.31-6.96 (m, 20 H), 5.55 (br s, 1 H), 4.92 (dAB, 
J = 11.3 Hz, 1 H), 4.88 (dAB, J = 11.5 Hz, 1 H), 4.84 (dAB, J = 
10.7 Hz, 1 H), 4.62 (dAB, J = 10.7 Hz, 1 H), 4.55-4.24 (m, 8 H), 3.90 (dd, J = 9.0, 8.6 Hz, 
1 H), 3.79 (dd, J = 8.6, 8.6 Hz, 1 H), 3.71-3.60 (m, 4 H), 2.47 (br s, 1 H), 2.19 (br s, 1 H), 
1.45 (s, 9 H). 13C-NMR (75 MHz, CDCl3) δ = 173.2, 155.7, 145.1, 138.4, 137.9, 137.8, 
137.7, 128.3, 128.1, 127.9, 127.7, 127.6, 124.0, 87.0, 81.8, 80.5, 79.4, 78.2, 75.7, 75.2, 74.9, 
73.8, 73.4, 69.1, 51.4, 47.1, 33.8, 28.6. IR (film) ν = 3391, 3019, 2902, 2859, 2353, 2327, 
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1714 cm-1. HRMS (ESI) m/z calculated for C45H53N4O9 (M+H)+ 793.3812, found 
793.3854. [@] D = +21.0 (c = 1.06, CHCl3). 
Boc-L-T1P{4-[β-D-Glc(Bn)4]}-OH (18) 
Applying general procedure A gave 18 as a white solid 
(59 mg, 0.07 mmol, 71%). Rf (1% AcOH in EtOAc) = 0.59. 
1H-NMR (400 MHz, CDCl3) δ = 9.87 (br s, 1 H), 7.42 (s, 
1 H), 7.29-6.98 (m, 20 H), 5.26 (d, J = 7.64 Hz, 1 H), 4.93 
(dAB, J = 11.1 Hz, 1 H), 4.89 (dAB, J = 11.1 Hz, 1 H), 4.84 
(dAB, J = 10.9 Hz, 1 H), 4.62 (dAB, J = 10.9 Hz, 1 H), 4.57-4.52 (m, 3 H), 4.48 (dAB, 
J = 12.3 Hz, 1 H), 4.28 (dAB, J = 10.9 Hz, 1 H), 4.30-4.10 (m, 3 H), 3.89 (dd, 
J = 9.2, 9.2 Hz, 1 H), 3.81 (dd, J = 9.0, 8.8 Hz, 1 H), 3.74-3.67 (m, 3 H), 3.63-3.59 (m, 
1 H), 1.92-1.62 (m, 4 H), 1.42 (s, 9 H). 13C-NMR (75 MHz, CDCl3) δ = 173.7, 155.0, 
145.0, 138.0, 137.4, 137.3, 137.3, 128.5, 127.9, 127.9, 127.8, 127.7, 127.7, 127.5, 127.4, 
127.4, 127.2, 127.2, 127.1, 127.1, 124.8, 122.5, 86.5, 81.3, 79.8, 78.9, 77.8, 75.3, 74.7, 74.4, 
73.5, 73.0, 68.7, 52.3, 49.4, 29.3, 28.2, 25.9. IR (film) ν = 3417, 3334, 3062, 3028, 2920, 
2863, 2362, 2332, 2237, 1701 cm-1. HRMS (ESI) m/z calculated for C46H54N4NaO9 
(M+Na)+ 829.3788, found 829.3787. [@]D = +11.2 (c = 0.92, CHCl3). 
Boc-L-T1M{4-[β-D-Glc(Bn)4]}-OMe (20) 
Applying general procedure A gave 20 as a white solid 
(175 mg, 0.22 mmol, 84%). Rf (1/1 EtOAc/heptane) = 0.40. 
1H-NMR (400 MHz, CDCl3) δ = 7.43 (s, 1 H), 7.33-7.00(m, 
20 H), 5.31 (br d, J = 6.2 Hz, 1 H), 4.94 (dAB, J = 11.1 Hz, 
1 H), 4.90 (dAB, J = 11.1 Hz, 1 H), 4.85 (dAB, J = 10.8 Hz, 1 H), 4.86-4.80 (m, 1 H), 4.75-
4.65 (m, 2 H), 4.61 (dAB, J = 11.7 Hz, 1 H), 4.58 (dAB, J = 10.9 Hz, 1 H), 4.56 (dAB, 
J = 12.1 Hz, 1 H), 4.51 (d, J = 9.7 Hz, 1 H), 4.51 (dAB, J = 12.1 Hz, 1 H), 4.28 (dAB, 
J = 10.7 Hz, 1 H), 3.92 (dd, J = 9.4, 9.2 Hz, 1 H), 3.81 (dd, J = 9.0, 8.8 Hz, 1 H), 3.75-3.67 
(m, 6 H), 3.63-3.60 (m, 1 H). 13C-NMR (75 MHz, CDCl3) δ = 181.1, 168.7, 154.4, 145.2, 
138.0, 137.4, 137.4, 127.9, 127.8, 127.7, 127.4, 127.3, 127.2, 127.2, 127.1, 123.6, 86.5, 81.4, 
80.4, 79.1, 77.8, 75.3, 74.7, 74.5, 73.6, 73.1, 68.8, 53.5, 52.8, 50.6, 28.1. IR (film) ν = 3028, 
2924, 2850, 2353, 2332, 1748, 1714 cm-1. HRMS (ESI) m/z calculated for C45H52N4NaO9 
(M+Na)+ 815.3632, found 815.3615. [@] D = +21.9 (c = 0.96, CHCl3). 
Cbz-L-T1P{4-[β-D-Glc(Bn)4]}-OMe (22) 
Applying general procedure A gave 22 (10.2 g, 11.9 mmol, 
87%) as a white solid. Rf (1/1 EtOAc/heptane) = 0.22. 1H-
NMR (400 MHz, CDCl3) δ = 7.41 (s, 1 H), 7.35-6.98 (m, 
25 H), 5.30 (br d, J = 8.0 Hz, 1 H), 5.13-5.07 (m, 2 H), 4.94 (d, 
J = 10.9 Hz, 1 H), 4.90 (d, J = 10.9 Hz, 1 H), 4.85 (d, J = 10.5 Hz, 1 H), 4.64-4.49 (m, 
5 H), 4.44-4.37 (m, 1 H), 4.35-4.27 (m, 3 H), 3.92 (t, J = 9.3 Hz, 1 H), 3.81 (t, J = 8.9 Hz, 
1 H), 3.74-3.60 (m, 4 H), 3.69 (s, 3 H), 1.92-1.62 (m, 4 H). 13C-NMR (50 MHz, CDCl3) 
δ = 172.0, 155.7, 145.4, 138.3, 137.8, 137.7, 135.9, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 
127.7, 127.7, 127.6, 127.5, 127.4, 122.6, 86.6, 81.5, 79.1, 77.9, 75.3, 74.8, 74.5, 73.8, 73.1, 
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68.9, 66.8, 52.9, 52.3, 49.2, 29.2, 25.9. IR (film) ν = 3321, 3028, 2950, 2863, 2249, 1951, 
1722, 1515 cm–1. HRMS (ESI) m/z calculated for C50H54N4NaO9 (M+Na)+ 877.3788, 
found 877.3805. 
Fmoc-L-T1P{4-[β-D-Glc(Bn)4]}-OH (24) 
Applying general procedure A gave 24 as a white solid 
(626 mg, 0.695 mmol, 69%). 1H-NMR (400 MHz, CDCl3) δ = 
7.74 (d, J = 7.5 Hz, 2 H), 7.55-7.51 (m, 2 ), 7.39-6.94 (m 24 H), 
5.01-4.33 (m, 13 H), 4.18-4.03 (m, 2 H), 3.88-3.81 (m, 5 H), 
3.58-3.42 (m, 1 H). IR (film) ν = 3058, 3032, 2863, 2245, 1718 cm-1. HRMS (ESI) m/z 
calculated for C54H52N4NaO9 (M+Na)+ 923.3632, found 923.3629. 
Fmoc-L-T1B{4-[β-D-Glc(Bn)4]}-OH (26) 
Applying general procedure A gave 26 as a white solid 
(662 mg, 0.702 mmol, 71%). 1H-NMR (400 MHz, CDCl3) δ = 
7.75 (d, J = 7.5 Hz, 2 H), 7.61-7.55 (m, 2 H), 7.45-6.95 (m, 
25 H), 5.40 (d, J = 6.9 Hz, 1 H), 4.92 (dd, J = 24.0, 11.1 Hz, 
2 H), 4.82 (d, J = 10.8 Hz, 1 H), 4.67 (d, J = 10.9 Hz, 1 H), 4.59-4.23 (m, 10 H), 4.20 (t, 
J = 6.8 Hz, 1 H), 4.01 (t, J = 9.5 Hz, 1 H), 3.81 (t, J = 8.7 Hz, 1 H), 3.75-3.53 (m, 4 H), 
2.02-1.78 (m, 2 H), 1.77-1.58 (m, 2 H), 1.39-1.22 (m, 1 H), 1.14-0.96 (m, 1 H). IR (film) 
ν = 3058, 3021, 2924, 2859, 1714 cm-1. HRMS (ESI) m/z calculated for C57H58N4NaO9 
(M+Na)+ 965.4101, found 965.4126. 
(2S,4R)-N-Cbz-4-{4-[β-D-Glc(Bn)4]-[1,2,3]triazol-1-yl} pipecolic acid methyl ester 
(28) 
Applying general procedure A gave 28 (39 mg, 
0.045 mmol, 49%) as a white solid. 
Rf (1/1 EtOAc/heptane) = 0.36. 1H-NMR (400 MHz, 
CDCl3) δ = 7.45 (s, 1 H), 7.39-6.95 (m, 25 H), 5.24-5.08 (m, 3 H), 4.95 (d, J = 11.1 Hz, 
1 H), 4.91 (d, J = 11.2 Hz, 1 H), 4.85 (d, J = 10.8 Hz, 1 H), 4.66-4.47 (m, 6 H), 4.39-4.25 
(m, 2 H), 3.95 (t, J = 9.2 Hz, 1 H), 3.84-3.61 (m, 8 H), 3.21 (dt, J = 25.0, 12.5 Hz, 1 H), 
2.84-2.67 (m, 1 H), 2.20-2.10 (m, 2 H),  2.00-1.86 (m, 1H). 13C-NMR (75 MHz, CDCl3) 
δ = 170.7, 155.9, 145.8, 138.5, 138.0, 137.9, 136.1, 129.6, 128.4, 128.3, 128.3, 128.1, 128.0, 
127.9, 127.7, 127.6, 127.5, 127.4, 121.8, 86.9, 81.7, 79.2, 78.1, 75.5, 75.0, 74.5, 74.0, 73.3, 
69.1, 67.6, 52.8, 52.4, 52.1, 37.9, 30.9, 28.3. HRMS (ESI): m/z calculated for 
C51H54N4NaO9 (M+Na)+ 889.3789, found 889.3815. 
(2S,4S)-N-Cbz-4-{4-[β-D-Glc(Bn)4]-[1,2,3]triazol-1-yl} pipecolic acid methyl ester (30) 
Applying general procedure A gave 30 (42 mg, 
0.049 mmol, 60%) as a white solid. 
Rf (1/1 EtOAc/heptane) = 0.36. 1H-NMR (400 MHz, 
CDCl3) δ = 7.44 (s, 1 H), 7.34-7.03 (m, 25 H), 5.17-5.14 (m, 2 H), 4.92 (d, J = 2.8 Hz, 
2 H), 4.85 (d, J = 10.9 Hz, 1 H), 4.73-4.47 (m, 6 H), 4.38 (d, J = 11.0 Hz, 1 H), 4.00-3.59 
(m, 7 H), 3.43 (s, 2 H), 2.84-2.78 (m, 1 H), 2.42-2.35 (m, 2 H), 2.19-2.11 (m, 1 H). 
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13C-NMR (75 MHz, CDCl3) δ = 170.7, 155.8, 145.4, 138.4, 137.9, 136.0, 129.6, 128.5, 
128.3, 128.2, 128.2, 128.1, 128.0, 127.9, 127.8, 127.8, 127.7, 127.6, 127.5, 127.4, 120.9, 86.8, 
81.6, 79.3, 78.1, 75.5, 75.0, 74.7, 73.9, 73.3, 69.0, 67.9, 55.0, 54.9, 53.7, 52.7, 40.5, 32.7, 
31.8. HRMS (ESI): m/z calculated for C51H54N4NaO9 (M+Na)+ 889.3789, found 
889.3812. 
Boc-L-T1M{4-[:-D-Glc(Bn)4]}-OH (37) 
Applying general procedure A gave 37 as a white solid (10 mg, 
0.01 mmol, 60%). Rf (1% AcOH in EtOAc)= 0.52. 1H-NMR 
(400 MHz, CDCl3) δ = 7.67 (s, 1 H), 7.31-7.09 (m, 20 H), 5.48 (br 
d, J = 4.7 Hz, 1 H), 5.29 (br d, J=4.9 Hz, 1 H), 4.95-4.90 (m, 2 H). 
4.80-4.74 (m, 3 H), 4.68-4.58 (m, 4 H), 4.49 (d, J = 10.8 Hz, 1 H), 
4.45 (d, J = 12.1 Hz, 1 H), 4.04-3.94 (m, 2 H), 3.75 (t, J = 8.9 Hz, 
1 H), 3.67-3.55 (m, 3 H). 13C-NMR (75 MHz, CDCl3) δ = 170.3, 
155.2, 142.9, 138.5, 137.9, 137.8, 137.7, 129.0, 128.5, 128.3, 128.0, 127.9, 127.7, 127.6, 
125.6, 125.3, 82.4, 80.7, 79.4, 78.0, 75.5, 75.1, 73.6, 73.4, 73.0, 69.2, 68.6, 54.1, 51.3, 28.6. 
IR (film) ν = 3404, 3032, 2915, 2859, 2358, 2336, 1709 cm-1. HRMS (ESI) m/z calculated 
for C44H50N4NaO9 (M+Na)+ 801.3475, found 801.3445. [@] D = +55.2 (c = 0.48, CHCl3). 
Boc-L-T1E{4-[:-D-Glc(Bn)4]}-OH (38) 
Applying general procedure A gave 38 as a white solid 
(49 mg, 0.06 mmol, 60%). Rf (1% AcOH in EtOAc) = 0.53. 
1H-NMR (400 MHz, CDCl3) δ = 7.64 (s, 1 H), 7.34-7.09 (m, 
20 H), 5.45 (br s, 1 H), 5.28 (d, J = 5.5 Hz, 1 H), 4.98 (dAB, 
J = 11.1 Hz, 1 H), 4.85 (dAB, J = 10.9 Hz, 1 H), 4.80 (dAB, 
J = 10.7 Hz, 1 H), 4.69 (dAB, J = 11.7 Hz, 1 H), 4.61 (dAB, 
J = 11.7 Hz, 1 H), 4.56 (dAB, J = 12.3 Hz, 1 H), 4.49 (dAB, 
J = 10.7 Hz, 1 H), 4.46 (dAB, J = 12.1 Hz, 1 H), 4.45-4.20 (m, 3 H), 3.98 (dd, 
J = 9.4, 9.2 Hz, 1 H), 3.75-3.56 (m, 5 H), 2.47 (br s, 2 H), 1.44 (s, 9 H). 13C-NMR 
(75 MHz, CDCl3) δ = 155.4, 143.3, 138.6, 137.6, 137.4, 128.3, 128.1, 127.9, 127.7, 127.6, 
124.8, 82.4, 80.4, 79.7, 78.4, 75.5, 75.1, 73.6, 73.4, 72.5, 69.2, 69.0, 46.3, 32.8, 30.0, 28.7. IR 
(film) ν = 3408, 3023, 2976, 2872, 2353, 2332, 1705 cm-1. HRMS (ESI) m/z calculated for 
C45H53N4O9 (M+H)+ 793.3812, found 793.3836. [@] D = +60.0 (c = 0.31, CHCl3). 
Cbz-L-T1P{4-[β-D-Glc(Bn)4]}-Gly-NH2 (39) 
Applying general procedure C gave 39 (361 mg, 
82%). Applying general procedure B gave 39 (22 mg, 
96%). Rf (2/1 EtOAc/heptane) = 0.17. 1H-NMR 
(400 MHz, CDCl3/MeOD) δ = 7.73 (s, 1 H), 7.33-6.95 
(m, 25 H), 5.10 (d, J = 12.3 Hz, 1 H), 5.09 (d, 
J = 12.3 Hz, 1 H), 4.91 (s, 2 H), 4.85 (d, J = 10.9 Hz, 1 H), 4.61-4.50 (m, 4 H), 4.47 (d, 
J = 12.0 Hz, 1 H), 4.34 (d, J = 7.0 Hz, 2 H), 4.23 (d, J = 11.0 Hz, 1 H), 4.14 (dd, 
J = 5.4, 8.4 Hz, 1 H), 3.91-3.70 (m, 7 H), 3.63-3.60 (m, 1 H), 2.02-1.60 (m, 4 H). 13C-NMR 
(50 MHz. CDCl3/MeOD) δ = 173.0. 172.5. 157.1. 145.6. 138.3. 137.8. 137.7. 137.6. 136.2. 
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128.3. 128.3. 128.3. 128.2. 128.0. 127.9. 127.8. 127.8. 127.7. 127.7. 127.6. 127.6. 127.5. 
123.6. 86.7. 81.7. 79.1. 78.0. 75.5. 75.0. 74.6. 73.8. 73.3. 68.8. 66.9. 54.5. 42.0. 28.5. 26.3. IR 
(film) ν = 3343, 2945, 2824, 2483, 2232, 2072 cm–1. HRMS (ESI) m/z calculated for 
C51H56N6O9Na (M+Na)+ 919.40065, found 919.39922. 
Cbz-L-T1P{4-[β-D-Glc(Bn)4]}-L-Phe-NH2 (40) 
Applying general procedure C gave 40 (418 mg, 
86%). Applying general procedure B gave 40 (21 mg, 
87%). Rf (2/1 EtOAc/heptane) = 0.20. 1H-NMR 
(400 MHz, CDCl3/MeOD) δ = 7.71 (s, 1 H), 7.33-6.93 
(m, 30 H), 5.06 (d, J = 12.2 Hz, 1 H), 5.03 (d, 
J = 12.2 Hz, 1 H), 4.89 (s, 2 H), 4.83 (d, J = 10.9 Hz, 
1 H), 4.62-4.48 (m, 5 H), 4.44 (d, J = 11.9 Hz, 1 H), 4.25 (t, J = 7.0 Hz, 2 H), 4.24 (d, 
J = 10.9 Hz), 4.03 (dd, J = 5.8, 8.0 Hz, 1 H), 3.85-3.76 (m, 2 H), 3.73-3.66 (m, 3 H), 3.62-
3.58 (m, 1 H), 3.16 (dd, J = 5.8, 14.0 Hz, 1 H), 2.90 (dd, J = 8.4, 14.0 Hz, 1 H), 1.78-1.48 
(m, 4 H). 13C-NMR (75 MHz, CDCl3/MeOD) δ = 174.4, 172.4, 157.3, 146.1, 138.8, 138.3, 
138.2, 138.1, 137.0, 136.5, 129.5, 128.8, 128.8, 128.6, 128.5, 128.4, 128.3, 128.2, 128.1, 
128.1, 128.0, 127.2, 123.8, 87.2, 82.2, 79.6, 78.4, 76.0, 75.4, 75.1, 74.3, 73.8, 69.3, 67.4, 54.8, 
54.3, 50.0, 37.9, 29.2, 26.3. IR (film) ν = 3369, 3282, 2945, 2828, 1696, 1645 cm−1. HRMS 
(ESI) m/z calculated for C58H62N6O9Na (M+Na)+ 1009.44760, found 1009.44631. 
Cbz-L-T1P{4-[β-D-Glc(Ac)4]}-L-Phe-NH2 (43) 
Applying general procedure B gave 43 (18 mg, 88%). 
Rf (EtOAc) = 0.42. 1H-NMR (400 MHz, 
CDCl3/MeOD) δ = 7.71 (s, 1 H), 7.36-7.16 (m, 10 H), 
5.37 (t, J = 9.4 Hz, 1 H), 5.23 (t, J = 9.7 Hz, 1 H), 5.19 
(t, J = 9.7 Hz, 1 H), 5.09 (d, J = 12.1 Hz, 1 H), 5.05 (d, 
J = 12.1 Hz, 1 H), 4.75 (d, J = 10.0 Hz, 1 H), 4.63 (dd, 
J = 8.1, 14.3 Hz, 1 H), 4.37-4.21 (m, 3 H), 4.14 (dd, J = 2.0, 12.5 Hz, 1 H), 4.12-4.05 (m, 
1 H), 3.91 (ddd, J = 2.0, 4.8, 12.4 Hz, 1 H), 3.17 (dd, J = 6.3 14.4 Hz, 1 H), 2.94 (dd, 
J = 8.2, 13.8 Hz, 1 H), 2.07 (s, 3 H), 2.06 (s, 3 H), 2.02 (s, 3 H), 1.88 (s, 3 H), 1.84-1.74 (m, 
2 H), 1.68-1.59 (m, 1 H), 1.54-1.43 (m, 1 H). 13C-NMR (50 MHz, CDCl3/MeOD) δ = 
173.5, 171.5, 170.9, 170.2, 169.9, 169.7, 143.9, 136.3, 135.7, 128.9, 128.2, 128.2, 128.0, 
127.7, 126.6, 122.6, 75.8, 73.6, 72.8, 71.4, 68.1, 66.9, 61.9, 54.0, 53.5, 49.5, 37.2, 25.7, 20.3, 
20.2, 20.0. IR (KBr) ν = 3307, 2955, 1753, 1675, 1533 cm–1. HRMS (ESI) m/z calculated 
for C38H46N6O13Na (M+Na)+ 817.30205, found 817.29744. 
Cbz-L-T1P{4-[β-D-Glc(Ac)4]}-Gly-NH2 (45) 
Applying general procedure B gave 45 (11 mg, 62%). 
Rf (EtOAc) = 0.11. 1H-NMR (400 MHz, 
CDCl3/MeOD) δ = 7.71 (s, 1 H), 7.33-7.28 (m, 5 H), 
5.33 (t, J = 9.4 Hz, 1 H), 5.20 (t, J = 9.6 Hz, 1 H), 5.15 
(t, J = 9.6 Hz, 1 H), 5.09 (d, J = 12.2 Hz, 1 H), 5.05 (d, 
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J = 12.3 Hz, 1 H), 4.72 (d, J = 10.0 Hz, 1 H), 4.44-4.29 (m, 1 H), 4.26 (dd, 
J = 12.4, 4.8 Hz, 1 H), 4.17-4.08 (m, 1 H), 4.11 (dd, J = 12.5, 1.9 Hz, 1 H), 3.94-3.75 (m, 
2 H), 3.88 (ddd, J = 9.6, 4.7, 2.0 Hz, 1 H), 2.05 (s, 3 H), 2.04 (s, 3 H), 1.99 (s, 3 H), 1.98-
1.90 (m, 2 H), 1.85 (s, 3 H), 1.82-1.71 (m, 1 H), 1.63-1.51 (m, 1 H). 13C-NMR (75 MHz, 
CDCl3/MeOD) δ = 172.3, 171.9, 170.8, 170.2, 169.9, 169.7, 156.7, 144.2, 135.8, 128.2, 
128.0, 127.7, 122.7, 75.9, 73.6, 72.8, 71.4, 68.2, 66.9, 66.7, 62.0, 54.1, 42.0, 30.5, 28.5, 26.0, 
20.3, 20.2, 20.1. IR (KBr) ν = 3351, 2953, 1754, 1675, 1525 cm–1. HRMS (ESI) m/z 
calculated for C31H40N6O13Na (M+Na)+ 727.25510, found 727.25131. 
Cbz-L-T1P[4-(β-D-Glc)]-L-Phe-NH2 (46) 
To a solution of glucodipeptide 43 (12 mg, 15 µmol) 
in MeOH (2 mL) was added K2CO3 (0.29 mg, 
1.5 µmol). The reaction mixture was stirred overnight 
at ambient temperature. The reaction mixture was 
neutralized with acidic Amberlite and stirring was 
continued for another 10 min. The product 46 was 
isolated after filtration and evaporation of solvent as a white solid (8.9 mg, 95%). 
1H-NMR (CDCl3/MeOD, 400 MHz) δ = 7.86 (s, 1 H), 7.35-7.30 (m, 5 H), 7.26-7.16 (m, 
5 H), 5.10 (d, J = 12.7 Hz, 1 H), 5.06 (d, J = 12.0 Hz, 1 H), 4.62 (dd, J = 8.6, 5.8 Hz, 1 H), 
4.41 (d, J = 8.6 Hz, 2 H), 4.33 (t, J = 6.8 Hz, 2 H), 4.06 (dd, J = 7.9, 5.8 Hz, 1 H), 3.88 (d, 
J = 11.3 Hz, 1 H), 3.72 (dd, J = 12.1, 4.7 Hz, 1 H), 3.60-3.43 (m, 4 H), 3.18 (dd, 
J = 14.0, 5.8 Hz, 1 H), 2.92 (dd, J = 14.0, 8.8 Hz, 1 H), 1.86-1.75 (m, 2 H), 1.68-1.49 (m, 
2 H). 13C-NMR (CDCl3/MeOD, 75 MHz) δ = 173.7, 171.7, 156.4, 136.1, 135.6, 128.4, 
127.6, 127.5, 127.3, 127.0, 125.9, 122.4, 79.9, 76.5, 73.5, 72.9, 69.4, 66.1, 61.0, 53.8, 53.3, 
48.9, 36.7, 27.9, 25.2. HRMS (ESI) m/z calculated for C30H38N6O9Na (M+Na)+ 
649.25980, found 649.26012. 
Cbz-L-T4M{1-[β-D-Glc(Ac)4]}-Gly-NH2 (49) 
Appying general procedure B gave 49 (18 mg, 99%). 
Rf (EtOAc) = 0.52. 1H-NMR (CDCl3/MeOD, 
400 MHz) δ = 7.93 (s, 1 H), 7.42-7.25 (m, 5 H), 5.99-
5.90 (m, 1 H), 5.53 (s, 1 H), 5.50-5.45 (m, 2 H), 5.34-
5.23 (m, 1 H), 5.11 (d, J = 12.4 Hz, 1 H), 5.08 (d, 
J = 12.4 Hz, 1 H), 4.49 (t, J = 6.2, 6.2 Hz, 1 H), 4.32 (dd, J = 12.6, 4.8 Hz, 1 H), 4.18 (dd, 
J = 12.6, 2.1 Hz, 1 H), 4.16-4.10 (m, 1 H), 3.92 (d, J = 17.1 Hz, 1 H), 3.84 (d, J = 17.0 Hz, 
1 H), 3.29-3.18 (m, 2 H), 2.09 (s, 1 H), 2.08 (s, 1 H), 2.04 (s, 1 H), 1.83 (s, 1 H). 13C-NMR 
(75 MHz, CDCl3/MeOD) δ = 172.1, 171.5, 170.5, 169.7, 169.3, 168.9, 156.3, 135.6, 127.9, 
127.6, 127.4, 121.6, 85.0, 74.2, 72.1, 70.2, 67.3, 66.6, 61.1, 54.1, 41.8, 27.1, 19.7, 19.6, 19.1. 
IR (KBr) ν = 3292, 2948, 1753, 1687, 1535 cm–1. HRMS (ESI) m/z calculated for 
C29H36N6O13Na (M+Na)+ 699.22380, found 699.22129. 
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Cbz-L-T4M{1-[β-D-Glc(Ac)4]}-L-Phe-NH2 (50) 
Appying general procedure B gave 50 (18 mg, 92%). 
Rf (EtOAc) = 0.60. 1H-NMR (400 MHz, 
CDCl3/MeOD) δ = 7.74 (s, 1 H), 7.41-7.16 (m, 10 H), 
5.96-5.87 (m, 1 H), 5.53 (s, 1 H), 5.49-5.41 (m, 2 H), 
5.06 (s, 2 H), 4.63 (dd, J = 8.1, 5.9 Hz, 1 H), 4.42 (t, 
J = 6.4, 6.4 Hz, 1 H), 4.31 (dd, J = 12.6, 4.9 Hz, 1 H), 4.16 (dd, J = 12.6, 2.1 Hz, 1 H), 4.11 
(ddd, J = 10.2, 4.8, 2.1 Hz, 1 H), 3.20-3.15 (m, 2 H), 3.05 (dd, J = 15.2, 6.9 Hz, 1 H), 2.96 
(dd, J = 13.9, 8.3 Hz, 1 H), 2.09 (s, 3 H), 2.06 (s, 3 H), 2.04 (s, 3 H), 1.82 (s, 3 H). 
13C-NMR (75 MHz, CDCl3/MeOD) δ = 173.6, 170.7, 170.5, 169.8, 169.4, 168.9, 156.1, 
143.1, 136.2, 135.6, 128.6, 128.5, 128.0, 127.7, 127.4, 126.3, 121.4, 85.0, 74.3, 72.2, 70.1, 
67.3, 66.6, 61.2, 53.9, 53.6, 36.8, 27.2, 19.8, 19.7, 19.2. IR (KBr) ν = 3351, 2942, 1748, 1693, 
1666, 1524 cm–1. HRMS (ESI) m/z calculated for C36H42N6O13Na (M+Na)+ 789.27075, 
found 789.26751. 
Boc-L-Phe-L-Dap(N3)-L-Ala-OMe (51) 
To a solution of Boc-L-Dap(N3)-OH (0.50 g, 2.2 mmol) 
and L-Ala-OMe (328 mg, 2.28 mmol) in CH2Cl2 (25 mL) at 
0 °C was added DIPEA (561 mg, 4.34 mmol), HOBt 
(323 mg, 2.39 mmol) and was stirred for 5 min before 
adding EDCI (458 mg, 2.39 mmol) very slowly. The reaction was stirred at 0 ºC for 
30 min and then at rt over night. The reaction was diluted with EtOAc (50 mL), 
washed with saturated NaHCO3, brine, dried (Na2SO4) and concentrated. The 
product was purified by column chromatography (5% MeOH in DCM) to obtain 
dipeptide Boc-L-Dap(N3)-L-Ala-OMe (596 mg, 1.89 mmol). 
Rf (EtOAc/heptane 2:1) = 0.68. 1H-NMR (300 MHz, CDCl3) δ = 6.83-6.82 (bd, 1 H), 
5.26 (bs, 1 H), 4.59 (q, J = 7.2 Hz , 1 H), 4.28 (bs, 1 H), 3.88 (dd, J = 4.2, 12.3 Hz, 1 H), 
3.54-3.50 (m, 1 H), 1.47 (s, 9 H), 1.44 (d, J = 7.2 Hz, 3 H); 13C-NMR (75 MHz, CDCl3) 
δ = 172.4, 168.5, 154.8, 53.2, 52.1, 51.7, 47.9, 27.8, 17.8; HRMS (ESI) m/z calculated for 
C12H22N5O5 (M+H)+ 316.1621, found 316.1627. Boc-L-Dap(N3)-L-Ala-OMe was 
dissolved in TFA/CH2Cl2 (1:1 10 mL). After 20 min the solvent was removed by 
evaporation The desired product was obtained sufficiently pure in a quantitative 
way. Rf (EtOAc/heptane 2:1) = 0.21. The same procedure as the first part of this 
synthesis was used for the coupling with Boc-Phe-OH. After purification by gradient 
flash chromatography (EtOAc/heptane) the desired product was obtained (596 mg, 
1.29 mmol, 63%); Rf (EtOAc/heptane 2:1) = 0.53. IR (film) ν = 3300, 3062, 2977, 2924, 
2106, 1745, 1692, 1649, 1526 cm-1. 1H-NMR (400 MHz, CDCl3) δ = 7.35-7.20 (m, 5 H), 
6.95 (br s, 1 H), 6.73 (d, J = 7.8 Hz, 1 H), 6.42 (d, J = 6.3 Hz, 1 H), 4.58-4.49 (m, 2 H), 
4.37 (dd, J = 6.5, 13.3 Hz, 1 H), 3.88 (m, 1 H), 3.75 (s, 3 H), 3.44 (dd, J = 5.6, 12.3 Hz, 
1 H), 3.15 (dd, J = 6.0, 14.1 Hz, 1 H), 3.06 (dd, J = 7.6, 14.1 Hz, 1 H), 1.41 (d, J = 7.2 Hz, 
3 H), 1.41 (s, 9 H). 13C-NMR (75 MHz, CDCl3) δ = 138.1, 129.1, 128.8, 127.2, 80.7, 77.4, 
77.0, 76.6, 58.0, 52.5, 52.2, 51.8, 48.4, 37.8, 28.2, 17.8. HRMS (ESI) m/z calculated for 
C21H31N6O6 (M+H)+ 463.2305, found 463.2328. 
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Boc-L-Phe-L-T1M{4-[β-D-Glc(Ac)4]}-L-Ala-OMe (52) 
Applying general procedure B (adjusted to 13 mg 51 
(28 µmol) and 10 mg 8 (28 µmol)) afforded the 
desired product 52 (21 mg, 26 µmol, 91%). Rf (5% 
MeOH in DCM) = 0.34. 1H-NMR (400 MHz, CDCl3) 
δ = 7.67 (s, 1 H), 7.34-7.19 (m, 5 H), 7.10-7.06 (m, 2 H), 
5.35 (t, J = 9.4 Hz, 1 H), 5.19 (t, J = 9.7 Hz, 1 H), 5.15 
(t, J = 9.7 Hz, 1 H), 5.02 (d, J = 6.0 Hz, 1 H), 4.96-4.91 (m, 1 H), 4.86 (dd, 
J = 4.7, 13.7 Hz, 1 H), 4.72-4.65 (m, 2 H), 4.42 (p, J = 7.2 Hz, 1 H), 4.33-4.24 (m, 2 H), 
4.11 (dd, J = 2.1, 12.4 Hz, 1 H), 3.85 (ddd, J = 2.1, 4.9, 10.0 Hz, 1 H), 3.74 (s, 3 H), 3.19 
(dd, J = 5.4, 14.1 Hz, 1 H), 2.96 (dd, J = 8.6, 14.1 Hz, 1 H), 2.06 (s, 3 H), 2.05 (s, 3 H), 
2.01 (s, 3 H), 1.38 (s, 9 H), 1.35 (d, J = 7.3 Hz, 3 H). 
Boc-L-Phe-L-T1M[4-(β-D-Glc)]-L-Ala-OMe (53) 
Applying general procedure B, (adjusted to 13 mg 51 
(28 µmol) and 5.4 mg 9 (28 µmol)) afforded the 
desired product 53 (9 mg, 14 µmol, 50%). Rf (10% 
MeOH in DCM) = 0.12. 1H-NMR (300MHz, MeOD) 
δ = 7.98 (s, 1 H), 7.29-7.18 (m, 5 H), 4.72-4.54 (m, 1 H), 
4.22 (dd, J = 9.8, 5.1 Hz, 1 H) , 3.85-3.81 (m, 1 H), 3.73 
(s, 3 H), 3.66-3.62 (m, 1 H), 3.56-3.49 (m, 1 H), 3.48-3.44 (m, 1 H), 3.42-3-39 (m, 2 H), 
3.09-2.71 (m, 2 H), 1.38 (d, J = 7.3 Hz, 3 H), 1.35 (s, 9 H). 
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4 Chemoenzymatic 
glycosylation of triazole-
linked glycopeptides 1 
Abstract 
Triazole-linked C- and N-glycodipeptides were enzymatically glycosylated with a 
carbohydrate oxazoline donor under the action of the enzyme Endo A. Although the 
conversion of the C-triazolyl glycopeptide stopped at a conversion of 50%, the 
corresponding N-triazolyl derivative was converted to the pentasaccharide with an 
efficiency of 80%. Next, the same chemoenzymatic glycosylation procedure was 
applied to a triazole-linked N-GlcNAc-modified peptide C34, of the C-terminal 
fragment of HIV-1 gp41. The resulting novel triazole-linked glycopeptide appeared 
fully resistant to peptide N-glycanase (PNGase F), a serum peptidase that effectively 
digests the native amide-linked glycopeptide. 
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1 Part of the research described in this chapter was performed in the research group of Prof. 
Dr. Lai-Xi Wang, Institute of Human Virology, Department of Biochemistry and Molecular 
Biology, University of Maryland. 
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4.1 Introduction 
Methods for the chemical synthesis of glycopeptides have advanced considerably, 
and peptides carrying relatively simple saccharides can now be prepared by a variety 
of procedures.1 Most commonly preformed Fmoc-protected glycoamino acid 
building blocks are employed in the stepwise solid phase assembly of the peptide 
backbone, since the very nature of the glycosidic bond-forming reaction conditions 
often hamper the side-chain glycosylation of preformed full-length peptides and is 
not suitable for the synthesis of O-linked glycopeptides. A disadvantage of early 
introduction of oligosaccharides onto the peptide, however, is that O–glycosidic 
linkages are known to be labile towards the harsh acidic conditions often used in 
peptide synthesis (Scheme 4.1),2 or can be subject to β-elimination under basic 
conditions. A range of alternative techniques have also been developed for the 
synthesis of glycoproteins, e.g. native chemical ligation and suppressor tRNA 
technology, but have not yet matured to the level of suitability for the synthesis of 
glycoproteins containing complex glycans. 
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Scheme 4.1 Acidic lability of an α-fucosidic linkage in 1 
Given the limitations pertaining to current state-of-the-art for synthesis of complex 
glycoproteins, an interesting alternative involves the chemical elongation of a 
growing peptide chain with a chemically inert amino acid building block carrying 
only a single sugar. Subsequently, after cleavage from the resin and purification, the 
glycopeptide can be conjugated to the full glycan. A promising possibility to achieve 
such a saccharide expansion is the chemoenzymatic approach to glycoprotein 
synthesis.3,4 This is in particular true when larger and more complex carbohydrate 
moieties have to be incorporated, since a preformed oligosaccharide can be 
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incorporated in one single chemoenzymatic step, which is in contrast to a chemical 
incorporation where only one monosaccharide moiety at a time is added. The most 
commonly employed enzyme to couple complex glycans to peptides is 
endo-β-N-acetylglucosaminidase, an enzyme that normally hydrolyzes the chitobiose 
(GlcNAc–(β1→4)-GlcNAc) core of N–linked glycoproteins to produce a free 
oligosaccharide and a protein possessing a single GlcNAc at the reaction site. For 
example, trimming of natural glycoproteins followed by subsequent introduction of 
alternative carbohydrate fragments lies at the core of so-called glycoprotein 
remodeling. Importantly, it has been shown that several members of the family of 
glucosaminidases, especially endo–β–N–acetylglucosaminidase A (Endo A) from 
Anthrobacter protophormiae and endo–β–N–acetylglucosaminidase M (Endo M) from 
Mucor hiemalis, can also catalyze transglycosylation, i.e. the transfer of an 
oligosaccharide from GlcNAc to another sugar residue. Consequently, if the acceptor 
sugar is already attached to a peptide, the result of such a transglycosylation is a 
glycopeptide bearing a complex N-linked glycan. An impressive application of 
glycoprotein remodeling is the synthesis of a homogeneous glycoform of RNase B 
(124 amino acid residues).5 Following treatment of a mixture of RNase B glycoforms 
with Endo H to produce a RNase containing a single GlcNAc residue, the 
glycopeptide was treated with Endo A and (Man)6GlcNAc2Asn (obtained from 
ovalbumin)6 to afford (Man)6(GlcNAc)2RNase B (Scheme 4.2). The yield of these 
reactions is low, and although it was shown that the presence of organic solvents 
could increase the synthetic utility of the process,7 a huge excess of one of the 
reactants is necessary to obtain moderate yields of the desired product. 
Man5-9 GlcNAc2 GlcNAc
Endo H
Man6 GlcNAc2 Asn
GlcNAc2Man6
Endo A
mixture of RNase B GlcNAcRNase B
Man6GlcNAc2RNase B  
Scheme 4.2 Glycopeptide remodeling of RNase B 
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Wang et al. applied this Endo A-mediated transglycosylation to a peptide sequence of 
gp120 (residues 336-342), which is an envelope glycoprotein part of HIV-1 (4, Scheme 
4.3).8 In addition to the use of Endo A for the incorporation of high mannose type 
N-glycan, Wang et al. showed the transglycosylation of a biantennary 
sialylglycopeptide (Ac-SGP; Ac-Lys–Val–Ala–Asn[(NeuAc–Gal–GlcNAc–Man)2–
Man–GlcNAc2]–Lys–Thr–OH)9 to form complex type CD52 5, by applying enzyme 
Endo M (Scheme 4.4).10 
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Scheme 4.3 Chemoenzymatic synthesis of Man9–glycopeptide 4 
A significant improvement to the oligosaccharide transfer of glycoprotein 
remodeling was developed utilizing sugar oxazolines as the donor component. The 
oxazolines, which were designed based on putative transition state mimetics, greatly 
enhance the rate of transglycosylation.11 This results in high product yields with only 
a small excess (ca. 3-fold) of the sugar donor. Using this method, Wang and 
coworkers were able to efficiently synthesize a homogeneous glycoform of RNase B 
in high yield (Scheme 4.5),12 which is a significant improvement compared to the 
original publication by Takegawa et al. (Scheme 4.2).5 
Chemoenzymatic glycosylation of triazole-linked glycopeptides   
 61 
O
HO
HO
H
N
NHAc
O
HO
HO
O
NHAc
OHO
O
OH
O
HO
HO
O
HO
O
HOHO
HO
O O
O
HO
HO
O
AcHN
O
HO
HO
O
NHAc
O
HO O
OH
OH
O
HO O
OH
OH
O
CO2H
O
HO
AcHN
HO
OHHO
O
CO2H
O
HO
AcHN
HO
OHHO
Ac-G-Q-N-E-T-S-
Q-T-S-S-P-S-NH2
O
HO
HO
H
N
NHAc
HO O
Ac-G-Q-N-E-T-S-
Q-T-S-S-P-S-NH2
Ac-SGP
GlcNAc-P
Endo M
GlcNAc-CD52
Complex type CD52 5
 
Scheme 4.4 Chemoenzymatic synthesis of complex type CD52 5 
Man5-9 GlcNAc2
Endo H
Endo A
buffer (pH 6.5)
23 °C, 2 h
mixture of RNase B GlcNAcRNase B
homogeneous glycoprotein 7
O
HO
HO
NHAc
O
HO
HO
O
NHAc
OHO
O
OH
O
HO
OH
O
HO
O
HO
HO
O
OH
O
HO
OH
O
OH
OH
O
OH
OHOH
HO O
O
HO
HOOHO
O
OH
O
HO
OH
O
HO
O
HO
HO
O
OH
O
HO
OH
O
OH
OH
O
OH
OHOH
HO O N O
(96%)
(80%)
O
HO
HO
NHAc
HO
6
 
Scheme 4.5 Efficient chemoenzymatic synthesis of homogeneous glycoform RNase B (7) 
using the oligosaccharide oxazoline 6 
The efficient method using carbohydrate oxazolines was applied in bisglycosylation 
of the peptide domain HIV–1 V3, containing two N–glycans.13 Furthermore, the 
technique was applied in probing the substrate structural requirement. It was 
revealed that the minimum substrate structure required for Endo A-catalyzed 
transglycosylation is a Man-(β1→4)-GlcNAc oxazoline moiety, although the enzyme 
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can tolerate modifications at the 3'- and/or 6'-positions of the disaccharide oxazoline, 
thereby allowing the transfer of both larger and selectively modified oligosaccharide 
moieties to the peptide acceptor.14  
O
HO
Man3
HO
HN
O
HO
O
Asn
NHAc
OH
O
OH2N
N175
Me
N175A
E177
OHO
O
HO
Man3
HO
OH2N
N175
HN+ O
E177
O-O
OH
Y217
O
H
R
hydrolysis product
hydrolysis
oxazoline
formation
transglycosylation O
HO
Man3
HO
HN
O
HO
O
R
NHAc
OH
O
OH2N
N175
E177
OHO
transglycosylation product
hydrolysis
O
HO
Man3
HO
HN
O
HO
O
Asn
NHAc
OH
O
OH2N
N175
E177
OHO
O
HO
Man3
HO
OH2N
N175
HN+ O
E177
O-O
Y217F
O
H
R
hydrolysis product
hydrolysis
oxazoline
formation
transglycosylation O
HO
Man3
HO
HN
O
HO
O
R
NHAc
OH
O
OH2N
N175
E177
OHO
transglycosylation product
hydrolysis
O
HO
Man3
HO
HN
O
HO
O
Asn
NHAc
OH
O
E177
OHO
O
HO
Man3
HO
HN+ O
E177
O-O
OH
Y217
O
H
R
hydrolysis product
hydrolysis
oxazoline
formation
transglycosylation O
HO
Man3
HO
HN
O
HO
O
R
NHAc
OH
O
E177
OHO
transglycosylation product
hydrolysis
O
HO
Man3
HO
HN+ O
Me
N175A Me
N175A
A
B
C
(nucleophile)
(nucleophile)
(nucleophile)
 
Scheme 4.6 Schematic models of the plausible mechanism of endo M catalysis.  
A, wild-type; B, enhanced transglycosylation mutant Y217F; C, glycosynthase-like mutant N175A. The 
Glu177 residue acts as the catalytic proton donor to activate the glycosidic bond, while the Asn175 
residue assists the essential orientation of the 2–acetamido group for nucleophilic attack at the 
activated anomeric center, leading to oxazolinium ion formation. The Tyr217 residue is important for 
the recognition of acceptors or water molecule activated by the Glu177 residue. The mutation of Y217F 
facilitates the approach of an acceptor to promote the transglycosylation and/or the exclusion of water 
to diminish the hydrolysis (B). The N175A mutant displays a loss of oxazoline formation ability; 
therefore, the mutant is inactive for N–glycan, but utilizes sugar oxazoline for transglycosylation 
without hydrolysis of the product (C). 
Recently, Wang et al. reported that mutants of Mucor hiemalis 
endo-β-N-acetylglucosaminidase (Endo M) show enhanced transglycosylation and 
glycosynthase-like activities.15 One mutant (Y217F) possessed much enhanced 
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transglycosylation activity and yet much diminished hydrolytic activity in 
comparison with the wild-type Endo M. Another mutant (N175A) acted like a 
glycosynthase. It was also found that the hydrolytic activity was knocked out, but 
that the mutant was able to take the highly active sugar oxazolines as donor 
substrates. The glycosynthase derived from endo-β-N-acetylglucosaminidases acts via 
a substrate-assisted mechanism (Scheme 4.6). 
In 2005 Wang et al. published a chemoenzymatic synthesis of the glycopeptide C34 
derived from HIV-1 gp41 (Figure 4.1).16 The GlcNAc-C34 domain was 
transglycosylated with a Man9 unit using Endo A (Scheme 4.7). 
 
Figure 4.1 Schematic depiction of HIV-1 gp41.  
The glycosylation sites, the amino acid sequences of N36 and C34, and their locations in the gp41 
ectodomain are shown. FP, fusion peptide; NHR, the N-terminal heptad repeat; CHR, the C-terminal 
heptad repeat; TM, the transmembrane domain 
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Scheme 4.7 Transglycosylation in the synthesis of M9-C34 
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The anti-HIV activity of the synthetic C34 glycopeptide was measured by means of a 
cell-fusion assay, and demonstrated potent inhibitory activities against HIV-1 
infection at nanomolar concentration (IC50 = 7.7 nM). Although the inhibitory activity 
of the synthetic C34 glycopeptide was slightly decreased with respect to C34 
(IC50 = 1.1 nM), the glycosylated C34 might still be superior to C34 in two aspects. 
Firstly, glycosylated C34 has a much better solubility and secondly, because of the 
general protective effect of glycosylation, the glycopeptides could be more resistant 
to protease digestion than C34, although the overall efficiency of glyco-C34 and C34 
has yet to be tested in animal models. 
It would therefore be of great interest to mimic these C34 glycopeptides by 
replacement of the amide linker between the peptide and the N-glycan, by our 
triazole linker (Figure 4.2). First of all it would be a synthetic challenge, but moreover 
it may answer some fundamental questions with respect to the biological activity and 
resistance to protease and peptide N-glycanase digestion17 of isosteric replacement of 
the amide bond in glycoproteins with a triazole. 
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Figure 4.2 Isosteric replacement of the native amide functionality by a triazole linker 
4.2 Chemoenzymatic glycosylation 
Before the chemoenzymatic transglycosylation to the full-length glyco-triazole-C34 
peptide was investigated, it was decided to first evaluate whether the triazole-linked 
glycopeptides are good substrates for chemoenzymatic transglycosylations. To this 
end, triazole–linked C-glycodipeptide 12 (Chapter 6)18,19 was deprotected first, as 
depicted in Scheme 4.8, in an overall yield of 71%. Furthermore, an N–linked 
glycoamino acid coupled to L-proline on the N–terminus was synthesized as a 
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substrate for transglycosylation (Scheme 4.8).20 It must be noted that both 
glycopeptides differ not only in amino acid constitution, but are also differentiated in 
an isosteric sense, since compound 13 belongs to the class of C-triazole-linked 
glycopeptides, while compound 16 has the carbohydrate fragment attached to N1 of 
the triazole moiety. 
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Scheme 4.9 Glycosylation of glucose dipeptides 13 and 16 with sugar oxazoline 17 
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The fact that both glycopeptides 13 and 16 do not carry a glucosamine sugar, but a 
β-linked glucose instead, may also shed further light on the substrate promiscuity of 
Endo A. For practical reasons, the hexasaccharide oxazoline 6 was not used as the 
donor, but the more easily accessible tetrasaccharide Man3-GlcNAc-oxazoline 17,11 
which was added in threefold excess (Scheme 4.9). 
Figure 4.3 shows the conversion as followed by HPLC analysis. It becomes clear that 
the conversion levels off after 45 min for both glycopeptides. Interestingly, under the 
same chemoenzymatic glycosylation conditions there was a large difference in 
maximum conversion: while 19 reaches a conversion of ca. 80%, glycopeptide 18 
stopped at only 52% conversion. The likely hydrolysis of products 18 and 19 by Endo 
A, thereby lowering the yield of product, was not observed within 24 h. Although at 
this stage no sound explanation can be provided for the difference in suitability 
between the two substrates, one could reason that a better isosteric reminiscence of 
the N-linked triazole to the natural amide linkage might play a role.  
 
 
Figure 4.3 Formation of glycopeptides 18 and 19. The oxazoline was added in 3-fold excess. 
Since it was discovered that conversion of the C-linked glycopeptide 13 into 18 
proceeded less efficiently as compared to conversion of 16 into 19, incorporation of 
the carbohydrate fragment onto C34 domain via the N-triazole linkage (GlcNAc-
C34**, 11) was considered the more logical option. 
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Scheme 4.10 SPPS and CuAAC reactions on the resin 
Thus, GlcNAc-C34** (11) was synthesized on a resin using solid phase peptide 
synthesis (SPPS) by using the standard Boc strategy.21 Two principal strategies can be 
followed, i.e. incorporation of a triazole-linked glycoamino acid in the growing 
peptide chain or a two-step approach involving initial incorporation of 
propargylglycine followed by introduction of the carbohydrate by 1,3-dipolar 
cycloaddition. Since the latter strategy is more modular in nature, i.e. it allows the 
attachment of a variety of sugars post-solid phase synthesis, it was investigated first. 
Therefore, propargylglycine20 was incorporated in the peptide synthesis sequence, 
followed by ligation with glucosamine 22 using the CuAAC reaction (Scheme 4.10). 
Unfortunately, CuAAC reaction on the resin did not succeed, neither on the terminal 
(21) nor on the internal (23) propargylglycine residue. 
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Scheme 4.11 SPPS of glycopeptide GlcNAc-C34** (11) with glycoamino acid 24 
In contrast, the desired glycopeptide 11 was smoothly obtained by incorporation of 
the glycoamino acid 2420 (Scheme 4.11). The protecting groups were removed from 
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the peptide backbone and GlcNAc O-6, but it was found that after cleavage from the 
resin two acetyl groups on O-3 and O-4 were retained requiring removal with 
hydrazine.22 The thus obtained product was purified by preparative reversed-phase 
HPLC and the structure established as being 11 by characterization using ESI-HRMS. 
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Scheme 4.12 Endo A-catalyzed glycosylation of the mimic (11) and wild-type (8) GlcNAc-
C34 
 
Figure 4.4 HPLC conversions of GlcNAc-C34 and GlcNAc-C34**. A, mimic 11 into 25 and B, 
native 8 into 26 
GlcNAc-C34** (11), as well as native GlcNAc-C34 (8),16 were glycosylated with the 
sugar oxazoline donor 17 under the action of Endo A. Gratifyingly, after 2 hours full 
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conversion (>95%) was observed by HPLC for both glycopeptides (Figure 4.4). The 
product peaks from the HPLC analyses were fractionated and the structures were 
confirmed by ESI-MS (Figure 4.5). 
 
Figure 4.5 ESI-MS spectra of A Man3GlcNAc2-C34** (25) and B Man3GlcNAc2-C34 (26) 
4.3 Stability towards enzymes 
Peptide-N4-(N-acetyl-β-D-glucosaminyl)asparagine amidase F (PNGase F) is an 
example of a peptide N-glycanase that cleaves the β-aspartylglucosamine bond of 
asparagine-linked oligosaccharides, thereby converting the asparagine residue into 
an aspartic acid. The enzyme PNGase F has a broad substrate specificity, but both the 
amino and carboxyl groups of the asparagine residue have to be in a peptide linkage, 
while the oligosaccharide must consist at least of the N,N’-diacetylchitobiose core, 
GlcNAc-(β1→4)-GlcNAc. Therefore, subjection of either 25 or 26 to the action of 
PNGase F provides a good insight into the stability of the triazole-linked 
glycopeptide 25 towards enzymes (Scheme 4.13). Much to our satisfaction, the native 
glycopeptide 26 was completely hydrolyzed within 1 hour, whereas the triazole-
linked glycopeptide 25, as expected, appeared unaffected (Figure 4.6). 
Man3GlcNAc2-C34 Man3GlcNAc2 C34+
PNGase F
tris-buffer
Man3GlcNAc2-C34**
PNGase F
tris-buffer
(100% conv)
No conversion
26
25  
Scheme 4.13 PNGase F-catalyzed hydrolysis of glycopeptides 25 and 26 
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Figure 4.6 Hydrolysis of glycopeptides 25 and 26 
4.4 Conclusions 
Triazole-linked glycopeptides can be effectively obtained by glycosylation of 
monosaccharide peptides with carbohydrate oxazolines catalyzed by Endo A, with a 
clear preference for the N-linked glycopeptide over the C-linked glycopeptide. The 
latter phenomenon may be explained by better isosteric mimicry of the N-triazole to 
the natural amide bond of N-glycoproteins. Apart from dipeptides, Endo 
A-catalyzed transglycosylation appeared also effective for a 34-mer synthetic 
glycopeptide, obtained by incorporation of a Boc-protected glycoamino acid in the 
growing peptide chain. The alternative approach, involving CuAAC reaction of an 
azidosugar onto the resin containing an acetylene-containing amino acid was not 
successful, although only preliminary results were shown. Possibly, a better 
efficiency can be obtained by switching to a solvent such as DMF in order to avoid 
shrinkage of the resin as is the case with acetonitrile. 
Finally, we have shown that the triazole-linked glycopeptide showed complete 
resistance towards PNGase F, an encouraging finding with respect to future in vivo 
applications of triazole-linked glycoproteins for e.g. imaging purposes or 
pharmaceutical use. 
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4.5 Outlook 
Currently, the triazole-linked glycopeptide 25 is being evaluated for its ability to 
form six-α-helix bundles with the corresponding N-terminal peptide fragment N36. 
Both C34 and N36 complexes will be analyzed by circular dichroism (CD), to give a 
measure for the α-helical content of the complex. Moreover, the measurement of the 
anti-HIV activity of the triazole-linked C34 glycopeptide 25 and the native 
glycopeptide 26 are in progress and their antiviral activities will be compared. 
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4.7 Experimental section 
For general experimental details, see section 2.6. Analytical reversed phase high 
pressure liquid chromatography (RP-HPLC) was performed on a Varian Prostar 
HPLC system with a Vydac™ protein peptide C18 column (0.5 × 15 cm, flow 
1 mL/min), eluted with a linear gradient of 0–60% CH3CN in 0.1% aqueous TFA in 
30 minutes. The HPLC system was coupled to a UV/Vis detector probing at 214 nm. 
Semipreparative RP-HPLC was performed on a HP1050 HPLC system with a 
Vydac™ C18 column (2.5 × 20 cm, 10 mL/min), eluted with a linear gradient of 
0-60% MeCN in 0.1% aqueous TFA in 90 minutes. LRMS (ESI-MS) was performed on 
a SCIEX API-150 EX single quadruple mass spectrometer. 
General procedure (glycosylation with sugar oxazoline) 
A mixture of the Man3GlcNAc-oxazoline 17 (290 nmol) and the glycopeptide 
(100 nmol) in a phosphate buffer (40 µL, pH 7.0, 50 mM) was incubated at 23 °C with 
the enzyme Endo A (0.4 µg). The reaction was monitored by analytical HPLC on a 
Waters Nova-Pak C18 column (3.9 × 150mm) at 40 °C with a linear gradient (0-90% 
MeCN containing 0.1% TFA in 30 min, flow rate 1 mL/min). The GlcNAc-peptide 
was converted into a new species that was eluted slightly earlier than the starting 
material. The chemoenzymatic reaction was stopped by heating in a boiling water 
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bath for 3 min. The product was purified by preparative HPLC on a Waters 
preparative column (Symmetry 300, 19 × 300 mm) to afford the glycopeptide. 
Procedure for PNGase digestion 
Glycosylated C34 peptides (25 or 26, 30 µg) in Tris-Cl buffer (20 µL, pH 7.5, 20 mM) 
was incubated at 37 °C with PNGase (6 U). The digestion was monitored by analytic 
HPLC under the conditions as applied in enzymatic glycosylation reactions.  
L-T1M[4-(β-D-Glc)]-L-Phe-NH2 (13) 
Cbz-L-T1M{4-[β-D-Glc(Ac)4]}-L-Phe-NH2 (12; 73 mg, 
0.095 mmol) was dissolved in MeOH (1 mL), and 
K2CO3 (2 mg, 9 µmol) was added. The reaction was 
stirred for 1.5 h at room temperature. The crude 
mixture was neutralized with Amberlite IR 120 
(prewashed with MeOH), filtered and evaporated to obtain the deacetylated product. 
This was dissolved again in MeOH (2 mL) and Pd/C (12 mg, 10 µmol) was added. 
The reaction was stirred overnight under an atmospheric pressure of H2. The 
suspension was filtered and the solvent was evaporated. The product was 
lyophilized from AcOH (1 M in H2O) to yield the desired product 13 (35 mg, 71%). 
1H-NMR (400 MHz, D2O) δ = 8.04 (s, 1 H), 7.51-7.31 (m, 5 H), 4.72-4.50 (m, 4 H), 4.06-
3.90 (m, 2 H), 3.84-3.74 (m, 2 H), 3.72-3.55 (m, 3 H), 3.20 (dd, J = 13.9, 6.5 Hz, 1 H), 
3.06 (dd, J = 13.9, 8.4 Hz, 1 H). 13C NMR (75 MHz. D2O) δ = 174.7, 172.6, 172.6, 144.2, 
135.8, 128.7, 128.2, 126.7, 125.1, 79.5, 76.5, 72.9, 72.4, 69.0, 60.3, 54.0, 52.5, 36.5. HRMS 
(ESI) m/z calculated for C20H29N6O7 [M+H]+ 465.20977; found 465.20851. 
L-T1M[4-(Man3GlcNAcGlc)]-L-Phe-NH2 (18) 
Applying the general procedure to 13 gave 18 (52% conversion). ESI-MS m/z 
calculated for C46H73N7O27 [M+H]+ 1155; found 1155. 
L-Pro-L-T4M[4-(Man3GlcNAcGlc)]-OH (19) 
Applying the general procedure to 16 gave 19 (79% conversion). ESI-MS m/z 
calculated for C42H69N6O28 [M+H]+ 1105; found, 1105. 
GlcNAc-C34** (11) 
The peptide was obtained via manual solid phase 
peptide synthesis (SPPS) using the in situ 
neutralization/HBTU activation procedure for Boc 
chemistry on a MBHA resin.23 N-terminus 
acetylation was performed by 2 × 2 min treatment 
with 1/1 v/v Ac2O/pyridine (5 mL 0.5 M in DMF). DNP was removed from the His 
with 2 × 30 min treatment with a mixture of DIPEA (1% v/v) and mercaptoethanol 
(4% v/v) in DMF (7 mL). Formyl groups were removed by treatment with a 
continuous flow of piperidine (250 mL; 20% v/v in DMF) in 8 min. The Boc groups 
were removed with a 2 × 1 min treatment with TFA. After a DMF, DCM, and a 
Ac-W-M-E-W-D-R-E-I-N-N*-Y-T-S-L-I-H-S-
L-I-E-E-S-Q-N-Q-Q-E-K-N-E-Q-E-L-L-NH2
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HO
N
NHAc
HO
NN
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1:1  v/v MeOH/DCM flow wash, the resin was dried under vacuum. HF cleavage 
(4% v/v of p-cresol added as a scavenger) and subsequent lyophilization gave the 
acetylated crude product. The acetyl protected glycopeptide was dissolved in 10% 
MeCN in H2O ( 1 mg/1 mL) and treated with hydrazine hydrate (10% v/v in H2O) for 
2 h.22 The fully deprotected GlcNAc-C34** was purified by preparative RP HPLC 
over a C18 column. The product was analyzed by HRMS (ESI): calculated for 
C195H299N54O68S [M+3H]3+ 4517.13193; found 4517.11479 (based on the deconvolution 
of the data). 
Man3GlcNAc2-C34** (25) 
Applying the general procedure to 11 gave 25 (100% conversion). ESI-MS calculated 
for C221H342N55O88S , M = 5207; found, 5207 (deconvolution by MaxEnt). 
Man3GlcNAc2-C34 (26) 
Applying the general procedure to 8 gave 26 (100% conversion rate). ESI-MS 
calculated for C220H342N53O89S M = 5182; found, 5182 (deconvolution by MaxEnt). 
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5 Supramolecular gel 
formation of triazole-linked 
oligosaccharides 
Abstract 
Glycoacetylenes were condensed with tri- and hexaazidohexamethylbenzene in the 
presence of a copper-wired stirring rod. The resulting triazole-linked 
oligosaccharides were found to form supramolecular gels, presumably by a 
combination of hydrogen bonding between the saccharide moieties and pi-pi stacking 
of the arene moieties, as indicated by molecular modeling. The trisaccharide gel was 
visualized using SEM, TEM and AFM techniques, all of which manifested the 
presence of intertwined fibers. 
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5.1 Formation of supramolecular gels 
A gel primarily consists of a solvent (or in exceptional cases air or gas) and an 
immobilizing agent. Typically, a solvent is entrapped in a 3D-network of the 
immobilizing agent, formed through cross-linking of polymeric strands by chemical 
binding, physical forces or mechanical entanglements.1-3  
There are many types of gels. One can make a classification depending on the 
medium or the source(Figure 5.1).4  
 
Figure 5.1 Classification of gels based on source or medium 
The simplest of the two categorizations is based on the medium in which the gel is 
formed. In general, gels form either in an organic solvent or a protic, polar solvent. 
Alternatively, gelation without solvent can also be recognized. 
A more sophisticated classification focuses on the source of the gelator. Thus, gels 
can be divided in natural and artificial gels. Artificial gels, in turn, can be subdivided 
based on constitution, i.e. supramolecular or macromolecular gels. A final 
subdivision of macromolecular gels, consisting of 3D-network forming polymers, 
reflects either physical or covalent bonding.  
A supramolecular gel consists of a 3D-network of non-covalently bound (e.g. via 
hydrogen bonding) fibers, which themselves are also the result of non-covalent 
interactions (Figure 5.2). The self-assembly of such small molecule gelators into Self-
Assembled Fibrillar Networks (SAFINs) is accomplished via hydrogen bonds, ionic 
bonds, van der Waals interactions, hydrophobic or hydrophilic interactions, metal 
coordination or pi-pi stacking.2 Because a supramolecular gel is built up entirely from 
non-covalent interactions, gel formation is reversible and the gel can be transformed 
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into a fluid by external factors such as temperature, pressure, concentration or 
addition of other solvents. 
 
Figure 5.2 Self-assembly of a supramolecular gel5 
A supramolecular gel is normally formed by heating a solution of a gelator and 
cooling the supersaturated solution to room temperature. Different possibilities arise 
when the solution is cooled (Figure 5.3). A gel is obtained when the gelator does not 
precipitate or form a crystal (as the result of multidirectional aggregation), but self-
assembles instead into a cross-linked 3D-network.2, 3, 6 
 
Figure 5.3 Schematic representation of gel aggregation 
The structure of a supramolecular gel and the conditions to obtain a gel from a 
gelator solution are currently understood at the supramolecular level. However, 
much less is known about the structure of the building blocks of the gel, i.e. the 
gelators. Van Esch et al. has proposed guidelines of properties that gelators should 
possess, which are: 1) complementary and unidirectional intermolecular interactions 
to favor fibrillar formation; 2) sufficiently high solubility to prevent crystallization; 
and 3) potential to form fiber cross-links for 3D-network formation.7 
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Taking these prerequisites in consideration, it becomes possible to design a molecule 
destined to form a gel. For example, unprotected glycosides have a high solubility 
and are able to form intermolecular hydrogen bonds that can aid in the formation of 
a cross-linked 3D-network. According to the guidelines, the glycoside should also 
have unidirectional intermolecular interactions. We envisioned that an arene core 
provides a suitable scaffold for the formation of a unidirectional fiber via pi-pi 
stacking (Figure 5.4). Based on the glycoacetylenes (Chapter 3), a logical 
retrosynthetic disconnection from the substituted benzene ring leads to an arene core 
charged with azides, thereby allowing access to the projected gelator via the well-
established CuAAC reaction (Figure 5.4). 
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Figure 5.4 Retrosynthesis of trimeric or hexameric glycoside 
5.2 Synthesis 
In order to equip the benzene scaffold with hexa- and trisaccharides, the requisite 
hexaazidohexamethylbenzene (HAB, 1) and triazidohexamethylbenzene (TAB, 2) 
were prepared first from the corresponding bromides (Scheme 5.1). 8, 9  
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Scheme 5.1 Synthesis of tri- and hexaazidohexamethylbenzene 1 and 2, respectively 
Since Gilbert et al.8 synthesized HAB as a potential explosive, precaution was 
compulsory. Indeed, DSC measurements of 1 showed exothermal decomposition 
energy of 3621 kJ/kg when heated above the melting point (166 °C). Although this 
high temperature suggests that 1 can be handled relatively safely at ambient 
temperature, it is uncertain if unknown material (e.g. metal ions) can initiate 
undesired decomposition. 
Initially, cycloaddition experiments were conducted with three azido compounds, i.e. 
benzyl azide, HAB (1) and TAB (2). As the acetylenic coupling partner, both 
unprotected and acetyl-protected glycoacetylenes 4 and 5 were employed.10 Recently, 
we established11 that CuAAC of acetylenic sugars and azido-modified amino acids is 
best performed under the action of Cu(OAc)2 and sodium ascorbate in a 
H2O/t-BuOH mixture. Thus, under the same conditions, 69% yield was obtained for 
cycloaddition of benzyl azide (3) with fully unprotected glycoacetylene 4 (Table 5.1, 
entry 1). Since it was realized that a higher yield was desirable for the multiply 
substituted benzene derivatives, cycloaddition was also attempted under the action 
of a copper-wired stirring rod, leading to full conversion of starting materials and a 
quantitative yield of the desired triazole adduct (entry 2). On the other hand, no 
difference in yield was observed between the different conditions upon CuAAC 
reaction of benzyl azide with the acetyl-protected sugar. 
A completely different situation occurred in case of the triple CuAAC addition of 
compound 4 or 5 onto triazide 2. The unprotected sugar gave little or no 
incorporation at all (entries 5 and 6) irrespective of the conditions employed. On the 
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other hand, the acetyl-protected sugar smoothly reacted with the triazide under 
either conditions, leading to quantitative (entry 7) or excellent (entry 8) yield of the 
desired adduct. It must be noted that a slightly elevated temperature was employed 
for the copper-wire-catalyzed reaction. Finally, the conditions with Cu(OAc)2 or 
copper-wire were tried in the CuAAC reaction with HAB (1). Unfortunately, for this 
particular azide no complete glycosylation took place for the unprotected 
carbohydrate (entries 9 and 10). More surprisingly, a striking difference in coupling 
efficiency was observed for the acetylated sugar 5 depending on the source of copper 
(entry 11 and 12).12 
Table 5.1 CuAAC reactions of glycoacetylenes 4 and 5 with azido-substituted arenes 
O
RO
RO
RO
OR
+ N3 core
n
ORO
RO
OR
NN
N core
n
RO
4 R = H
5 R = Ac
1 n = 6
2 n = 3
3 n = 1  
entry core R conditions a yield product 
1 H A 69% 6 
2  B quant. 6 
3 Ac A quant. 9 
4 
n = 1
3
 
 B quant. 9 
5 H A 6% 7 
6  B - b 7 
7 Ac A quant. 10 
8 n = 3
MeMe
Me
2
  B 84% 10 
9 H A - b 8 
10  B - b 8 
11 Ac A - b 11 
12 n = 6
1
  B 87% 11 
a Conditions: A. Cu(OAc)2, Na-ascorbate, H2O/t-BuOH (1:1); B. copper-wire, 
MeCN, 40 °C; b Multiple partially glycosylated products. 
The acetyl-groups of tri- and hexameric glucosides 10 and 11 were removed under 
the action of K2CO3 in methanol (reflux, 1 h) to form 1,3,5-tris-
Supramolecular gel formation of triazole-linked oligosaccharides 
 81 
(glucosyltriazolylmethyl)-2,4,6-methylbenzene (TGB, 7) and 1,2,3,4,5,6-hexakis-
(glucosyltriazolylmethyl)benzene (HGB, 8) as depicted in Scheme 5.2.  
OHO
HO
OH
NN
N core
n = 3 7 (TGB)
n = 6 8 (HGB)
OAcO
AcO
OAc
NN
N core
n = 3 10
n = 6 11
AcO HO
K2CO3
MeOH, ∆
(quant.)
 
Scheme 5.2 Deprotection of tri- and hexameric glucosides 10 and 11 
5.3 Supramolecular behavior of TGB and HGB 
5.3.1 Modeling 
In order to estimate the likeliness of supramolecular aggregation, information was 
needed about the molecular conformation of TGB and HGB first. To this end, some 
attempts were undertaken to obtain crystals for X-ray diffraction,3 but unfortunately 
no suitable crystals could be grown. Alternatively, semi-empirical modeling studies 
could give an indication about the conformational preference of the sugars.  
As shown in Figure 5.5, HGB can exist in eight specific conformers, depending on the 
glucotriazolyl moiety pointing up (A) or down (B) with respect to the plane of 
benzene core. The situation for TGB is much less complex, since only two possible 
conformers can exist, either with all substituents at the same side of the plane or an 
AAB-type conformation. 
A A A A A A
A A A A A B
A A A A B B
A A A B A B
A A B A A B
A A A B B B
A A B A B B
A B A B A B B B
B
AA
A
B
A
A A A
A A B
B
A
A
7
8  
Figure 5.5 Possible TGB and HGB conformers 
The structures were calculated using Spartan ’04 from Wavefunction, Inc, Irvine, CA 
and obtained by a geometry optimization in vacuum, using the semi-empirical 
module with PM3 parameters. PM3 is a semi-empirical method for the quantum 
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calculations of molecular electronic structure that was optimized for organic 
molecules.13, 14  
For steric reasons, one may assume that the AAB conformer of TGB is the lowest 
energy conformer. Surprisingly, PM3 calculations established the AAA conformation 
of TGB as the more stable conformer (AAB is 5.9 kcal/mol higher in energy). 
Presumably, intramolecular hydrogen bonding between the carbohydrate moieties is 
the reason for the preference for the AAA conformation. It has to be mentioned that 
the suggested preference for AAA conformation is based on calculations in vacuum 
and that factors like solvation might give different results. From the calculated 
geometry, the dimensions of the molecule could be readily determined (Figure 5.6). 
 
Figure 5.6 3D image of the calculated AAA conformation of TGB 
For HGB, PM3 calculations predict the lowest energy for the expected ABABAB 
conformation (Figure 5.7). Also in this case, the dimensions of the molecule HGB 
were determined from the calculated geometry (Figure 5.8). 
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Figure 5.7 Calculated relative energies of the eight conformers of HGB 
 
Figure 5.8 3D image and dimensions of the ABABAB conformation of HGB 
It is clear, however, that the optimal geometry of a single molecule in vacuum does 
not necessarily reflect the conformation of the same substrate during gel-formation. 
Therefore, PM3 geometry optimization was also performed on the stacked form of 
two molecules of TGB.* It became clear that now the AAB conformer was more 
favored and stacked nicely in the direction perpendicular to the benzene core (Figure 
5.9). It is not completely sure if the pi-pi stacking assures the linear nature of the strand 
 
* Unfortunately, the stacking of HGB could not be measured. 
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since the distance in this between the benzene-cores is approximately 4.8 Å which is 
significant larger than the ideal distance of 3.4 Å. The hydroxyl groups add 
additional stability through intermolecular hydrogen bonding. The diameter of this 
supramolecular strand is 1.8 nm. 
 
Figure 5.9 3D image for the calculated conformation for two stacked TGB molecules 
5.3.2 Gel formation 
Normally, gels are formed through a process that closely resembles recrystallization:1 
a supersaturated solution is cooled, resulting in the formation of a gel. The possibility 
of gel formation was tested for both TGB and HGB in the only solvents that could be 
used to dissolve the substrates, i.e. H2O, DMSO and DMF. Unfortunately, no gel 
formation was observed in any of these solvents for either oligomeric glycoside at 
different concentrations up to saturation. Furthermore addition of variety of 
anti-solvents (like toluene, MeOH, EtOH, CH2Cl2, MeCN, EtOAc, THF, and dioxane) 
to solutions of TGB and HGB in H2O, DMSO and DMF led to precipitation in stead of 
the desired gelation. 
A higher concentration of TGB and HGB in these solvents (H2O, DMSO and DMF) 
was expected to enlarge the chance of successful gel formation. Therefore, 
supersaturated solutions of TGB (8.5% w/w) and HGB (5.0% w/w) were prepared in 
H2O, DMSO or DMF by sonication. Unexpectedly, no clear solutions were obtained 
but to our satisfaction, gel formation occurred for both oligomeric glycosides in 
DMF. Apparently, the added energy of the sonication process was necessary to break 
intramolecular hydrogen bonds and molecule–solvent interactions, in order to form 
Supramolecular gel formation of triazole-linked oligosaccharides 
 85 
intermolecular hydrogen bonds of the gel. These intermolecular hydrogen bonds, 
combined with the linear character of the presumed pi-pi stacking interactions, led to a 
supramolecular strand. 
Surprisingly, gel formation still occurred when the concentrations of TGB and HGB 
in DMF were decreased. The critical gel concentration (Cgel), the minimal 
concentration at which a gel could be formed, was determined for both oligomeric 
glucosides: Cgel of HGB is 4.6% w/w and the Cgel of TGB is 8.1% w/w. Typical 
concentrations reported are below 15%,15 although very low concentrations have 
been reported in the case of sugar-derived “supergelators”.16 The nearly double 
value Cgel of TGB with respect to the Cgel of HGB can be explained by the fact that 
HGB contains more glycosides compared to TGB. Presumably, HGB can therefore 
form more hydrogen bonds than TGB at the same concentration. 
The gelation temperature (Tgel), the temperature at which the gel dissolves again, was 
also determined for the oligomeric glucoside: Tgel of TGB (8.3% w/w) is 96 °C. The 
Tgel of HGB (5.9% w/w) could not be determined exactly since DMF has a boiling 
point of 153 °C and at this temperature the gel did not yet dissolve. Moreover this 
indicates that the HGB gel consist of strong interactions. 
5.3.3 Scanning Electron Microscopy 
 
Figure 5.10 SEM images of the TGB-gel in DMF; A) bar is 1 µm; B) bar is 200 nm 
A B 
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The TGB-gels described above were studied with a range of microscopic techniques 
(i.e. SEM, TEM, AFM) to visualize the gel structures.† Several scanning electron 
microscopy (SEM) images were obtained from the TGB-gel (Figure 5.10). The 
3D-network, distinctive for a gel consisting of intertwined fibers,17 was clearly 
visible. The various fibers did not have a consistent thickness, which can be taken as 
an indication that there was not a single way in which the strands of one molecule 
interact to form larger fibers. 
5.3.4 Transmission Electron Microscopy 
After determination of the gel morphology with SEM, the dimensions of single 
strands were also determined with transmission electron microscopy (TEM). 
 
Figure 5.11 TEM images of TGB-gel in DMF; A) bar is 1 µm; B) bar is 500 nm; C) bar is 200 
nm 
The TEM images obtained from our experiments showed agglomerates of fibers, 
with some individual fibers distinguishable from the agglomerates (Figure 5.11). 
TEM is suitable for determining the width of the observed fibers. Several individual 
TGB-fibers have been measured. This resulted in a distribution of fiber width over 6 
to 18 nm (Figure 5.12). 
 
† Unfortunately, the HGB-gel could not be visualized by SEM, TEM or AFM, since during 
sample preparation the HGB gel dissolved upon dilution with water 
A B  C 
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Figure 5.12 Single strand width distribution of the TGB-gel 
5.3.5 Atomic Force Microscopy 
Finally, the TGB-gel was studied with atomic force microscopy (AFM). The images 
obtained display some agglomerates as well as some individual fibers (Figure 5.13). 
 
Figure 5.13 AFM images of TGB-gel in DMF 
The heights of several of these fibers were determined, resulting in a height 
distribution as shown in Figure 5.14. The fibers that are around 8 nm in height 
consist possibly of two stacked fibers, which is in agreement with the majority of the 
measured heights of around 4 nm. 
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Figure 5.14 Supramolecular fiber height distribution of the TGB-gel 
5.4 Gel formation hypothesis 
The SEM images show a characteristic 3D-network of the TGB-gel. The AFM images 
visualized some individual fibers, thereby allowing height measurements. A fiber 
height distribution around 4 nm was clearly observed, along with another 
distribution around 8 nm, probably the result of overlaying fibers. In contrast, width 
determination based on the individual fibers visualized by the TEM images resulted 
in a distribution of fiber width between 6 and 18 nm. The apparent discrepancy 
between the different measurements based on TEM or AFM may be explained by the 
fact that TEM (and SEM) is measured in vacuum and AFM in ambient atmosphere. 
Also the nature of the sample grids may play a role: the AFM samples were prepared 
on hydrophobic carbon grids, whereas the TEM samples were prepared on 
hydrophilic Formvar grids. The fibers in the TEM sample can be wider, because the 
glucoside groups are drawn towards the Formvar grid through hydrophilic 
interactions. Moreover, the resolution of the TEM images was not as good as the 
resolution of the AFM images and there was not a distinct pattern in the fiber width. 
Therefore, it was difficult to draw a clear-cut conclusion from the fiber width data. 
The diameter of a single molecular strand of TGB is 1.8 nm, according to PM3 
geometry optimization. This indicates that a single fiber must consist of more than 
one strand. A fiber consisting of more than one strand has more intermolecular 
hydrogen bonds, which is beneficial to the fiber stability. The single fibers are then 
Supramolecular gel formation of triazole-linked oligosaccharides 
 89 
intertwined to aggregate and form bigger fibers. Finally, the bigger fibers get 
entangled, resulting in the typical gel 3D-network. 
Another possibility might be that during the sample preparation with water, the 
fibers absorb water, which can position between the sugar units, and cause chain 
swelling. Since TEM and SEM measurements are in vacuum and AFM is ambient, it 
might be possibly that the fibers shrink in vacuum and cling together, and therefore 
the width distribution is not unambiguous. This can be further investigated by AFM 
studies and changing the relative humidity, like Samorí et al. did for 
polyisocyanides.18 
5.5 Conclusions 
A tri- and hexaglycosylated hexamethylbenzene derivative were efficiently 
synthesized by the CuAAC reaction and in good yield, starting from the oligoazides 
and glucoacetylene 5. The unprotected TGB (7) and HGB (8) were both able to form a 
supramolecular gel in DMF, using sonication at 90 °C. The TGB gel could be 
visualized using SEM, TEM, and AFM. Unfortunately, the HGB-gel could not be 
visualized by SEM, TEM or AFM, probably as a result of the dilution in water for the 
sample preparation procedure. 
Modeling studies using PM3 calculations showed large energy differences for the 
postulated TGB and HGB conformers. The lowest energy conformation of TGB was 
AAA. However, AAB was the lowest energy conformation in the two-molecular 
stack calculations, due to intermolecular interactions. The lowest energy 
configuration of HGB was ABABAB.  
5.6 Outlook 
Since the work described in this chapter is a first attempt to study the behavior of 
these tri- and hexameric glucosides, the conclusions drawn from the measurements 
are not unambiguous. In order to extend the research and validate the hypotheses, 
several additional measurements need to be performed. 
First of all, the modeling experiments need to be expanded to involve several aspects 
like modeling on solvated molecules instead of vacuum. The solvent can play an 
important role in the conformation and stacking, since the molecules can form, 
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besides inter- and intramolecular hydrogen bonds, hydrogen bonds with the solvent. 
Also, further calculations can be made on expanding the TGB stack from two to 
three, and stacking of two or more HGB molecules. Finally, it would be interesting to 
obtain an X-ray diffraction pattern from single crystals of one of the oligosaccharides. 
From this data, hard evidence can be obtained about the conformation of the 
carbohydrate moieties as well as the stacking of the molecules. 
Secondly, NMR experiments from the gel in D2O with stepwise dilution can shed 
light on the intermolecular interaction of the glycoclusters before gelation takes 
place. Chemical shifts (in particular the benzylic and triazole protons) can reveal new 
aspects of the self-association just before gelation, because these are characteristic for 
the geometry of the molecules in the final aggregates. 
Furthermore, a different sample preparation should allow visualization of the 
HGB-gels with different microscopic techniques. 
From a safety point of view, it had to be studied whether the synthesis and isolation 
of the oligoazides could be bypassed, for instance via a one-pot synthesis of the 
oligosaccharides from in-situ generated azides (Scheme 5.3).17 
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Scheme 5.3 One-pot synthesis of HGB via an in-situ generated oligoazide 
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5.8 Experimental section 
Materials 
For general experimental details, see section 2.6. Peaks were assigned based on 2D 
analyses (gCOSY, gHSQC, and/or gHMBC). Size exclusion chromatography was 
performed with sephadex superdex 75 silica gel using the indicated solvent 
(mixture). TEM experiments were performed using a JEOL 100 CX Transmission 
microscope (100kV). SEM experiments were performed using a JEOL JSM T300 
Scanning microscope (30kV). AFM experiments were performed using a Nanoscope 
III instrument from Digital Instruments. 
For the semi-empirical modeling studies, the structures are calculated using Spartan 
’04 from Wavefunction, Inc, Irvine, CA and are obtained by a geometry optimization 
in vacuum, using the semi-empirical module with PM3 parameters. 
Sample preparations 
Gel formation: TGB or HGB was dissolved in DMF in a sealed HPLC vial. This was 
sonicated at 90 °C for 90 minutes. 
SEM sample preparation: The TGB DMF gel was diluted with a small amount of 
water. A carbon grid was doped into the water and subsequently dried under 
vacuum. Finally it was stained with gold/platinum. 
TEM sample preparation: The TGB DMF gel was diluted with water. A Formvar grid 
was doped into the water and subsequently dried under vacuum. There was no 
additional staining. 
AFM sample preparation: The TGB DMF gel was diluted with water. A carbon grid 
was doped into the water and subsequently dried under vacuum.  
Warning 
Azide containing molecules can be very explosive. Especially if more than one of this 
functional group is present in a relative small molecule. Nitrogen gas is released when an 
azide group degrades. This can result in a rapid expansion of volume, which can break the 
container that holds the azide compound. Hexakis-azide 1 has even been tested for its 
explosive characteristics.8 Special attention with regard to security should be paid while 
synthesizing and handling these azides. 
HAB (1) 
To a solution of 1,2,3,4,5,6-hexakis(bromomethyl)benzene (1.84 g, 
2.89 mmol) in DMF (7 mL) was added sodium azide (1.69 g, 
26.0 mmol). The mixture was stirred at room temperature for 24 h 
and then heated to 50 °C for 23 h. The solvent was evaporated in 
high vacuum and the white solid was dissolved in EtOAc. The 
organic phase was washed with H2O (4 ×) and brine and dried over 
MgSO4. Then the organic phase was concentrated in vacuo and recrystallization 
yielded 1 (0.840 g, 2.06 mmol, 71%) as a white solid. 1H-NMR (300 MHz, acetone-d6) 
δ = 2.76 (s, 12H). IR (film) ν = 2358, 2098, 1247 cm-1. Elemental Analysis: %C = 35.52, 
%H = 4.02, %N = 61.17. In agreement with literature.8 
N3
N3
N3
N3
N3
N3
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TAB (2) 
To a solution of 1,3,5-tris(bromomethyl)-2,4,6-trimethylbenzene 
(0.500 g, 1.26 mmol) in acetone (10 mL) was added sodium azide 
(0.370 g, 5.64 mmol). The mixture was stirred and heated to reflux for 
24 h. The mixture was concentrated in vacuo. The excess of sodium 
azide was washed away with H2O and 2 (0.358 g, 1.26 mmol, quant.) 
was obtained. Rf (EtOAc/heptane 1:10) = 0.27. 1H-NMR (200 MHz, CDCl3) δ = 4.50 (s, 
6 H), 2.46 (s, 9 H). 13C-NMR (50 MHz, CDCl3) δ = 138.3, 131.0, 49.1, 16.6. IR (film) 
ν = 2085, 1334, 1235 cm-1. Elemental Analysis: %C = 50.39, %H = 5.30, %N = 44.28. In 
agreement with literature.19 
MGB (6) 
A solution of benzyl azide (3, 30 mg, 0.23 mmol) and 4 (27 mg, 
0.14 mmol) in MeCN (2.5 mL) was stirred with a stirring bar 
winded with copper wire at room temperature for 7 d. The solvent 
and excess benzyl azide were evaporated in vacuo and yielded 6 (46 mg, 0.14 mmol, 
quant.) as a white solid. Rf (MeOH/toluene 1:5) = 0.21. 1H-NMR (400 MHz, CD3OD) 
δ = 7.98 (s, 1 H), 7.36-7.32 (m, 5 H), 5.58 (s, 2 H), 4.39 (d, J = 9.2 Hz, 1 H), 3.85 (d, 
J = 12.0 Hz, 1 H), 3.66 (dd, J = 4.6, 12.1 Hz, 1 H), 3.55 (t, J = 8.2 Hz, 1 H), 3.47-3.40 (m, 
3 H). 13C-NMR (75 MHz, CD3OD) δ = 147.8, 136.7, 130.0, 129.6, 129.3, 124.8, 82.2, 79.6, 
75.7, 75.0, 71.6, 63.0, 55.0. IR (film) ν = 3342, 2357, 1643 cm-1. HRMS (ESI) m/z 
calculated for C15H19N3Na1O5 (M+Na)+ 344.12224, found 344.12199. 
(Ac)MGB (9) 
A solution of benzyl azide (3, 75 mg, 0.56 mmol) and 5 (0.100 g, 
0.281 mmol) in MeCN (5 mL) was stirred with a stirring bar 
winded with copper wire at 40 °C for 49 h. H2O was added and 
the product was extracted with CH2Cl2. The organic phase was concentrated in vacuo 
and the product was purified by chromatography (EtOAc/heptane 1:1) to obtain 9 
(0.13 g, 0.27 mmol, 96%) as a white solid. Rf (EtOAc/heptane 1:1) = 0.21. 1H-NMR 
(400 MHz, CDCl3) δ = 7.54 (br s, TrH), 7.40-7.21 (m, PhH), 5.50 (s, CH2Ph), 5.32 (t, 
J = 9.3 Hz, H-C(3)), 5.23 (t, J = 9.4 Hz, H-C(2)), 5.14 (t, J = 9.6 Hz, H-C(4)), 4.77 (d, 
J = 9.3 Hz, H-C(1)), 4.25 (dd, J = 4.6, 12.4 Hz, H-C(6)), 4.10 (d, J = 12.2 Hz, H-C(6)), 3.85 
(dd, J = 3.3, 9.8 Hz, H-C(5)), 2.04 (s, OAc), 2.03 (s, OAc), 1.99 (s, OAc), 1.85 (s, OAc). IR 
(film) ν = 2358, 1748, 1217 cm-1. HRMS (ESI) m/z calculated for C23H28N3O9 (M+H)+ 
490.18255, found 490.18173. 
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(Ac)TGB (10) 
A solution of 2 (15 mg, 0.053 mmol) and 5 (62 mg, 
0.17 mmol) in MeCN (2 mL) was stirred using a 
stirring bar winded with copper wire at 40 °C for 
23 h. H2O was added and the product was 
extracted with CH2Cl2. The organic phase was 
concentrated in vacuo and the product was purified 
by chromatography (EtOAc) to obtain 10 (61 mg, 
0.045 mmol, 84%) as a white solid. Rf 
(MeOH/CH2Cl2 1:19) = 0.10. 1H-NMR (400 MHz, CDCl3) δ = 7.42 (br s, (C=CH)3), 5.61 
(br s, (CH2Ph)3), 5.30 (t, J = 9.4 Hz, H-C(3)3), 5.20 (t, J = 9.7 Hz, H-C(2)3), 5.10 (dd, 
J = 9.4, 10.0 Hz, H-C(4)3), 4.71 (d, J = 10.0 Hz, H-C(1)3), 4.25 (dd, 5.1, 12.4 Hz, H-C(6)3), 
4.12-4.08 (m, H-C(6)3), 3.83 (ddd, J = 2.3, 5.0, 10.1 Hz, H-C(5)3), 2.33 (s, (CH3Ph)3), 2.03 
(s, (OAc)3), 2.02 (s, (OAc)3), 1.99 (s, (OAc)3), 1.84 (s, (OAc)3). 13C-NMR (75 MHz, 
CDCl3) δ = 170.6, 170.1, 169.5, 144.2, 140.0, 130.3, 122.0, 76.3, 73.9, 73.2, 71.2, 68.5, 62.2, 
49.2, 20.8, 20.6, 16.5. IR (film) ν = 2920, 2358, 1748, 1364, 1225, 1044, 603 cm-1. HRMS 
(ESI) m/z calculated for C60H76N9O27 (M+H)+ 1354.48506, found 1354.47769. 
(Ac)HGB (11) 
A solution of 1 (35 mg, 0.085 mmol) and 5 
(0.200 g, 0.561 mmol) in MeCN (4 mL) was 
stirred with a stirring bar winded with copper 
wire at 40 °C for 90 h. H2O was added and the 
product was extracted with CH2Cl2. The organic 
phase was concentrated in vacuo and the 
product was purified by gradient 
chromatography (100% CH2Cl2 to 90% 
CH2Cl2/MeOH) to obtain 11 (0.19 g, 
0.074 mmol, 88%) as a white solid. Rf (CH2Cl2/MeOH 9:1) = 0.25. 1H-NMR (400 MHz, 
CDCl3) δ = 7.96 (s, (C=CH)6), 5.73 (d, J = 15.9 Hz, ½(CH2Ph)6), 5.41-5.33 (m, H-C(2)6, 
H-C(3)6 and H-C(4)6), 5.25-5.20 (m, ½(CH2Ph)6), 4.75 (d, J = 9.6 Hz, H-C(1)6), 4.28 (dd, 
J = 5.0, 12.5 Hz, H-C(6)6), 4.14 (dd, J = 1.9, 12.5 Hz, H-C(6)6), 3.88 (ddd, 
J = 2.3, 5.0, 10.0 Hz, H-C(5)6), 2.06 (s, (OAc)6), 2.05 (s, (OAc)6), 2.04 (s, (OAc)6), 1.88 (s, 
(OAc)6). 13C-NMR (75 MHz, CDCl3) δ = 170.6, 170.0, 169.5, 144.7, 137.1, 124.0, 76.3, 
73.6, 73.1, 71.5, 68.5, 62.2, 47.6, 20.6. IR (film) ν = 2954, 2358, 1744, 1364, 1221, 1035, 
914 cm-1. 
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TGB (7) 
A solution of 10 (0.160 g, 0.118 mmol) in 2.8 mM K2CO3 
MeOH solution (10 mL) was stirred at reflux temperature 
for 1 h. Water and amberlite IR120 were added and the 
solution was stirred for another ½ h. The beads were 
filtered off and the product was concentrated in vacuo. 
This yielded 7 (0.101 g, 0.119 mmol, quant.) as a white 
solid. Rf (MeOH/CH2Cl2 1:9) = 0.0. 1H-NMR (400 MHz, 
D2O) δ = 7.92 (s, 3 H), 5.79 (s, 6 H), 4.53 (d, J = 9.7 Hz, 3 H), 
3.89 (dd, J = 1.7, 12.4 Hz, 3 H), 3.75 (dd, J = 5.1, 12.4 Hz, 3 H), 3.69 (d, J = 9.5 Hz, 3 H), 
3.63 (d, J = 8.7 Hz, 3 H), 3.58 (dd, J = 2.3, 5.5 Hz, 3 H), 3.55 (d, J = 8.8 Hz, 3 H), 2.32 (s, 
9H). 13C-NMR (75 MHz, D2O) δ = 144.3, 140.0, 129.4, 123.9, 79.4, 76.6, 73.0, 72.3, 69.0, 
60.3, 48.8, 15.2. HRMS (ESI) m/z calculated for C36H51N9Na1O15 (M+Na)+ 872.34023, 
found 872.33954. 
HGB (8) 
A solution of 11 (0.15 g, 0.058 mmol) in 2.8 mM K2CO3 
MeOH solution (10 mL) was stirred at reflux 
temperature for 1½ h. Water and amberlite IR120 were 
added and the solution was stirred for another ½ h. 
The beads were filtered off and the product was 
concentrated in vacuo. This yielded 8 (90 mg, 
0.059 mmol, quant.) as a white solid. 
Rf (MeOH/CH2Cl2 1:9) = 0.0. 1H-NMR (400 MHz, D2O) 
δ = 7.87 (s, TrH), 6.00 (s, CH2Ph), 4.46 (d, J = 9.3 Hz, 
H-C(1)), 3.93 (dd, J = 2.0, 12.5 Hz, H-C(6)), 3.77 (dd, J = 5.3, 12.4 Hz, H-C(6)), 3.61-3.51 
(m, 24H). 13C-NMR (75 MHz, D2O) δ = 144.8, 136.9, 123.9, 79.5, 76.5, 73.0, 72.5, 69.1, 
60.5, 48.1. IR (film) ν = 3321, 2876, 2103, 1048 cm-1. HRMS (ESI) m/z calculated for 
C60H84N18Na1O30 (M+Na)+ 1559.54984, found 1559.54258. 
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6 Chemoenzymatic peptide 
coupling in the synthesis of 
triazole-linked 
glycopeptides1 
Abstract 
Chemoenzymatic peptide coupling of azide- or acetylene-containing amino acid 
methyl esters with natural amino acid amides under the influence of alcalase was 
investigated. Condensation was found to proceed cleanly and in high yield. 
Incorporation of glycoamino acid esters in peptides is investigated for a range of 
different protective groups and side-chains, and was most successful for glycoamino 
acid esters with acetyl protecting groups (R1 = Ac) and a short side-chain (n = 1). 
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1 Part of this chapter has been published: a) Groothuys, S.; Kuijpers, B. H. M.; Quaedflieg, P. 
J. L. M.; Roelen, H. C. P. F.; Wiertz, R. W.; Blaauw, R. H.; van Delft, F. L.; Rutjes, F. P. J. T., 
Synthesis 2006, 3146. b) Kuijpers, B. H. M.; Groothuys, S.; Hawner, C.; ten Dam, J.; 
Quaedflieg, P. J. L. M.; Schoemaker, H. E.; van Delft, F. L.; Rutjes, F. P. J. T. Org. Process Res. 
Dev. 2008, 12, 503 
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6.1 Introduction 
The current state-of-the-art of peptide synthesis typically involves a reiterative 
deprotection-coupling protocol starting from the amino acid at the C-terminus of a 
desired peptide. Such an approach has proven to be highly valuable and peptides 
numbering over one hundred residues can thus be prepared on the solid phase. 
Conceptually quite distinct, chemoenzymatic peptide synthesis has received 
relatively sparesome but increasing interest over the last decade,1, 2 and is 
characterized by a number of specific advantages over chemical peptide synthesis: 
(a) chemoenzymatic peptide coupling reactions are always free from racemization, 
(b) side-chain protection can mostly be omitted, (c) the coupling reagent (enzyme) 
can be recycled efficiently, (d) the process is environmentally friendly, (e) the 
reaction proceeds under mild conditions and (f) can be readily scaled up. On the 
down-side, there lies a great challenge in chemoenzymatic peptide synthesis 
involving incorporation of proline3 and/or non-proteinogenic amino acids such as 
D-, β- and unnatural amino acids.4 In Chapter 3 we showed that triazole-linked 
glycoamino acids and peptides can be acquired by a combination of Cu(I)-catalyzed 
azide acetylene 1,3-dipolar condensation (CuAAC) and a typical diimide-mediated 
peptide coupling.,5 We have now broadened the repertoire of preparation of triazole-
linked glycopeptides by elongation of glycoamino acids with proteinogenic amino 
acids via both conventional solution-phase chemical peptide synthesis and 
chemoenzymatic procedures. Under the influence of alcalase, not only acetyleno- and 
azidoalkylamino acid methyl esters were found to act as acyl donors for 
condensation with N-unprotected amino acid amides, but also triazole-linked 
glycoamino acids could be successfully coupled. 
In a typical chemoenzymatic peptide synthesis protocol,2 an N-protected amino acid 
(bearing a free carboxy group) is condensed with a C-protected amino acid. 
Unfortunately, since the reaction is equilibrium-controlled (Scheme 6.1A), the 
thermodynamically more stable starting materials (in other words, the hydrolysis 
products) are usually favored unless the desired condensation product precipitates 
or is otherwise removed from the solution. An alternative kinetically controlled 
approach (Scheme 6.1B) involves C-activation of an N-protected amino acid.6 Such an 
approach is potentially more favorable since the yield is now predominantly 
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determined by enzymatic properties such as substrate specificity and the ratio of 
synthesis vs. hydrolysis.2 The most suitable enzymes for chemoenzymatic peptide 
synthesis include the majority of the commercially available serine, metallo-, and 
aspartate endo- and exoproteases.7,8,9 
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Scheme 6.1 Equilibrium-controlled (A) and kinetically controlled (B) enzymatic peptide 
synthesis (R1-COOH = carboxy component; R1-CO-X = slightly activated carboxy 
component; H2N-R2 = amino component; HX = leaving group) 
6.2 Peptide coupling 
In order to effect enzymatic coupling of a neutral and bulky N-protected unnatural 
amino acid such as azidopropylglycine methyl ester (1) and propargylglycine methyl 
ester (2), with a proteinogenic C-protected amino acid, the enzymes that were 
considered involved the typical subtilisin or carboxypeptidase Y.1 However, inspired by 
the work of Chen et al.,7 it was instead decided to focus attention on cheap and 
industrially available alcalase, a proteolytic enzyme mixture produced by Bacillus 
licheniformis (containing subtilisin Carlsberg as the major enzyme component), with 
high activity and stability in alcoholic solvents. Thus, in order to determine whether 
1 and 2 are suitable substrates for alcalase, initial experiments involved hydrolysis to 
the free acids in a 1:1 mixture of t-butyl alcohol and 1 M aqueous potassium 
bicarbonate (Scheme 6.2). 
It was observed that both 1 and 2 were completely hydrolyzed after 5 min, but 
hydrolysis of the triazole-linked glycoamino acid methyl ester 3 was much slower 
(complete conversion after 24 h with a 5-fold excess of alcalase). Most likely, the bulky 
glycosidic side-chain of 3 is not well accommodated in the active site of the enzyme. 
Nevertheless, the successful chemoenzymatic hydrolysis under the action of alcalase 
was a clear indication the amino acid esters were suitable substrates for the enzyme. 
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Scheme 6.2 Alcalase-induced hydrolysis of amino acid methyl esters. 
Table 6.1 Chemical and chemoenzymatic condensation of azidopropylglycine methyl ester 1 
CbzHN
N3 ( )3
OMe
O
1
+
CbzHN
N3 ( )3 H
N
O
NH2
Ochemicalor
enzymatic
coupling R
H2N NH2
O
R
 
entry R conditions dipeptide yield 
1 H chemicala 4 80% 
2 H chemoenzymaticb  95% 
3 CH2Ph chemicala 5 69% 
4 CH2Ph chemoenzymaticb  77% 
a 1. NaOH, THF; 2. EDCI, HOAt, DIPEA, DMF 
b alcalase, t-BuOH, DMF, 35 °C 
In the next step, alcalase-promoted condensation of the ornithine-derived donor 1 was 
explored with amino acid nucleophiles glycine amide and phenylalanine amide, 
under anhydrous conditions (Table 6.1). We were delighted to find that the 
respective dipeptides 4 and 5 were formed in high yields (entries 2 and 4) by 
chemoenzymatic condensation, comparing favorably to chemical coupling with 
EDCI (entries 1 and 3). Furthermore, the resulting dipeptides were formed with 
exclusive diastereoselectivity, i.e. without detectable racemization. 
Chemoenzymatic peptide coupling in the synthesis of triazole-linked glycopeptides  
 101 
Table 6.2 Chemical and chemoenzymatic condensation of propargylglycine methyl ester 2 
CbzHN OMe
O
2
+
CbzHN
H
N
O
NH2
Ochemicalor
enzymatic
coupling R
H2N NH2
O
R
 
entry R conditions dipeptide yield 
1 H chemicala 6 60% 
2 H chemoenzymaticb  80% 
3 CH2Ph chemicala 7 55% 
4 CH2Ph chemoenzymaticb  79% 
a 1. NaOH, THF; 2. EDCI, HOAt, DIPEA, DMF 
b alcalase, t-BuOH, DMF, 35 °C 
Similarly, dipeptides 6 and 7 were formed successfully by alcalase-mediated coupling 
of propargylglycine 2 to glycine amide and phenylalanine amide, respectively (Table 
6.2, entries 2 and 4). Again, the isolated yields compare favorably to the same 
condensations executed under the action of EDCI in DMF. 
Table 6.3 Chemical and chemoenzymatic condensation of T1P(GlcBn4) methyl ester 3 
O
BnO
BnO
BnO
OBn
N
NN
CbzHN CO2Me
( )3
O
BnO
BnO
BnO
OBn
N
NN
CbzHN
( )3
O
H
N
NH2
O
R
chemical
or
enzymatic
coupling
H2N NH2
O
R
3  
entry R conditions dipeptide yield 
1 H chemicala 8 82% 
2 H chemoenzymaticb  10% 
3 CH2Ph chemicala 9 86% 
4 CH2Ph chemoenzymaticb  0% (40%)c 
a 1. NaOH, THF; 2. EDCI, HOAt, DIPEA, DMF 
b alcalase, t-BuOH, DMF, 35 °C 
c conversion of acyl donor as determined by HPLC 
Not unexpectedly, under similar conditions the condensation of glycine amide and 
phenylalanine amide with the sterically hindered tetrabenzylated glycoamino acid 
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methyl ester 3 proceeded extremely slow (40% conversion of 3 after 8 days) and did 
not lead to a satisfactory yield of the desired dipeptides 8 and 910 (Table 6.3, entries 2 
and 4). In contrast, chemical amide bond formation was not sensitive to the sterical 
bulk of the glycoamino acid and proceeded without incidence in good yield (entries 1 
and 3). 
Table 6.4 Chemoenzymatic condensation of T1P and T1M methyl esters 10 and 11 
O
AcO
AcO
AcO
OAc
N
NN
CbzHN CO2Me
( )n
alcalase
solvent, 35 °C
O
AcO
AcO
AcO
OAc
N
NN
CbzHN
( )n
O
H2N NH2
O
R
H
N
NH2
O
R10 n = 3
11 n = 1  
entry R n solvent time ester (%)a impurities (%)a peptide (%)a 
1 H 3 t-amyl-OH 24 h 87 4 12      9 
2    48 h 84 4 12 
3    9 d 57 9 34 
4 CH2Ph 3 t-amyl-OH 24 h 67 10 13     23 
5    48 h 54 19 27 
6    9 d 4 88 8 
7 H 1 t-BuOH, DMF 20 h 100 0 14      0 
8    4 d 58 19 23 
9    8 d 42 21 37 
10    14 d 16 26 58 
11    15 d 0 34 66 
12 CH2Ph 1 t-BuOH, DMF 2 h 93 - 15      7 
13    20 h 61 - 39 
14    4 d 6 - 94 
15    6 d 6 - 94 
a Based on HPLC analysis 
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Replacement of the bulky benzyl protecting groups to less hindered acetyl functions 
was expected to give some increase in enzyme activity. Indeed, as shown in Table 6.4 
(entries 1-3 and 4-6), a small increase in yield with respect to benzyl protection is 
accomplished, although the isolated yields were still not satisfactory. 
Much to our surprise, altering the glycoamino acid from triazolylpropylglycine (T1P; 
n = 3) to a CTGA with a shorter side-chain (T1M; n = 1) and coupling with glycine 
amide and phenylalanine amide now gave the desired dipeptides with significantly 
enhanced yields after prolonged stirring (14, entries 7-11 and 15, entries 12-15, 
respectively). Interestingly, the coupling of phenylalanine amide with tetraacetylated 
glycoamino acid 11 proceeded in near quantitative yield to form 15, while the 
coupling with glycine amide to form 14 was a little more troublesome but still led to 
the desired dipeptides in satisfactory yield. 
The latter chemoenzymatic coupling was followed closely by RP-HPLC as visualized 
in Figure 6.1. From the graph, it becomes clear that although complete conversion of 
T1M 11 is attained with 66% formation of the dipeptide 14, an increasing amount of 
an impurity is also observed, reaching 34%after 15 days of stirring. 
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Figure 6.1 Chemoenzymatic conversion of 11 (♦) to 14 (■) and the formation of unidentified 
impurities (▲) 
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Unfortunately, the identity of the impurity could not be established, although it was 
clear that chemoenzymatic hydrolysis of starting material was not an issue. Since 
glycine amide was added in excess to the reaction mixture, formation of a tripeptide 
(T1M(GlcAc4)-Gly-Gly-NH2) might be one of the possibilities. The dipeptides 14 and 
15 were isolated, after crystallization, in 65% and 98% yield respectively. 
6.3 Conclusions 
A chemoenzymatic coupling strategy was successfully applied to the preparation of 
triazole-linked glycodipeptides. In particular, alcalase-induced condensation of an 
acetyleno- or azidoalkylamino acid methyl ester with an amino acid amide 
proceeded with high conversion and good yield. For the chemoenzymatic 
condensation of carbohydrate-substituted triazolylamino acids (CTGAs) optimal 
results were obtained with a carbohydrate component protected with acetyl 
functions rather than benzyl groups, an observation that may be rationalized in 
terms of either lipophilicity or steric factors, or a combination thereof. Finally, it was 
found that amino acid methyl esters with a shorter side-chain length afforded the 
desired dipeptides with good to excellent yield. 
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6.5 Experimental section 
General information 
Before use in the coupling reactions, L-Phe-NH2 was dried by coevaporation with 
DMF (2 × 5 mL per mmol) and Gly-NH2·HCl was first neutralized by treatment with 
1 equiv of NaOMe (25% in MeOH) in EtOH (0.5 M), subsequently isolated as solid 
(Gly-NH2) by filtration and evaporation, and repeated coevaporation with toluene. 
t-BuOH was dried by distillation under reduced pressure and kept under nitrogen. 
Alcalase was obtained from Novo Industrial (Denmark) as a brown aqueous liquid. 
For the hydrolysis experiments this enzyme solution was used as such. For the 
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(anhydrous) peptide coupling reactions the water in the alcalase solution was 
removed using the method of Chen et al.7 As a matter of fact, the aqueous alcalase 
(0.5 mL) and absolute ethanol (1.0 mL) were mixed in an Eppendorf cup and the 
resulting suspension was agitated on a Vortex mixer for 5 min and centrifuged 
(3000 rpm) for 10 min to spin down the enzyme. The supernatant was decanted and 
the enzyme resuspended in absolute EtOH (1.0 mL), agitated for 5 min on a Vortex 
mixer and spun down by centrifugation. This procedure was repeated once with 
absolute EtOH (1.0 mL) and finally once with dry t-BuOH (1.0 mL). The resulting 
enzyme was resuspended in t-BuOH (1.0 mL) for use in the chemoenzymatic peptide 
coupling reactions. All other commercially available reagents were used as received. 
HPLC analyses were performed with an Inertsil RP-18 column (25 × 0.46 cm) (RP-18, 
5 µm). For further general information, see section 2.6. 
General procedure for chemoenzymatic peptide coupling 
The N-Cbz-protected amino acid methyl ester (1 mmol) was dried by coevaporation 
with toluene and dissolved in t-BuOH (0.25 M). After adding a solution of Phe-NH2 
or Gly-NH2 (1.5 mmol) in DMF (1 M), the reaction mixture was stirred at 35 °C. 
Subsequently, the alcalase suspension in t-BuOH (1 mL) was added and the reaction 
mixture was stirred at 35 °C. Samples were taken at regular time intervals and 
analyzed by HPLC. After almost complete conversion of the methyl ester, the 
reaction mixture was concentrated. The residue was redissolved in EtOAc (50 mL) 
and H2O (20 mL), to which a few drops of 1 N aqueous HCl were added. The 
aqueous layer was extracted with EtOAc (30 mL) and the combined organic phase 
was washed with aqueous KHCO3 (1 M, 40 mL), aqueous HCl (1 N, 40 mL) and brine 
(40 mL), dried (Na2SO4) and concentrated. Analytically pure samples were obtained 
by recrystallization. 
General procedure for chemical peptide coupling 
Cbz-amino acid (1 mmol) was dissolved in DMF (2.5 mL). To the clear cooled (0-5 °C) 
solution was added DIPEA (0.35 mL, 2.1 mmol) followed by EDCI (211 mg, 
1.1 mmol) and HOAt (150 mg, 1.1 mmol) and the mixture was stirred for at least 0.5 h 
at 0-5°C. Subsequently, a solution of Phe-NH2 or Gly-NH2 (1.1 mmol) in DMF 
(2.5 mL) was added and the mixture was stirred for 1 h at 0-5 °C. The mixture was 
warmed to rt and stirred overnight. TLC analysis (EtOAc) showed complete 
conversion of the carboxylic acid starting material. The reaction mixture was 
partitioned between EtOAc (75 mL) and H2O (15 mL) to which a few drops of 1 N 
aqueous HCl were added. The aqueous layer was extracted with EtOAc (40 mL) and 
the combined organic phase was washed with 0.5 N aqueous HCl (40 mL), 1 M 
aqueous KHCO3 (40 mL) and brine (40 mL), dried (Na2SO4) and concentrated. 
Cbz-L-Orn(N3)-Gly-NH2 (4) 
 Chemical coupling, yield: 277 mg (80%). Chemoenzymatic 
coupling, yield: 325 mg (93%). Rf (EtOAc) = 0.39. 1H-NMR 
(400 MHz, CDCl3/MeOD) δ = 7.36-7.30 (m, 5 H), 5.13 (d, CbzHN
N3 ( )3 H
N
O
NH2
O
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J = 12.3 Hz, 1 H), 5.08 (d, J = 12.3 Hz, 1 H), 4.13-4.10 (m, 1 H), 3.93 (d, J = 17.1 Hz, 
1 H), 3.81 (d, J = 17.1 Hz, 1 H), 3.34-3.31 (m, 2 H), 1.94-1.62 (m, 4 H). IR (film) ν = 
3343, 2483, 2241, 2072, 1662 cm–1. HRMS (ESI) m/z calculated for C15H20N6O4Na 
(M+Na)+ 371.14437, found 371.14351. 
Cbz-L-Orn(N3)-L-Phe-NH2 (5) 
Chemical coupling, yield: 302 mg (69%). Chemoenzymatic 
coupling, yield: 339 mg (77%). Rf (2/1 EtOAc/heptane) = 0.29. 
1H-NMR (400 MHz, CDCl3/MeOD) δ = 7.38-7.17 (m, 10 H), 5.10 
(d, J = 12.3 Hz, 1 H), 5.06 (d, J = 12.3 Hz, 1 H), 4.63 (dd, 
J = 5.9, 8.4 Hz, 1 H), 4.04 (dd, J = 5.7, 8.0 Hz, 1 H), 3.25-3.16 (m, 3 H), 2.93 (dd, 
J = 5.5, 8.6 Hz, 1 H), 1.74-1.44 (m, 4 H). IR (film) ν = 3304, 2470, 2098, 1679, 1640 cm–1. 
HRMS (ESI) m/z calculated for C22H26N6O4Na (M+Na)+ 461.19132, found 461.19216. 
Cbz-L-propagylglycine-Gly-NH2 (6) 
 Chemical coupling, yield: 181 mg (60%). Chemoenzymatic 
coupling, yield: 244 mg (80%). Rf (EtOAc) = 0.39. 1H-NMR 
(400 MHz, CDCl3/MeOD) δ = 7.34-7.27 (m, 5 H), 5.12 (d, 
J = 12.3 Hz, 1 H), 5.08 (d, J = 12.3 Hz, 1 H), 4.28 (t, J = 6.5 Hz, 
1 H), 3.91 (d, J = 17.1 Hz, 1 H), 3.81 (d, J = 17.1 Hz, 1 H), 2.71 (ddd, 
J = 2.6, 6.2, 17.0 Hz, 1 H), 2.65 (ddd, J = 2.6, 6.8, 17.0 Hz, 1 H), 2.19 (t, J = 2.6 Hz, 1 H). 
IR (film) ν = 3291, 3066, 3036, 2941, 2409, 1658, 1532 cm–1. HRMS (ESI) m/z calculated 
for C15H17N3O4Na (M+Na)+ 326.11168, found 326.11042. 
Cbz-L-propargylglycine-L-Phe-NH2 (7) 
 Chemical coupling, yield: 536 mg (55%). Chemoenzymatic 
coupling, yield: 312 mg (79%). Rf (2/1 EtOAc/heptane) = 0.25. 
1H-NMR (400 MHz, CDCl3/MeOD) δ = 7.39-7.20 (m, 10 H), 5.10 
(s, 2 H), 4.65-4.62 (m, 1 H), 4.28-4.25 (m, 1 H), 3.20-3.15 (m, 1 H), 
3.00-2.95 (m, 1 H), 2.65-2.54 (m, 2 H), 2.12 (br s, 1 H). IR (film) 
ν = 3351, 2474, 2220, 2064, 1671, 1632 cm–1. HRMS (ESI) m/z calculated for 
C22H23N3O4Na (M+Na)+ 416.15863, found 416.15939. 
Cbz-L-T1M{4-[β-D-Glc(Ac)4]}-OMe (11) 
To a solution of Ac4Glc-acetylene (1.0 g, 2.8 mmol) and 
Cbz-L-Dap(N3)-OMe (0.78 g, 2.8 mmol) in t-BuOH (15 mL) 
and MeCN (2 mL) was added a mixture of Cu(OAc)2 
(112 mg, 0.56 mmol) and sodium ascorbate (218 mg, 
1.1 mmol) in water (15 mL), and the reaction was stirred 
overnight at rt, after the addition of EtOAc (250 mL) the mixture was washed with 
H2O (2 × 50 mL), brine (2 × 50 mL), dried (Na2SO4) and concentrated. Purification by 
gradient flash chromatography (MeOH in CH2Cl2 0 → 10%) yielded product 11 
(1.7 g, mmol, 96%) as a white solid. Rf (EtOAc) = 0.74. 1H-NMR (400 MHz, 
CDCl3/CD3OD) δ = 7.75 (s, 1 H); 7.41-7.29 (m, 5 H); 5.37 (t, J = 9.4 Hz, 1 H); 5.25 (t, 
CbzHN
N3 ( )3 H
N
O
NH2
O
Ph
CbzHN
H
N
O
NH2
O
CbzHN
H
N
O
NH2
O
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O
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AcO
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N
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O
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J = 9.7 Hz, 1 H); 5.18 (dd, J = 10.0, 9.4 Hz, 1 H); 5.12 (s, 2 H); 4.91-4.71 (m, 4 H); 4.28 
(dd, J = 12.5, 4.9 Hz, 1 H); 4.13 (dd, J = 12.5, 2.2 Hz, 1 H); 3.94 (ddd, 
J = 10.1, 4.8, 2.2 Hz, 1 H); 3.79 (s, 3 H); 2.07 (s, 3 H); 2.05 (s, 3 H); 2.02 (s, 3 H); 1.86 (s, 
1 H). 13C-NMR (75 MHz, CDCl3) δ = 170.5, 170.0, 169.7, 169.4, 169.0, 155.6, 144.3, 
135.8, 128.5, 128.2, 128.0, 123.2, 76.2, 73.7, 73.1, 71.3, 68.3, 67.3, 62.0, 53.9, 53.1, 50.7, 
20.6, 20.5, 20.3. IR (film) ν = 3356, 3140, 2950, 2885, 2250, 1748, 1532 cm-1. HRMS (ESI) 
m/z calculated for C28H34N4NaO13 (M+Na)+ 657.20201, found 657.19955. 
Cbz-L-T1M{4-[β-D-Glc(Ac)4]}-Gly-NH2 (14) 
Applying general method (with 0.37 mmol 11, and 
5 equiv. Gly-NH2) for chemoenzymatic peptide 
coupling gave 14 (165 mg; 65%). Rf (EtOAc) = 0.25. 
1H-NMR (400 MHz, CDCl3/CD3OD) δ = 7.93 (s, 1 H), 
7.33 (m, 5 H), 5.38 (t, J = 9.4 Hz, 1 H), 5.28 (t, 
J = 9.7 Hz, 1 H), 5.17 (t, J = 9.7 Hz, 1 H), 5.10-5.04 (m, 2 H), 4.90 (dd, J = 13.8, 4.5 Hz, 
1 H), 4.81-4.64 (m, 3 H), 4.28 (dd, J = 12.4, 4.8 Hz, 1 H), 4.12 (dd, J = 12.4, 2.1 Hz, 1 H), 
3.98 (ddd, J = 10.0, 4.8, 2.2 Hz, 1 H), 3.92 (d, J = 17.1 Hz, 1 H), 3.83 (d, J = 17.1 Hz, 
1 H), 2.05 (s, 3 H), 2.03 (s, 3 H), 2.00 (s, 3 H), 1.85 (s, 3 H). 13C-NMR (75 MHz, CD3OD) 
δ = 174.0, 172.3, 171.7, 171.3, 171.0, 145.4, 137.7, 129.5, 129.1, 129.0, 125.8, 77.1, 75.4, 
73.6, 72.9, 69.8, 68.1, 63.4, 56.2, 51.7, 43.2, 20.6, 20.5. IR (film) ν = 3330, 2955, 1744, 
1671, 1524 cm-1. HRMS (ESI) m/z calculated for C29H36N6NaO13 (M+Na)+ 699.22380, 
found 699.22173. 
Cbz-L-T1M{4-[β-D-Glc(Ac)4]}-L-Phe-NH2 (15) 
Applying general method (with 0.39 mmol 11, and 
5 equiv. Phe-NH2) for chemoenzymatic peptide 
coupling gave 15 (0.30 g; 98%).Rf (EtOAc) = 0.25. 
1H-NMR (400 MHz, CDCl3/CD3OD) δ = 7.81 (s, 1 H), 
7.41-7.14 (m, 10 H), 5.37 (t, J = 9.4 Hz, 1 H), 5.24 (t, 
J = 9.7 Hz, 1 H), 5.17 (t, J = 9.7 Hz, 1 H), 5.06 (s, 2 H), 
4.81-4.74 (m, 2 H), 4.66-4.60 (m, 3 H), 4.28 (dd, J = 12.5, 4.9 Hz, 1 H), 4.12 (dd, 
J = 12.4, 2.1 Hz, 1 H), 3.96 (ddd, J = 10.1, 4.7, 2.1 Hz, 1 H), 3.16 (dd, J = 13.9, 5.9 Hz, 
1 H), 2.95 (dd, J = 13.9, 8.3 Hz, 1 H), 2.06 (s, 3 H), 2.03 (s, 3 H), 2.01 (s, 3 H), 1.85 (s, 
3 H). 13C-NMR (75 MHz, CD3OD) δ = 175.1, 172.1, 171.5, 171.0, 170.8, 170.0, 157.5, 
145.0, 137.7, 137.3, 130.0, 129.3, 129.3, 129.0, 128.8, 128.6, 127.6, 125.4, 76.9, 75.1, 73.5, 
72.6, 69.5, 67.9, 63.2, 55.7, 55.4, 51.4, 38.5, 20.7, 20.6. IR (neat) ν = 3417, 3283, 2950, 
1748, 1697, 1636, 1532 cm-1. HRMS (ESI) m/z calculated for C36H42N6NaO13 (M+Na)+ 
789.27075, found 789.26506. 
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Summary 
Glycopeptides – conjugates of peptides with O- or N-glycans – are biologically active 
compounds which play an essential role in nature. However, the exact biological role 
and mode of action of these glycopeptides is still largely unsolved. This calls for the 
synthesis of specific glycopeptide fragments and application in biological systems in 
order to gain further inside into these matters. Since the natural sugar-peptide acetal 
linkage is readily cleaved by hydrolytic enzymes, it is also attractive to prepare 
glycopeptide mimics containing stable acetal isosteres. An example of such an 
isosteric replacement is the substitution of the native linkage by the unnatural C-
linker as shown in Scheme 1. 
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Scheme 1 Isosteric replacement of the native linkage in glycoamino acids and peptides by 
alkyne (A) and triazole (B) linkers, which both can be made from glycoacetylenes 
Glycoacetylenes, carbohydrate derivatives functionalized with an acetylene group at 
one of the ring-carbons, constitute a compound class that can be used as a versatile 
starting point for synthesizing C-glycosides, such as C-glycoamino acids and 
peptides. The research described in this thesis aims at using glycoacetylenes for the 
synthesis of different classes of stable glycopeptide mimics and their evaluation in a 
biological setting. 
Chapter 1 provides an overview of the synthesis of glycoacetylenes by a range of 
different methodologies. In general, the methods leading to glycoacetylenes comprise 
the application of nucleophilic metal acetylide addition to carbohydrate electrophiles, 
in particular at the anomeric carbon. A sophisticated choice of metal counterions (e.g. 
magnesium, lithium, zinc and tin) and conditions leads to the selective formation of 
either +- or β-configured glycoacetylenes. Glycoacetylenes can be applied in different 
ways for the synthesis of C-glycoamino acids. Examples given involve the synthesis 
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of alkane-, alkyne-, tryptophan-, and triazole-linked glycoamino acids, as well as 
conformationally restricted glycoamino acids. 
In Chapter 2, the synthesis of alkyne-linked glycoamino acids via ring-closing alkyne 
metathesis is investigated. Two different strategies are described to attach 
alkynylamino acids to an alkynylsugar, which may proceed either via a linker at O-4 
(Scheme 2, path A) or at O-9 (path B) of the alkynylsugar. Subsequent ring-closing 
alkyne metathesis of the O-4–linked diynes failed to proceed, but alkyne-linked 
glycoamino acids of varying chain length were effectively synthesized via 
attachment at O-9. 
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Scheme 2 Retrosynthesis of alkyne-linked glycoamino acid, by means of RCAM via O-4 
linkage (Path A) or O-9 linkage (Path B) 
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Chapter 3 delineates methodology for the synthesis of triazole-linked glycoamino 
acids and peptides based on the copper(I)-catalyzed azide acetylene cycloaddition of 
glycoacetylenes with azidoamino acids (Scheme 3). The resulting triazolyl 
glycoamino acids appeared suitable building blocks for the assembly of isosteric 
glycopeptides. An alternative route to such triazolyl glycopeptides was also 
developed by late-stage introduction of the carbohydrate portion, involving similar 
cycloaddition of glycoacetylenes with azidopeptides. 
Chapter 4 details the chemoenzymatic transglycosylation of C- and N-triazole-linked 
glycopeptides with a carbohydrate oxazoline donor under the action of the enzyme 
Endo A (Scheme 4). While the conversion of a small C-triazolyl glycodipeptide 
stopped at a conversion of 50%, the corresponding N-triazolyl derivative was 
converted to the corresponding pentasaccharide with an efficiency of 80%. Next, the 
same chemoenzymatic glycosylation procedure was successfully applied to a more 
complex glycopeptide, namely triazole-linked N-GlcNAc-modified peptide C34, 
which is present in the C-terminal fragment of HIV-1 gp41. The resulting novel 
triazole-linked glycopeptide appeared fully resistant to peptide N-glycanase 
(PNGase F), a serum peptidase that effectively digests the native amide-linked 
glycopeptide. 
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Scheme 4 Endo A-catalyzed glycosylation of GlcNAc-C34* 
Chapter 5 describes the synthesis of oligoglycosides by condensation of 
glycoacetylenes with tri- and hexaazidohexamethylbenzene in the presence of a 
copper-wired stirring rod. As depicted in Figure 1, the resulting triazole-linked 
oligosaccharides appear to form supramolecular gels, presumably by a combination 
of hydrogen bonding between the saccharide moieties and pi-pi stacking of the arene 
moieties, as indicated by molecular modeling. The trisaccharide gel was visualized 
using SEM, TEM and AFM techniques, all of which manifested the presence of 
intertwined fibers. 
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Figure 1 Triazole-linked trisaccharide aggregation to form supramolecular gels 
Chemoenzymatic peptide coupling of azide- and acetylene-containing amino acid 
methyl esters with natural amino acid amides under the influence of the enzyme 
alcalase was investigated in Chapter 6 (Scheme 5). Condensation appeared to proceed 
cleanly and in high yield. Incorporation of glycoamino acids in peptides was 
investigated for a range of different protective groups and side-chains, and was most 
successful for glycoamino acid esters with acetyl protecting groups (R1 = Ac) in 
combination with a short side-chain (n = 1). 
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Scheme 5 Chemoenzymatic coupling of glycoamino acid esters with glycine amide and 
phenylalanine amide 
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Samenvatting 
Glycopeptiden – conjugaten van peptiden met O- of N-glycanen – vervullen een 
belangrijke rol in cellulaire processen. Echter, de exacte biologische 
werkingsmechanismen van deze glycopeptiden zijn op moleculair niveau nog steeds 
grotendeels onopgelost. Dit vraagt om de synthese van specifieke glycopeptide 
fragmenten en hun toepassing in biologische systemen om verdere inzichten te 
verwerven in hun werking. Aangezien de natuurlijke acetaalbinding tussen suiker en 
peptide in een cellulaire omgeving snel kan worden verbroken door hydrolytische 
enzymen, is het aantrekkelijk om glycopeptide mimetica met stabiele acetaal 
isosteren te synthetiseren. Voorbeelden van een dergelijke isostere vervanging van 
de natuurlijke linker door stabiele onnatuurlijke linkers zijn weergegeven in 
Schema 1. 
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Schema 1 Isostere vervanging van de natuurlijke binding in glycoaminozuren en peptiden 
door alkyn (A) en triazool (B) linkers, die beide gemaakt kunnen worden uit glycoacetylenen 
Glycoacetylenen, koolhydraten gefunctionaliseerd met een acetyleen groep aan één 
van de ringkoolstoffen, vertegenwoordigen een klasse van verbindingen die gebruikt 
kunnen worden als startpunt voor de synthese van diverse C-glycosiden zoals C-
glycoaminozuren en peptiden. Het onderzoek in dit proefschrift richt zich op het 
gebruik van glycoacetylenen voor de synthese van verschillende klassen van stabiele 
glycopeptide mimetica en het bestuderen van de biologische eigenschappen van 
enkele daarvan. 
Hoofdstuk 1 geeft een literatuuroverzicht van verschillende methoden voor de 
synthese van glycoacetylenen. Meestal betreft dit de toepassing van een nucleofiele 
additie van een metaalacetylide op een suikerelectrofiel, in het bijzonder op het 
anomere koolstofatoom. Een geraffineerde keuze van condities en metaalionen 
(waaronder magnesium, lithium, zink en tin) leidt selectief tot vorming van het -- of 
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β-glycoacetyleen. Glycoacetylenen kunnen op verschillende manieren worden 
toegepast in de synthese van C-glycoaminozuren. Voorbeelden zijn onder meer 
alkaan-, alkyn-, tryptofaan-, en triazool-gelinkte glycoaminozuren, alsmede 
conformationeel vastgelegde glycoaminozuren. 
In Hoofdstuk 2 is de synthese van alkyn-gelinkte glycoaminozuren via 
ringsluitingsalkynmetathese (RCAM) onderzocht. Twee verschillende strategieën 
zijn beschreven om alkynylaminozuren te koppelen met alkynylsuikers, nl. via een 
linker aan O-4 (Schema 2, optie A) of aan O-9 (optie B) van de alkynylsuiker. RCAM 
van de O-4 gelinkte diyn leidde niet tot een succesvol resultaat, maar gelukkig gaf 
toepassing van dezelfde condities op de O-9 gelinkte diynen wel de overeenkomstige 
alkyn-gelinkte glycoaminozuren van verschillende ketenlengte. 
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Schema 2 Retrosynthese van alkyn-gelinkte glycoaminozuren middels 
ringsluitingsalkynmetathese via een O-4 linker (optie A) of een O-9 linker (optie B) 
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Schema 3 Synthese van triazool-gelinkte glycoaminozuren en peptiden 
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In Hoofdstuk 3 is methodologie beschreven voor de synthese van triazool-gelinkte 
glycoaminozuren en peptiden gebaseerd op de koper(I)-gekatalyseerde azide 
acetyleen cycloadditie (CuAAC) van glycoacetylenen met azidoaminozuren  
(Schema 3). De resulterende triazolyl glycoaminozuren blijken geschikte bouwstenen 
te zijn voor de bereiding van de overeenkomstige grotere glycopeptiden. Een 
alternatieve route voor de synthese van deze triazolyl glycopeptiden verloopt via 
latere introductie van het koolhydraatfragment middels dezelfde cycloadditiereactie 
van glycoacetylenen met in dit geval azidopeptiden. 
Hoofdstuk 4 beschrijft de chemoenzymatische transglycosylering van C- en N-
triazool-gelinkte glycopeptiden met een oxazoline-geactiveerd koolhydraat onder 
invloed van het enzym Endo A (Schema 4). Terwijl de conversie van een C-triazolyl 
glycodipeptide stopte bij 50%, werd het vergelijkbare N-triazolylderivaat omgezet 
naar het overeenkomstige pentasaccharide met een efficiëntie van 80%. Dezelfde 
chemoenzymatische glycosyleringsprocedure werd ook succesvol toegepast op een 
meer complex glycopeptide, het triazool-gelinkte N-GlcNAc-gemodificeerde peptide 
C34, dat voorkomt in het C-terminale fragment van HIV-1 gp41. Het resulterende 
nieuwe triazool-gelinkte glycopeptide bleek volledig stabiel in aanwezigheid van 
peptide N-glycanase (PNGase F), een serum peptidase dat het overeenkomstige 
natuurlijke amide-gelinkte glycopeptide efficiënt hydrolyseert. 
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Schema 4 Endo A-gekatalyseerde glycosylering van GlcNAc-C34* 
In Hoofdstuk 5 is de synthese van oligosacchariden door condensatie van 
glycoacetylenen met tri- en hexaazidohexamethylbenzeen in de aanwezigheid van 
koperdraad beschreven. Zoals weergegeven in Figuur 1, bleken de gevormde 
triazool-gelinkte oligosacchariden supramoleculaire gels te vormen, waarschijnlijk 
door een combinatie van waterstofbruggen tussen de saccharide fragmenten en pi-pi 
stacking van de areen eenheden, zoals blijkt uit berekeningen. De trisaccharide gel 
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werd gekarakteriseerd met de technieken SEM, TEM en AFM, die allen de 
aanwezigheid van verstrengelde fibers bevestigden. 
 
Figuur 1 Triazool-gelinkte trisaccharide aggregatie leidt tot tot supramoleculaire gels 
Chemoenzymatische peptidekoppeling van azide- en acetyleen-bevattende 
aminozure methylesters met natuurlijke aminozuuramiden onder invloed van het 
enzym alcalase is onderzocht in Hoofdstuk 6 (Schema 5). Deze condensatie bleek heel 
schoon te verlopen en in hoge opbrengst. De inbouw van glycoaminozuren in 
peptiden werd voor verschillende beschermgroepen en zijketens onderzocht en bleek 
het meest succesvol voor glycoaminozure esters met een acetyl beschermgroep 
(R1 = Ac) in combinatie met een korte zijketen (n = 1). 
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Schema 5 Chemoenzymatische koppeling van glycoaminozure esters met glycine amide en 
phenylalanine amide 
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Dankwoord 
Dan nu eindelijk het gedeelte van het boekje wat niet meer onder invloed van zeer 
grote hoeveelheden koffie geschreven hoeft te worden, maar waar ik in alle rust aan 
kan werken onder het genot van niets minder dan een heerlijk koud glas bier! 
Floris Rutjes en Floris van Delft, allereerst wil ik jullie bedanken voor het vertrouwen 
dat jullie in mij hebben gehad, door mij een promotieplaats aan te bieden in jullie 
jonge, dynamische en voortvarende groep. Ik heb de afgelopen jaren hier met veel 
plezier deel van uit mogen maken. Het was een zeer leerzame tijd, waarin jullie veel 
ontplooiing hebben geboden door de vele inhoudelijke werkbesprekingen, problem 
evenings, samenwerkingen met bedrijven en andere instituten en de geboden 
mogelijkheden voor congresbezoeken. Ook ben ik jullie dankbaar voor de afspraken 
die we samen hebben gemaakt voor de correcties van de hoofdstukken en het snelle 
en zeer grondige corrigeren, waardoor ik in de afronding van mijn 
promotieonderzoek ook nog veel heb mogen leren. 
Ik wil graag de mensen bedanken die hebben bijgedragen aan de inhoud van dit 
proefschrift:  
Jeroen (hofleverancier van de klassieke fouten borrel), ik wil je bijzonder bedanken 
voor jouw bijdrage aan het gehele hoofdstuk 5 van dit boekje. Je hebt in een 
synthetisch georiënteerde groep zeer veel werk verricht aan een fysisch chemisch 
onderwerp, waar we samen veel van hebben geleerd. Je hebt daarbij je leven 
gewaagd aan een chemisch niet ongevaarlijk stofje, waarbij je op eigen initiatief ook 
nog graag proefondervindelijk hebt willen vast stellen hoe explosief het hexa-azide 
wel niet is. Je hebt een mooie stap gemaakt door een promotieplaats te bemachtigen 
in Delft, succes hiermee en ik kijk uit naar jouw boekje over een paar jaar. 
Marta, thanks a lot for the work you did during your traineeship with me. You were 
always positive and happy and therefore I think you were the sunshine in the lab. It 
was also nice to learn some Spanish in the meantime (and I think that also counts for 
Sander): muchos gratias per tot! It is good to hear that you started your own PhD in 
Madrid, good luck the comming years!  
Bas van den Broek, je hebt een substantiële bijdrage geleverd aan hoofdstuk 2 en 
daarmee heeft je stageonderzoek een leuke publicatie opgeleverd (zij het pas na 
enkele jaren). Eigenlijk wel bizar dat je dit werk hebt gedaan, terwijl wij samen stage 
liepen in de groep van FvD. Bedankt en ook jij succes met de afronding van je 
promotieonderzoek. 
Maarten, bedankt voor de RCAM kat en dat je mij op gang hebt geholpen met de 
metathese en me de kneepjes hebt geleerd. 
Brian, ik wil je graag bedanken als partner in crime in het glycopeptide project  
(ik lees net in jouw eigen dankwoord dat je precies dezelfde bewoording hebt 
gebruikt :-). We hebben samen gezorgd voor een leuk stuk onderzoek en een zeer 
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aardig lijstje publicaties. We waren het niet altijd met elkaar eens, maar hebben toch 
een goede promotietijd gehad samen en veel van elkaar geleerd. 
Tevens wil ik iedereen, waarmee ik vanuit het SenterNovem project en het gp41 
onderzoek heb samengewerkt, bedanken: 
De DSM-ers: Peter Quaedflieg, Bernard Kaptein, Rinus Broxterman, Hans 
Schoemaker, Roel Wiertz, Harlof Roelen en Christine Hawner, bedankt voor jullie 
inbreng en hulp bij de enzymatische koppelingen en jullie gastvrijheid waardoor we 
(Brian en ik) enkele weken bij jullie hieraan hebben kunnen werken. PQ, en 
natuurlijk ook Freia, in het bijzonder wil ik jullie bedanken voor jullie gastvrijheid. 
Jullie hebben goed begrepen dat het altijd beter is om niet in een hotel te verblijven, 
maar dat je die tijd beter kunt benutten als PaiO bij de familie Quaedflieg. 
De Chiralici: Richard, Denis, Jasper, Peter, Christien, Bas en Roel het was een leuke 
en goede tijd om samen met een aantal van jullie het lab te mogen delen, alleen 
jammer dat we in de loop van de tijd wat (fysiek) uit elkaar zijn gegroeid. Van de 
Universiteit van Maastricht wil ik Tilman Hackeng en Wenke Adriaens bedanken 
voor de hulp bij de peptide synthese en de gastvrijheid van het zuiden waardoor ik 
tot 2 keer toe ben afgereisd om de C34 in elkaar te sleutelen. Met succes!  
I would like to thank prof. Lai-Xi Wang and Dr. Wei Huang, from the University of 
Maryland, for their chemoenzyamtic glycosylation reactions and the stability 
testing’s, I hope that the good results will be published soon, and that this research 
will lead to more interesting results in the future. 
Jan van Hest, Martin Feiters, graag wil ik jullie bedanken dat jullie plaats hebben 
willen nemen in mijn manuscriptcommissie samen met dr. Paul Murphy, whom I 
also would like to thank. 
Door een aantal verhuizingen zijn er een flink aantal mensen waarmee ik het lab heb 
mogen delen, die ik dan ook graag wil bedanken voor hun aanwezigheid en 
gezelligheid: Henri (in opperste staat van concentratie krullen in het haar draaiend), 
Ton (geïntimideerd door al die tukkers om zich heen), Susan (voor en na de 
verhuizing labgenoten op een lab met klassieke fouten) en Hester bedankt voor een 
goede vriendschap, ontstaan toen we elkaar bij DSM en in het AMVJ hebben leren 
kennen, die er tevens voor heeft gezorgd dat je Nijmegen bij mij onder de aandacht 
hebt gebracht met als gevolg dat ik er ben gaan studeren en promoveren. En 
natuurlijk in het Huygenslab: Koen, Jasper, Marcel, Bram, Guido, Valeria, Jordy (met 
je eervolle eerste paarse kleuren in het nieuwe gebouw), Silvie, Marjoke, Henri, Bas 
vd Lee, Heleen, Dennis (toch leuk om te horen dat het foute uurtje nog steeds op het 
lab leeft), Rik (natuurlijk als ministage-student bij mij en later bij Brian). 
Ook de overige mensen van de Rutjes groep bedankt voor de leuke tijd: Jando, Bas 
Gruijters (M.I.B.) Roel (M.I.B. II; heb je al weer een bestemming voor je volgende 
fietsvakantie gevonden?), Jorge (hoeveel tosti-ijzers heb je al versleten?), Sjef (oude 
en nieuwe stijl!), Claudia (ik regel dat wel even), Bas Sjlieps, Guuske (als collega 
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maar natuurlijk ook tijdens mijn stage aan jouw “sexmembered” rings), Daniel 
Girones (nice trip to Glasgow), Dani “knows-it-all” Blanco, Marloes, Bart, Roy, 
Waqar, Anup, Lieke, Rutger, Kaspar&Pieter (succes met jullie ‘toekomst-chemie’), en 
natuurlijk Martijn (De MSN sessies waren een vast ritueel tijdens het schrijven en gaf 
toch het idee dat je er niet alleen voor stond). Tevens wil ik ook de overige mensen 
van de afdeling Moleculaire Chemie bedanken: Matthijs &Irene (Beter een verre buur 
EN een goede vriend), Jaap&Paul (gastronomisch goed te verwennen en zelf ook 
prima culinaire verwenners), Ton&Susanne (jammer dat jullie Nijmegen hebben 
moeten verlaten, maar gelukkig is Weert maar een uurtje rijden), Joost&Annemiek, 
Richard, Hans Elemans (bedankt voor de goede feedback bij hoofdstuk 5), Johan, 
Nico, Marco (Capo), Andrés, Heather, Pili, Marta (Andalusië was echt geweldig!), 
Maria (bedankt voor al je Spaanse invloeden en gastvrijheid, zowel hier als ook zeer 
zeker in Castellón), Marc, Linda, Erik, Alexander, Friso, Joost&Steffie (bootsmaatjes), 
Joris, Rosalie, Sanne, Hans Adams, Dennis Löwik, Dennis Vriezema, Lee, Dennis 
Lensen, Onno, Paul Schlebos, Theo Peters, Paul Kouwer en alle mensen van de 
afdeling die ik niet expliciet heb genoemd. Verder wil ik nog graag de volgende 
mensen bedanken voor hun algemene (en onmisbare) rol op de afdeling: Peter van 
Dijk (keep on smiling), Heleen, Peter van Galen, Ad Swolfs, Pieter van de Meer, 
Desiree en last but not least Jacky (altijd gezellig om even bij te kletsen als ik weer 
eens wat van je nodig had :-). 
Graag wil ik daarnaast iedereen bedanken die een bijdrage heeft geleverd aan de 
hieronder genoemde zeer vele events ter ontspanning en afleiding de afgelopen 
jaren: bowling competitie, zeilen, BBQ’s, etentjes, Nijmegen-Eindhoven cup, 
volleybal, squash, labuitjes, rutjesbowling, 4 daagse intocht, promotiefeestjes, 
congressen, Lunteren, problem evenings, klassieke fouten-, tour-, 1e vrijdag v.d. 
maand-, spontane lab-, kerst-, Spanish-, voetbal-, afscheids-, demolition- en zomaar-
borrels. 
Terwijl ik dit zo schrijf bedenk ik mij dat heel veel vriendschappen zijn ontstaan met 
mensen waarmee ik het lab heb mogen delen, daaruit trek ik dan ook de conclusie 
dat op het lab dus niet alleen chemische preparaten worden gesynthetiseerd maar 
ook goede vriendschappen! Van deze vriendschappen wil ik er toch twee in het 
bijzonder noemen, en wel mijn paranimfen Sander en Richard. 
Sander, de afgelopen jaren zijn toch wel uitgegroeid tot een onmeunig goede 
vriendschap en uiteraard wil ik je bedanken voor je open mening (vaak wel 
onbesproken dezelfde als mijn eigen), de vele goede gesprekken, een zeer geslaagde 
vakantie, menig potje squash en natuurlijk veel meer van bovenstaande events, 
kortom een echte huisvriend! 
Richard Blaauw (toch bewust nog even je achternaam noemen om te laten zien dat 
met de spelling niets mis is!), naast het feit dat je inhoudelijk regelmatig betrokken 
bent geweest bij het werk waar dit boekje een resultaat van is, is door vele 
gezamenlijke interesses (waaronder zeilen, borrels en uiteraard de fenomenale 
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kookkunsten toch wel uitblinken) een mooie vriendschap ontstaan, waarvan ik zeker 
weet dat die niet makkelijk zal slijten! 
Pa & ma, bedankt voor alles, en ik moet er toch vaak weer om lachen als jullie me 
voor de zoveelste keer vragen wat ik nou precies heb gedaan de afgelopen jaren. 
Geloof me, ik ben ook wel blij dat ik nu eindelijk klaar ben met de ‘studie’. 
Stephan&Yvon jullie hebben altijd veel interesse getoond in de voortgang van mijn 
onderzoek en dit boekje, dat ik altijd zeer heb gewaardeerd.  
Manon&Tom, Bas&Nadine (ook nogmaals bedankt voor de supermooie kaft die je 
hebt ontworpen!), Léon-Matthieu (natuurlijk ook jouw correcties aan een voor jou 
onbegrijpelijke inhoud) en Antoine Julien bedankt voor jullie steun op afstand 
(hoewel de afstand Hengelo, Haaksbergen, Zwolle en Enschede tot Nijmegen niet zo 
groot is; ja OK Karlstad/Stockholm wel). 
En als laatste en zeker de meest belangrijke persoon wil ik Manon bedanken. Manon, 
met je uiterst zorgzame karakter heb je me de afgelopen jaren zeer veel gesteund. Er 
zullen vast wel eens momenten zijn geweest waarop je dacht dat dit ‘dekselse’ 
proefschrift op de 1e plaats kwam en jijzelf op de 2e plaats, maar ik neem aan dat ik 
het tegendeel heb weten te bewijzen door je in San Francisco enigszins onverwacht 
ten huwelijk te vragen en met jou te trouwen ruim voordat dit boekje af was! Een 
goede stap waarvan ik zeker weet dat die Cablecar nog lang zal rijden! 
 
Allen, hef het glas en Proost! 
Stan 
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